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Osteoarthritis is a multifactorial disease characterised by the degradation of cartilage and 
bone tissue within the joint. Research into novel therapies is currently limited by the 
throughput and replicative accuracy of early-stage in vitro disease models.  
Biofabrication represents an emerging technology which allows for the selective deposition 
of cells and material in order to create complex cell-laden structures. The aim of this 
research was to characterise a combination of inkjet and valve-based drop-on-demand 
printing processes for the construction of osteoarthritis tissue models. 
An inkjet printing platform was characterised to deposit material at the picolitre-scale. Single 
cell printing was achieved, with biological analysis confirming that the printing process does 
not significantly affect cellular viability or function. 
A valve printing process was applied for the production of cellular aggregates that could be 
used for both in vitro osteoarthritis research and in vivo therapeutic applications. Reliable 
jetting performance was demonstrated, enabling material deposition at the nanolitre-scale. 
Cell printing was achieved across a concentration range of 1-20 million cells per mL, with 
biological analysis of printed cells revealing no significant effects on viability or function. No 
discernible impact on aggregate tissue structure was observed as a result of the printing 
process, confirming its suitability for the manufacture of tissue aggregates. 
A bioprinted co-culture tissue model comprised of mesenchymal stromal cell and 
chondrocyte cell types was successfully generated using a 3D insert culture format. Cell 
proliferation was maintained over a 14 day period, alongside an increase in tissue density 
and cellular organisation. 
In combination, this research has demonstrated the suitability of inkjet and valve printing 
processes to selectively deposit cells. Bioprinted aggregate and insert-based 3D tissue 
models were validated using the valve printing technique, providing an effective method to 
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Chapter 1. Introduction 
Osteoarthritis (OA) is a chronic disease that involves the breakdown of cartilage and bone 
tissue within the joint. Current treatment strategies range from holistic approaches to 
strengthen the underlying joint and manage pain to full joint replacement surgery (National 
Institute for Health and Care Excellence, 2014). Although the development of novel 
pharmaceuticals and cellular therapies provide promising alternatives to traditional 
treatment methods, further research is required to fully ascertain the causes and 
mechanisms of the disease, as well as to explore the efficacy of therapies currently under 
development (Loeser, Collins and Diekman, 2016; Mobasheri and Batt, 2016; Armoiry et al., 
2019). 
In order to perform such research, developments within the field of in vitro tissue modelling 
are essential, as novel OA models may provide a mechanism by which it would be possible to 
facilitate the high-throughput screening of drug candidates or therapies in a short time span, 
and at a low cost to the end user. However, a current challenge in in vitro modelling is the 
ability to generate models which are user-friendly, scalable, and wholly replicative of the OA 
joint in vivo (DiMasi, Grabowski and Hansen, 2016). 
A key feature of 3D in vitro models is the ability to recapitulate the spatial organisation and 
cell-cell contact that exists within in vivo living tissue, a feature that is lost with traditional 2D 
monolayer culture approaches. Techniques which support this approach include aggregate 
culture, and those that utilise supportive inserts as exogenous extracellular matrix to 
improve cellular support (McMurtrey, 2016; Nath and Devi, 2016; Melissaridou et al., 2019). 
However, in spite of these developments, such 3D formats are currently limited to low-
throughput applications due to the labour-intensive requirements during setup, and 
increased cost and complexity when compared to traditional 2D culture techniques (Joshi 
and Lee, 2015). 
Biofabrication is an emerging field in which liquid handling and additive manufacturing 
processes are applied for the deposition of cells and materials to generate cell-laden 
structures. A range of different techniques have been developed to enable the selective 
deposition of cellular material, including inkjet, valve, laser-assisted and extrusion based 
processes. These techniques have been successfully utilised to generate cell, tissue and 




Of these techniques, droplet-based processes such as inkjet and valve printing show the 
most potential for cell printing applications due to the inherent scalability of each process, 
comparatively low cost of operation and demonstrated biocompatibility with a range of cell 
types (Xu et al., 2005; Gudapati, Dey and Ozbolat, 2016; Tse et al., 2016). 
Early research by Wilson and Boland first investigated the potential of using inkjet printing 
technology to deposit a combination of cell types in 2003 (Wilson and Boland, 2003). More 
recent projects, such as the work by Park et al. in 2017, have demonstrated that the inkjet 
printing process can be used to deposit a range cell types with a sufficient accuracy and 
precision to enable the production of complex cellular patterns without affecting cellular 
viability (J. A. Park et al., 2017). 
Valve printing processes have also been explored for the deposition of cellular material. 
Indeed, work by Faulkner-Jones et al. in 2013 successfully demonstrated the application of 
valve printing processes to generate cellular aggregates. This is further supported by work 
from Lee et al. in 2014, which used these techniques to generate human skin equivalents, 
and Horvath et al. in 2015 to construct an in vitro human alveolar tissue model (Faulkner-
Jones et al., 2013; Lee et al., 2014; Horvath et al., 2015). 
Despite such research however, droplet-based techniques are currently limited by the lack of 
process validation for cell printing applications, as well as the associated nozzle clogging and 
performance issues that have been reported when dispensing cell-containing ink solutions 
(Parsa et al., 2010; Chahal, Ahmadi and Cheung, 2012). In addition, little is known about the 
impact of mechanical forces induced by each printing process on cell types, and moreover 
how these factors might influence the mechano-responsive cell types involved in in vitro OA 
models. 
Nevertheless, droplet-based bioprinting techniques present a range of opportunities to 
automate and scale up the manufacture of in vitro tissue models for osteoarthritis research, 






1.1 Aims and Objectives 
The overall aim of this thesis is to evaluate the potential of using bioprinting techniques for 
the construction of in vitro osteoarthritis tissue models. 
To achieve this aim a number of specific objectives are defined: 
1. To evaluate the performance of an inkjet printing process for the selective deposition 
of cellular material 
2. To characterise the cell printing performance of a valve printing technique 
3. To assess the effects of each printing process on cellular viability and function 
4. To apply droplet-based bioprinting processes to manufacture tissue aggregates 
5. To print and characterise a novel cartilage tissue model for osteoarthritis research 
1.2 Thesis Structure 
This thesis is organised into 7 chapters with chapter 1 providing an introduction to the 
research area alongside the aims and objectives defined for this project. 
Chapter 2 provides a literature review of the underlying concepts of the thesis. This includes 
a review of osteoarthritis pathophysiology, treatment and available disease models, 
alongside considerations surrounding high-throughput screening. Information is provided on 
the field of biofabrication, with a focus on drop-on-demand bioprinting processes and bioink 
design, in order to explore its suitability for high-throughput model generation. 
Chapter 3 contains the methodologies for work performed in this thesis, including the 
biological culture and analysis techniques used across the individual chapters. In addition, 
this chapter provides an overview of the bioprinting setup used for inkjet and valve printing 
applications. 
Chapter 4 presents novel research into the application of a piezoelectric inkjet printing 
technique for the selective deposition of single cells. Material and cell printing performance 
characterisation is presented in response to changes in printer parameters. Evaluation of the 
biocompatibility of the inkjet printing process is also reported, alongside a combination of 
novel methods to reduce cellular agglomeration during printing. 
Chapter 5 reports an investigation into the application of a drop-on-demand valve printing 




characterisation is presented alongside biological analysis of printed cells and tissue 
aggregates. 
Chapter 6 presents a bioprinted osteoarthritis tissue model generated using the valve 
printing process upon well-based inserts, alongside biological characterisation of the culture 
format. 
Chapter 7 provides an overall discussion on the results displayed within this thesis and their 
impact on the fields of biofabrication and osteoarthritis research. It also provides 





Chapter 2. Literature Review 
2.1 Osteoarthritis 
2.1.1 Significance 
Osteoarthritis is a chronic joint disease characterised by the degradation of cartilage and 
underlying bone that leads to disability and pain as the disease progresses. It is most 
common amongst load-bearing joints within the knee, hip, hands and spine, with age-related 
articular tissue changes having been shown to contribute to disease pathophysiology 
(Loeser, Collins and Diekman, 2016). Globally, OA was responsible for approximately 17.1 
million years lived with disability in 2010, representing an increase of 64 % since 1990 (Vos 
et al., 2012).  
The most common joint affected by the disease is the knee, with a global prevalence of 
radiographically confirmed symptomatic OA within this joint estimated to be 3.8 % (Cross et 
al., 2014). Peak incidence occurs at 50 years of age, with hip OA prevalence most strongly 
correlating with increasing age. Risk factors include obesity, age, ethnicity, female gender, 
joint injury, joint laxity, muscle weakness and reduced bone density (Chaganti and Lane, 
2011). 
2.1.2 Pathophysiology 
Osteoarthritis is a multifactorial disease whereby biochemical changes within the cartilage 
and underlying bone combine with morphological damage, resulting in gross cartilage tissue 
loss through degradative processes. Although not a causative agent, inflammation is 
considered critical in the pathogenesis of the disease. Inflammatory mediators such as 
cytokines and prostaglandins released by cartilage, bone and synovium result in local tissue 
changes and synovitis, a characteristic symptom in OA patients (Berenbaum, 2013). The 
bone tissue response is also thought to play a considerable role in the development of OA, 
characterised radiographically within this tissue by osteophyte formation, joint space 
narrowing, subchondral sclerosis and cyst formation (Kellgren and Lawrence, 1957). 





Figure 2.1  – Osteoarthritis development within an articular joint. Reproduced from (Glyn-
Jones et al., 2015). 
Osteoarthritis is thought to be initiated by non-physiological joint loading disrupting the 
homeostatic mechanisms that maintain a healthy joint. Risk factors presented in Figure 2.2 
such as ligament damage and joint laxity or weakness contribute towards this by causing 
abnormal alignment of the joint, increasing load on specific regions of cartilage. In addition, 
under-loading and over-loading are also known to induce degradative processes within 



































Figure 2.2 – A flow diagram depicting the pathogenesis of osteoarthritis. IL-1 – Interleukin-
1, TNF-alpha – Tumour necrosis factor alpha, NF-κβ – Nuclear factor kappa beta, MMP – 
Matrix metalloproteinase, ADAMTS - A disintegrin and metalloproteinase with 
thrombospondin motifs. Adapted from (Dieppe and Lohmander, 2005). 
Healthy cartilage is comprised of chondrocytes and extracellular matrix (ECM), which 




and Richardson, 2008). Type II collagen is the most abundant ECM component within 
articular cartilage tissue and accounts for approximately 50 % of the total protein content. 
The fibril network of collagen provides tensile strength to the tissue during loading. 
Aggrecan is also an integral ECM component, conferring resistance to compressive forces 
during joint loading. Variations in chondrocyte cell density, size, shape, maturation status 
and orientation are present across different regions within cartilage tissue, alongside 
differences in ECM fibre composition, orientation and density. This is highlighted in the 
diagram in Figure 2.3 below. 
 
Figure 2.3 – Diagram displaying the stratification of hyaline cartilage tissue into different 
regions. Variations in ECM composition and fibre orientation, alongside chondrocyte cell 
density, maturation status, shape, size and orientation are present between each region. 
Reproduced from (Cova and Toffanin, 2002). 
Biochemical processes within the joint can damage cartilage ECM and increase catabolic 
activity in response to initiating factors such as those highlighted in Figure 2.4, leading to 
development of OA. Enzymes responsible for the breakdown of ECM collagen fibrils and 
proteoglycans include matrix metalloproteinases (MMPs) and a disintegrin and 
metalloproteinase with thrombospondin motifs (ADAMTS) (Cawston and Wilson, 2006; 
Rengel, Ospelt and Gay, 2007). Specific isoforms of the enzymes implicated in osteoarthritis 




space, and collagenases MMP-1 and 13, which are secreted by macrophage, fibroblast and 
chondrocyte cells (Cawston and Wilson, 2006; Gendron et al., 2007).  
However, it’s important to appreciate that whilst MMP activity may be significant 
pathologically, MMP activity is also crucial within a healthy joint, whereby they initiate 
osteoclastic resorption by removing surface collagen from bone tissue prior to 
demineralisation (Rengel, Ospelt and Gay, 2007). This process is balanced against the 
functionality of osteoblasts which synthesise crosslinked collagen, osteocalcin, osteopontin 
and hydroxyapatite to generate mineralised bone tissue. As such, MMP inhibition therapies 
can only be used for the treatment of OA if drug action can be selectively targeted towards 
degradative processes.  
Aggrecan degradation occurs via the activity of differentially regulated ADAMTS-4 and 
ADAMTS-5 aggrecanases. Conflicting research exists in determining the enzyme primarily 
responsible for the development of osteoarthritis, with the results of animal models 
contrasting with those of human studies (Glasson et al., 2005; Gendron et al., 2007). 
ADAMTS-5 has been demonstrated to have a greater role in proteolysis of ECM and is 
constitutively expressed. However, ADAMTS-4 has been shown to respond to interleukin-1 
beta (IL-1β) and tumour necrosis factor-alpha (TNF-α), with its upregulation transcriptionally 
dependant on nuclear factor-kappa beta (NF-κβ), a key signalling molecule elevated during 





Figure 2.4 – The nuclear factor-kappa beta (NF-κβ) signalling network in osteoarthritis. 
Reproduced from (Rigoglou and Papavassiliou, 2013). MMPs – Matrix metalloproteinases. 
ADAMTS – A disintegrin and metalloproteinase with thrombospondin motifs. COX-2 – 
Cyclooxygenase-2. NO – Nitric oxide. TNF-α – Tumour necrosis factor-alpha. IL-1β – 
Interleukin-1 beta. PGE2 – Prostaglandin E2. RANKL – Receptor activator of nuclear factor 
kappa-Β ligand. VEGF – Vascular endothelial growth factor. COL – Collagen. 
MMP activity also plays a role in chemokine processing, protease activity status modulation 
and cell membrane shedding (Löffek, Schilling and Franzke, 2011). Research has suggested 
that each MMP subtype is responsible for a specific role in the degradation process through 
location specific functions across cartilage tissue. This includes MMP 1, 8 and 13, each 
belonging to the collagenase group, MMP 2 and 9, belonging to the gelatinase group, and 
MMP 3, 7, 10 and 11, belonging to the stromelysin group, as well as other membrane-
specific and non-specific MMPs. MMP mRNA is upregulated in response to IL-1β signalling as 
well as MMP-specific responses to tissue inhibitors of metalloproteinases (TIMPs) (Brew, 
Dinakarpandian and Nagase, 2000; Mountain et al., 2007; Lin et al., 2009; Brew and Nagase, 
2010).  
MMPs have also been shown to be co-expressed in OA patient tissue samples indicating a 




et al., 2004). Cartilage breakdown products such as fibronectin components then enter the 
synovial fluid as a result and irritate the synovial membrane lining, causing the release of 
inflammatory mediators. Such breakdown products have been shown to have a significant 
role in disease progression through indirectly mediating cartilage destruction (Yasuda, 2006; 
Pérez-García et al., 2016). Mononuclear inflammatory cells are also recruited which in turn 
secrete IL-1β and TNF-α, further upregulating protease production via local chondrocytes 
and fibroblasts within the synovium. 
As a further consequence of non-physiological mechanical stimulation, pro-inflammatory 
signalling cascades are activated which induce synovitis. Secreted IL-1β and TNF-α further 
activate mitogen-activated protein kinases as a result of chondrocyte loading, a critical 
pathway for transducing the mechanical forces of cartilage shear and compression into 
biological responses (Fitzgerald et al., 2008). 
NF-κβ is also activated in OA, initiating a wide range of chondrocyte signalling pathways. 
Vascular endothelial growth factor (VEGF) expression is then stimulated, leading to the 
upregulation of ADAMTS-5 and MMPs 1, 2, 3, 9 and 13, further contributing to enzymatic 
tissue degradation. 
Cyclooxygenase-2 (COX-2) expression is considered an important mediator in osteoarthritis 
inflammation. An increase in COX-2 expression has been linked to prostaglandin-E2 synthesis 
local to disease sites. In addition, prostaglandin synthesis has been shown to upregulate 
COX-2 and interleukin-6 at inflammatory sites (Anderson et al., 1996). Prostaglandin-E2 has 
also been shown to be a significant catabolic mediator within cartilage tissue. Both 
prostaglandin-E2 and nitric oxide release by IL-1β have been shown to be upregulated by 
mitogen-activated protein kinase, activator protein-1 and NF-κβ within chondrocytes 
(Chowdhury et al., 2008). 
In contrast to overloading-induced OA, much less is known about the specific signalling 
pathways that lead to cartilage degradation within under loaded tissue such as that of an 
immobilised joint. Nitric oxide synthase, VEGF, prothrombin and hypoxia inducible factor 1-
alpha (HIF-1α) expression have been shown to increase following immobilisation, however 
the upstream or downstream effects in relation to osteoarthritis are not fully understood 




Although cartilage degradation remains a hallmark of OA, a number of other changes 
relating to other joint tissues such as bone also occur and contribute to its development. 
Moreover, there is clear dynamic between cartilage and underlying bone within OA 
pathophysiology, with osteoblast and osteoclast dysfunction resulting in net bone 
resorption, and the development of osteophytes; a key radiological feature associated with 
OA development (Junker et al., 2016). This feature is induced by the cytokines IL-1β and TNF-
α, which promotes the differentiation of osteoclasts within bone tissue, disrupting the 
homeostatic balance of bone modelling and bone resorption (Rengel, Ospelt and Gay, 2007).  
Changes to the subchondral bone have been previously associated with disease 
pathogenesis, with subchondral bone-modifying drugs considered as potential treatment 
options for OA (Bellido et al., 2011; Castañeda et al., 2012). In addition, pro-inflammatory 
signalling pathways elevated during OA development have been associated with 
subchondral bone sclerosis and hypo-mineralisation as a result of abnormal bone 
remodelling and tissue damage (Li et al., 2013). 
2.1.3 Current Treatment Strategies 
Treatment for OA are stratified according to disease progression and are outlined in Figure 
2.5. Initial treatment includes the use of exercise regimens to strengthen the muscles 
surrounding the joint and improve posture. Changes to a patient’s diet are often advised 
where obesity is present, due to it being a recognised risk factor in the pathogenesis of the 
disease wherein it promotes overloading of the afflicted joint. 
Painkillers such as paracetamol or non-steroidal anti-inflammatory drugs (NSAIDs) may be 
prescribed in order to manage symptoms in early stages of the disease. As the disease 
progresses, opioids and local corticosteroid injections are also used to manage pain where 
paracetamol or NSAIDs have proved to be ineffective. COX-2 inhibitors may also be 
incorporated into the treatment regime to reduce localised inflammation. If symptoms 
cannot be effectively managed through lifestyle modifications, pain management and anti-
inflammatories alone, additional options may be explored including the use of assistive 






Figure 2.5 – Diagram representing the treatment pathway for OA at various stages of 
disease progression in accordance with current National Institute for Health and Care 
Excellence clinical guidelines for OA management. NSAIDs – Non-steroidal anti-
inflammatory drugs, COX-2 – Cyclooxygenase-2. Adapted from (Dieppe and Lohmander, 
2005). 
Traditional surgical options for knee OA include arthrodesis, osteotomy and arthroplasty 
whereby the joint is fused, realigned or replaced respectively. More recent surgical methods 
include microfracture surgery, whereby small fractures are created in the underlying bone. 
This results in an influx of cells and signalling factors that generate a clot to stimulate 
cartilage repair (Erggelet and Vavken, 2016). 
Mosaicplasty, also known as osteochondral transplantation, can also be used to repair 




cylindrical osteochondral plugs taken from the less weight-bearing regions of the 
patellofemoral area and inserting them into defect regions following the drilling of cylindrical 
holes within affected tissue. 
Tissue engineering approaches have also been utilised as a treatment methodology. 
Autologous matrix-induced chondrogenesis is a technique whereby microfracture surgery is 
combined with the implantation of a bi-layer collagen membrane in order to restore large 
defect areas that would be difficult to repair using microfracture surgery alone. This 
improves the defect fill and clot stability at the defect site. 
Finally, the most recently adopted surgery for OA is autologous chondrocyte implantation 
(ACI). This is a cellular therapy performed to repair chondral defect sites, whereby a 2-300 
milligram sample of cartilage tissue is obtained via arthroscopic surgery from a healthy, 
reduced weight-bearing area of the patellofemoral region such as the superior ridge of the 
medial or lateral femoral condyle. The cell matrix is then enzymatically removed from this 
sample in order to isolate a population of healthy chondrocytes. These cells are grown ex 
vivo for 4-6 weeks in order to generate a cell number sufficient to repair the damaged area. 
A second surgical procedure is then performed to apply the expanded chondrocytes to the 
defect area. This surgery may be expanded further by utilising an implantable scaffold to 
provide support to the surgical site, however previous versions have relied upon a collagen 
membrane or periosteal flap. A clear limitation to the ACI procedure is that it requires 
multiple surgical procedures in order to repair the damaged area unlike other techniques. In 
addition, comprehensive laboratory practices are required to screen and select cells during 
the ex vivo growth period that will be most likely to form healthy hyaline cartilage following 
implantation, in order to minimise fibrocartilage formation. 
A review article published by Niemeyer et al. of the German Society of Orthopaedics and 
Trauma highlights the importance of considering the range of techniques available for the 
treatment of cartilage defects as a spectrum of cartilage-related treatments, with indication-
dependent advantages as opposed to competing treatment options. This is significant given 
the authors observations of current research suggesting that autologous chondrocyte 
implantation provides superior performance over alternative therapies at a defect size of >3-
4 cm2, with >2.5 cm2 considered for active sports patients. Defects of <2-3 cm2 are 
considered to be suitable candidates for mosaicplasty. Autologous chondrocyte implantation 




subsequent repair tissue however the author indicates a lack of studies outlining the 
functional superiority of this technique in comparison to mosaicplasty for periosteum repair 
(Niemeyer et al., 2016). 
Previous work by Elvidge et al. has evaluated the efficacy of ACI in comparison to traditional 
microfracture surgery within the UK. This work assessed the clinical outcomes of each type 
of surgery in relation to cost and quality-adjusted life years gained. ACI was estimated to 
reduce the lifetime probability of knee replacement by 50 % in comparison to microfracture 
surgery. Quality-adjusted life years were increased from 15.85 to 16.57 when using ACI, with 
an associated cost of £8,008 and £23,307 respectively. The cost per quality adjusted life year 
was calculated to be £21,245, representing cost-effectiveness in line with UK clinical 
thresholds whilst providing substantial patient benefits. This outcome, alongside the high 
incidence and associated morbidity of the disease, provides a clear objective for the 
generation of cost-effective clinical solutions to reduce the burden of osteoarthritis amongst 
the UK population. Current state-of-the-art treatments such as ACI therefore provide a 
temporary benchmark for new treatments to surpass in order to demonstrate clinical 
viability and may offer further opportunity to develop research into this new therapeutic 
area (Elvidge, Bullement and Hatswell, 2016). 
However, despite these recommendations, the efficacy of ACI surgery in comparison to 
more conventional procedures is not unanimously recognised. A randomised controlled trial 
funded by the French Ministry for Social Affairs and Health analysed the functional outcomes 
of third generation ACI in comparison to single-stage mosaicplasty over a period of 24 
months using the international knee documentation committee scoring system for patients 
with isolated symptomatic femoral chondral defects. The Cartipatch® solid agarose-alginate 
scaffold was selected for this study. Functional outcomes were found to be significantly 
worse in the Cartipatch® group when compared to those treated via mosaicplasty after 24 
months, with patients also exhibiting a greater number of recorded adverse events. This 
included the development of an infection within the Cartipatch® group. A two-fold increase 
in morbidity was observed when comparing the Cartipatch® and mosaicplasty treatment 
groups, which the authors attributed to the multi-stage surgical procedure required for ACI 
therapy. This research did not include data on the cost effectiveness of each treatment, 




mosaicplasty due to the increased number of procedures required and associated costs with 
scaffold production (Clav et al., 2016). 
In 2017, the National Institute for Health and Care Excellence published an updated technical 
appraisal report recommending the use of ACI as an option for the treatment of articular 
cartilage defects of the knee under specific conditions, based upon cost-effectiveness 
calculations incorporating a maximum cell cost of £16,000 per patient. These conditions 
include the requirements for patients to have not had previous articular cartilage defect 
surgery, have minimal osteoarthritic knee joint damage, and possess a cartilage defect of 
greater than 2 cm2 in size (National Institute for Health and Care Excellence, 2005; Mistry et 
al., 2015; National Institute for Health and Care Excellence, 2017). 
2.1.4 Novel Therapies 
Future treatment methods may include the use of gene therapy or targeted 
pharmacotherapy in order to treat OA. Such treatments have the potential to significantly 
improve the quality of life for patients diagnosed with OA by reducing associated symptoms, 
slowing progression or completely eliminating the disease. Therapies such as these would 
also provide new treatment options between the early and later stages of progression, 
reducing the need for high-risk surgical intervention. However, a lack of understanding of 
the pathophysiology of OA as well as concerns over the safety and cost effectiveness of such 
treatments currently limit development (Evans, Ghivizzani and Robbins, 2013; Thysen, 
Luyten and Lories, 2015; Madry and Cucchiarini, 2016). 
One potential method for treating osteoarthritis involves the use of drugs that affect 
subchondral bone metabolism. Strontium ranelate is an example of a drug that induces 
reduced bone-resorption and increased bone formation, having been previously licensed for 
the treatment of osteoporosis. This particular drug could therefore be used as an anabolic 
stimulant to encourage bone generation, treating the bone related symptoms of OA (Tat et 
al., 2011).  
Inhibition of the IL-1β pathway is also considered to be a potential therapeutic target for 
future treatment due its critical role in OA disease pathophysiology. This includes developing 
methodologies to block the function of IL-1β converting enzyme, pathway receptors or 
receptor antagonist. So far such methods have failed to provide clinically relevant effects on 




A similar methodology has been trailed on the TNF-α pathway through the generation of 
TNF-α antagonists such as Adalimumab, a drug currently prescribed in the UK for the 
treatment of rheumatoid arthritis. Adalimumab has been shown to have considerable 
therapeutic benefits in patients suffering from knee OA (Maksymowych et al., 2012). In 
contrast, the drug Anakinra failed to demonstrate similar disease-modifying effects when 
compared with a placebo for the treatment of OA. This was despite having a similar mode of 
action, being well tolerated, and having been extensively prescribed for the treatment of 
rheumatoid arthritis (Chevalier et al., 2009). Such results emphasise the need for an 
improved understanding of OA pathophysiology in order to more reliably identify treatment 
targets and predict patient outcomes. 
Inhibition of the OA-implicated ADAMTS isoforms is also an attractive therapeutic target. 
Inhibition of ADAMTS-4 and 5 would work to reduce cartilage degradation, limiting the 
development of more serious disease manifestations. However, non-specific inhibition of 
both enzymes is likely to have negative implications where such enzymes are required for 
normal physiological functions across different tissues within the body (Verma and Dalal, 
2011). Alternatively, pharmacotherapy may target the endogenous inhibitor of ADAMTS-4 
and 5, tissue inhibitor of metalloproteinases (TIMP)-3, in order to arrest enzymatic 
degradation of tissue within the joint and subsequent inflammatory signalling (Verma and 
Dalal, 2011). 
A range of cell-based therapies are also being researched as potential OA treatments. This 
includes the use of mesenchymal stromal cell (MSC) based therapies whereby cells are 
injected directly within the OA joint. Cells are commonly sourced from adipose tissue or 
bone marrow concentrate and are applied to the defect area. A wide range of cell sources, 
screening and culture conditions, and implantation parameters have been assessed across a 
number of studies. Conflicting research outcomes and insufficient clinical trials data have 
failed to provide sufficient evidence to justify therapeutic use (Pas et al., 2017; Hurley et al., 
2018; Xing et al., 2018). As a result, there are no MSC injection therapies currently 
recommended for use within the UK. 
Chondrosphere® is an aggregate based therapy representing a fourth-generation derivative 
of the ACI surgical procedure. During this surgery, a cartilage sample is collected from the 
patient for cell isolation and cultured ex vivo for 8-10 weeks. The cells are then seeded into 




then coalesced into larger tissues prior to implantation at the defect site at a density of 10-
70 aggregates per cm2 (Foldager et al., 2012). The National Institute for Health and Care 
Excellence currently recommend Chondrosphere® therapy as an option for the treatment of 
OA under same conditions as ACI surgical procedures, at an estimated cost effectiveness of 
£18,000 per quality-adjusted life year (National Institute for Health and Care Excellence, 
2018; Armoiry et al., 2019). 
However, despite the recent advances in OA therapies, it is crucial to emphasise that next-
generation treatments are currently hindered by our relatively limited understanding of the 
complex disease pathophysiology and multifactorial nature of OA (Berenbaum, 2013; Glyn-
Jones et al., 2015; Mobasheri and Batt, 2016). Therefore, further research is required to 
better understand the key signalling pathways involved in disease progression.  
There also remains a significant gap between the range of early-stage and late-stage 
treatments currently available, as previously illustrated. This results in a significant 
proportion of patients falling short of thresholds justifying surgical intervention whilst being 
burdened with poorly managed symptoms from limited early-stage treatment options. 
Future treatments must be able to target the disease at an earlier stage to delay the onset of 
symptoms and reduce the proportion of patients requiring invasive surgical procedures. This 
requires the detection and validation of potential therapeutic compounds or cellular 
therapies at an earlier stage within the pharmaceutical research and development process. 
2.1.5 Pharmaceutical Research and Development Process 
The development of novel pharmacotherapies requires extensive screening, optimisation 
and validation in order to determine potential lead compounds for further study. Once 
selected, lead compounds or cell therapies are then tested extensively in vitro to determine 
their biological compatibility and effectiveness at reducing OA-like pathophysiology. 
Following preliminary testing, the pharmacotherapy then undergoes a series of pre-clinical 
testing steps, followed by clinical trials, before being approved for clinical use. A breakdown 






























Figure 2.6 – Flow diagram depicting the pharmaceutical research and development process 
of bringing a drug to market. IND – Investigational new drug. CTA – Clinical trials 
authorisation. NDA – New drug application. MAA – Marketing authorisation application. 
Adapted from (Paul et al., 2010). 
The cost of drug discovery has been previously estimated to have reached in excess of $2.8 
billion dollars (DiMasi, Grabowski and Hansen, 2016). Increases in the cost of the 
development process, alongside a reduction in the number of lead compounds progressing 




increased total costs (Paul et al., 2010). Previous analysis of productivity across the sector 
has revealed the need to increase the productivity of early phase testing of potential lead 
compounds (Dimitri, 2011).  
Increased productivity within this area requires further developments within the fields of 
automation and high-throughput screening to increase the speed of candidate screening and 
reduce the associated cost, alongside improvements to the quality of testing methodologies 
to decrease the probability of detecting and developing false positives (Shun et al., 2011; 
Zhang et al., 2012; Imaduwage et al., 2017).   
As a result, there is growing interest in the development of disease models to better 
recapitulate OA in vitro and provide a more comprehensive screening platform to bridge the 
gap between lead discovery and preclinical trials. 
2.2 Models of Osteoarthritis 
A variety of different types of model are currently employed to study the pathophysiology of 
osteoarthritis, as well as to assess the efficacy of potential new treatments. This includes 
both in vitro and in vivo systems, with each approach possessing specific advantages and 
disadvantages in comparison to the gold standard of human clinical trials. These are outlined 




















In vivo mammalian models are typically used in the later stages of drug development or for 
larger research studies where the presence of full body physiological functions is required. 
Such models are able to more accurately replicate the pathophysiological changes caused by 
osteoarthritis within humans when compared to in vitro platforms. As a result, in vivo 
models generally provide a more replicative environment for research and pharmacological-
screening applications, at the expense of the cost, throughput and the welfare implications 
of animal use within scientific research (Thysen, Luyten and Lories, 2015). 
There are a number of different types of in vivo mammalian models. These can be defined by 
the mechanism through which osteoarthritis is induced. Spontaneous models rely on the 
development of osteoarthritis pathophysiology within the animal over a period of time 
(Kyostio-Moore et al., 2011). This includes the use of genetic modifications to induce 
structural changes within cartilage collagen fibres that promote tissue dysfunction. Such 
modifications can increase cartilage catabolic activity or reduce functionality, thus 
prematurely inducing tissue degradation and OA like symptoms (Hu et al., 2006; Kim and 
Cheon, 2012; McCoy, 2015). With chemical models, a local injection is given to induce joint 
degradation, resulting in the development of subsequent pathological processes that are 
characteristic of OA (Thakur et al., 2012; Van Lent et al., 2012; Kuyinu et al., 2016). Surgical 
models rely on physical modifications to the joint anatomy to impair function and induce 
degradative changes (Moskowitz et al., 1973; Pond and Nuki, 1973; Armstrong et al., 1993). 
Skeletally mature animals generally provide a more replicative model of OA to that of the 
human condition, with spontaneous models providing a better method for drugs testing 
applications (McCoy, 2015). In addition, the anatomy of the joint and body mass of larger 
species is also more similar to that of humans making histological, surgical, gait and wear 
analysis data more comparable to human studies. Pain-based research represents one of the 
areas of OA research that is most reliant on animal model use for early-stage research and 
therapy development. This is due to the difficulties in replicating pain signalling in vitro as a 
result of our poor understanding of pain mechanics and the associated markers of pain. 
Mammalian models remain critical for understanding and developing therapies for pain 
management, a key treatment target (Malfait, Little and McDougall, 2013; Teeple et al., 
2013). 
Despite these features, there remains a number of significant factors that limit the use of in 




variability, animal welfare concerns, high setup and running costs, and extensive assessment 
periods required for treatment screening (Vincent et al., 2012). 
As a consequence, there is an increasing demand within the field to minimise animal model 
use where possible, in accordance with the principles of the 3R’s (Replacement, Reduction 
and Refinement) in research (Russell and Burch, 1959). This framework has pushed for the 
development of improved experimental design when utilising animal models for OA research 
to reduce the number of animals used and nociception experienced where possible (Madden 
et al., 2012). In addition, increasing pressure is now placed on research where animal models 
are used to ensure that the experiment contributes significantly to the sector’s body of 
knowledge. 
A key outcome of such initiatives is the increased development and adoption of in vitro 
models for early-stage OA research applications. Such models provide an alternative 
mechanism to reduce animal model use and associated welfare concerns, whilst 
simultaneously reducing the costs and lead times associated with drug discovery 
(Astashkina, Mann and Grainger, 2012; Johnson, Argyle and Clements, 2016). Critical 
features of such models include the need to accurately replicate the pathophysiological 
nature of the disease, high-throughput and low cost of operation, as well as the ability to 
monitor biological response using real-time or near real-time cellular markers (Szymański, 
Markowicz and Mikiciuk-Olasik, 2012). Explant-based in vitro models have also been 
researched as a potential method to recapitulate conditions within the joint, but they are 
limited to low-throughput applications due to the limited supply of new tissue sources (Song 
et al., 2007; Amin et al., 2009; Geurts et al., 2018). 
A range of factors must be considered when developing an effective in vitro model of OA. 
This includes the cell types used, culture format, analysis techniques employed and the 
method of inducing an OA-like pathophysiology within the tissue. 
2.2.1 Cell Types 
Selection of appropriate cell types for use within disease models requires consideration of 
the availability of each cell type, growth rate in culture, degree of characterisation data 
available within the literature and phenotype stability over extended culture periods. 
There are two different classifications of cultured cell types, including both primary and 




tissue. This can be performed through enzymatic or mechanical methods in order to enable 
culture in vitro. Primary cell types have a limited life span and are heterogeneous in nature, 
reflecting conditions within the body. As a result, primary cell culture requires bespoke 
protocols and the total cell yield is finite. It is also important to consider the significant intra-
donor variability between each source of primary cells, as well as potential availability issues 
when sourcing donated material for long term culture (Ketterl et al., 2015; Trivedi et al., 
2019). 
Immortalised cell lines are a homogenous population of cells that can be continually cultured 
over an extensive period of time. This cell type is generated through the immortalisation of a 
primary cell type via genetic or biochemical mechanisms. These cells are often commercially 
available and are usually associated with a range of established protocols and culture 
conditions. Due to the continuous rate of growth, such cell lines provide a limitless source of 
cells, making them highly suitable for high-throughput applications. Despite this, it is 
important to consider the potential for genetic drift that can occur through repeated cell 
divisions, as well as the limited replicability of a homogenous population of cells to the 
heterogeneous environment found within living tissue (Torsvik et al., 2014; Gutbier et al., 
2018). Previous research has explored the use of both primary and immortalised cell types 
for the construction of in vitro osteochondral disease models, with cell type selection based 
upon the intended function of the model (Solorio et al., 2010; Mohanraj et al., 2014; Murphy 
et al., 2016; Yeung et al., 2018).  
The pathogenesis of osteoarthritis involves a range of different cell types, including cells that 
would normally reside in the cartilage, bone and synovium of an articular joint. MSCs 
represent a multipotent heterogeneous population of cells that possess mesodermal 
differentiation capabilities into osteogenic, chondrogenic and adipogenic cell types, as 
indicated in Figure 2.8, and also have the ability to produce local immunomodulatory effects. 
Additional research has also explored the potential for MSCs to commit to ectodermal and 
endodermal lineages (Hermann et al., 2006; Jeon et al., 2007; Karnieli et al., 2007; Mahay, 
Terenghi and Shawcross, 2008). Because of these properties, MSCs are considered to have a 
range of potential applications across the fields of tissue engineering, osteoarthritis 
treatment and in vitro disease model construction (Frith and Genever, 2008; Caplan, 2009; 





Figure 2.8 – Diagram depicting the mesenchymal stromal cell differentiation pathways 
that lead to the formation of articular joint tissue. Reproduced from (Caplan and Bruder, 
2001). 
MSCs were first isolated from the bone marrow by Friedenstein et al. in the 1970s and are 
defined as being colony-forming and fibroblastic in morphology, with plastic adherence and 
tri-lineage differentiation potential (Friedenstein, Chailakhjan and Lalykin, 1970; 
Friedenstein, Gorskaja and Kulagina, 1976). Other common sources of MSCs include adipose 
tissue, umbilical cord tissue and peripheral blood, with the source of MSCs having been 
shown to affect cellular functionality and surface marker expression (Hass et al., 2011; C. Li 
et al., 2015; Secunda et al., 2015; Elahi et al., 2016; Heo et al., 2016).  
Cell surface antigens commonly used to define MSC populations include expression of 
CD105, CD73 and CD90, and negative expression of CD45, CD34, CD14 or CD11b, CD79a or 
CD19 and HLA-DR (Dominici et al., 2006). MSCs are typically sourced from the bone marrow 
and are grown in primary culture, however more recent research has explored the potential 
of developing immortalised MSC lines due to the challenges associated with large-scale 
primary cell culture (James et al., 2015; Sawada et al., 2016).  
One example of such a cell line is the human bone marrow derived MSC generated and 
characterised by James et al. in 2015. This heterogeneous population of cells was isolated for 




overexpress telomerase reverse transcriptase, enabling continual culture in vitro. Four 
distinct single-cell-derived colonies were isolated and characterised from this subpopulation, 
with each colony displaying varying degrees of tri-lineage differentiation capacity. The 
resulting colonies were named Y101, Y102, Y201 and Y202. A high degree of cell 
characterisation has been performed on each line, including characterisation of the bone 
marrow derived MSC cell surface marker profiles, gene expression profiling, differentiation 
assays, lineage tracing and growth kinetics (James et al., 2015). Previous research has 
demonstrated that the Y201 cell line responds similarly to changes in the mechanical 
properties of its microenvironment as primary MSCs, with a virally delivered fluorescent 
reporter construct successfully delivered to detect and report substrate stiffness (Dobre et 
al., 2018). The Y201 cell line has also been shown to be capable of tri-lineage differentiation 
into osteoblasts, adipocytes and chondrocytes, representing key cell types involved in the 
pathogenesis of OA. These factors make Y201 cells highly suited for applications within 
osteochondral tissue models. 
One of the challenges when developing an in vitro model of OA is that cell types such as 
chondrocytes are particularly prone to dedifferentiation into fibroblasts after short periods 
in culture and require a specific cellular environment (Caron et al., 2012; Ma et al., 2013; 
Minegishi, Hosokawa and Tsumaki, 2013). In normal joint tissue, chondrocytes are 
suspended within an extensive ECM. This matrix has an important effect on cellular 
behaviour and tissue function that is challenging to replicate accurately in vitro (Bhosale and 
Richardson, 2008; Atala et al., 2012). Novel 3-dimensional (3D) culture formats provide a 
potential methodology to overcome such challenges through simulating the spatial 
organisation, ECM production and cell-cell contact that is present within living tissue. 
A number of immortalised cell types are available that were originally sourced from 
differentiated tissue within the articular joint. This includes the human chondrocyte cell lines 
SW-1353 and TC28a2 that have been previously used for osteoarthritis research. The SW-
1353 cell line was derived from the primary chondrosarcoma of a 72 year-old female. 
Previous research comparing the SW-1353 cell line to primary chondrocyte culture has 
demonstrated significant differences in gene expression in response to the IL-1β cell 
mediator, resulting in only a limited ability to replicate primary cells (Gebauer et al., 2005).  
The TC28a2 cell line was derived from costal cartilage of a 15 year-old female. Previous 




primary human chondrocyte cultures (Goldring et al., 1994). Additional research into the 
molecular phenotype of the TC28a2 cell line observed that the cells display reduced 
expression of genes involved in matrix synthesis and turnover when compared with primary 
chondrocyte cells, as well as a more rapid rate of proliferation (Finger et al., 2003). More 
recent research has demonstrated the potential for using the TC28a2 cell line to study sex 
hormone and insulin receptor interactions within the context of OA research (Claassen et al., 
2011). 
Primary chondrocytes have also been used across a range of research applications, however 
are prone to the limitations of primary culture as previously discussed. This includes 
reported changes to chondrocyte gene expression in response to extended periods of 
culture, resulting in a loss of chondrogenic phenotype and subsequent ability to generate 
cartilage tissue (Schnabel et al., 2002; Dehne et al., 2010; Ma et al., 2013). As a result, the 
selection of an optimal cell line to study osteoarthritis in vitro remains highly dependent 
upon the model culture format. 
2.2.2 Culture Format 
A range of different culture formats have been previously employed to recapitulate 
conditions within the joint. This includes primitive methods such as 2-dimensional (2D) 
monolayer culture of a single cell type to insert-based 3D culture systems incorporating a 





Figure 2.9 – Well-based cell culture techniques commonly used to generate in vitro disease 
models. 
Monolayer culture is a 2D cell culture technique widely employed within OA research due to 
its low cost and complexity as well as high scalability for larger experiments. With this 
technique, a single cell type is cultured in a simple monolayer and responses to the 
application of various chemical factors or environmental modifications are studied. The 
major downside to this method is that without a 3D architecture, these cultures show a lack 
of complex cellular organisation and a corresponding lack of ECM. As previously described, 
ECM components form a crucial element of OA pathophysiology, and so its presence is of 
vital importance. Due to these factors, monolayer culture techniques are considered to 
provide a gross oversimplification of the complex and multicellular nature of the joint, 
whereby a variety of different cell types interact continuously through various mechanisms 
in order to maintain normal tissue functions (Birgersdotter, Sandberg and Ernberg, 2005; 
Miki et al., 2012). This can lead to misleading research outcomes that provide a poor 
prediction of the in vivo response (Edmondson et al., 2014). Replication of these factors in 
vitro is therefore critical in order to fully understand the dysfunction of specific pathways or 
factors that lead to the onset and progression of disease. Through the use of 3D culture 




found within OA in vivo in order to better replicate disease pathology (Bhadriraju and Chen, 
2002).  
Co-culture techniques, including those incorporating technologies such as multi-well inserts, 
allow for the culture of multiple different cell types within a single spatially arranged 
environment. This enables further recapitulation of the in vivo cellular environment to 
decrease the discrepancies between research and clinical outcomes (Hendriks, Riesle and 
van Blitterswijk, 2007). Co-culture models also enable the study of interactions between 
multiple cell types in response to different stimuli or environmental conditions (Meretoja et 
al., 2012; Zhang et al., 2017). 
Aggregate culture techniques represent one of a number of 3D cell culture methods that 
enable the production of a large number of micro-tissues. Such culture techniques generally 
allow for an increase in cell-cell contact, a reduced dependence on adherence to plastic 
substrates, and more replicative nutrient and waste diffusion gradients within the aggregate 
(Malda et al., 2004; McMurtrey, 2016; Nath and Devi, 2016; Melissaridou et al., 2019). In 
addition, aggregate culture enables a greater level of cellular spatial organisation and ECM 
functionality than conventional monolayer culture methods (Fennema et al., 2013). 
Aggregate culture methods are therefore being explored for both in vitro research 
applications and in vivo disease treatments (National Institute for Health and Care 
Excellence, 2017; Ong et al., 2018; Yeung et al., 2018). 
A number of different methods exist for the production of aggregates. These most 
commonly include in-well, spinner flask and hanging droplet culture. However, alternative 
methods such as matrix, microencapsulation and microfluidic methods have also been 
reported (Tung et al., 2011; Kojima, Takeuchi and Sakai, 2012; Aijian and Garrell, 2015; 
Leung et al., 2015; Lee et al., 2018). Gravimetric methods, such as hanging droplet, rely upon 
gravitational force to move dispersed cells in suspension into a dense aggregate. Cell to cell 
contacts induce cell signalling responses which then encourages the growth of spherical 
tissue. In addition to hanging droplet, examples of this culture format include hanging well 





Figure 2.10 – Common cell culture techniques used for aggregate production. (A) Hanging 
droplet. (B) Hanging well. (C) In-well. 
A number of studies have explored the application of different aggregate production 
techniques for the construction of micro-tissue models. In 2015, Pennock et al. researched 
the use of a well-based 3D aggregate culture technique to dedifferentiate aged human 
mesenchymal stromal cells into an early mesoderm-like state. The authors show that such 
methodologies are capable of reversing age-associated cell hypertrophy in order to restore 
the regeneration capacity of tissues (Pennock et al., 2015). 
Previous research by Marshall et al. has developed a 3D aggregate model that combines 
MSCs in undifferentiated, osteogenic and chondrogenic states with endothelial cell 
populations. Within these studies, cellular signalling was shown to induce tissue self-
organisation within the aggregate culture format. This research demonstrates the versatility 
of the aggregate culture format when studying the interactions between multiple cell types 
(Marshall, Barnes and Genever, 2018). 
Tung et al. demonstrates the potential use of liquid handling equipment for the production 
of 3D cellular aggregates, overcoming one of the more labour-intensive stages of aggregate 
production. Here, a liquid handling robot was used to deposit a cell-containing solution onto 
a custom 384-well plate insert designed to promote the formation of hanging droplets. 




feasibility of using this platform for research applications. This paper provides a potential 
modification to existing plasticware designs in order to facilitate the use hanging droplet 
aggregate culture techniques within a high-throughput screening environment (Tung et al., 
2011). 
Previous work by Choi et al. investigated the use of the in-well aggregate culture technique 
for the production of embryoid bodies from embryonic stem cells. Within this research a 
polymethylsiloxane (PDMS) microwell array was fabricated and cells seeded on top of the 
wells to promote aggregate formation. Following sedimentation, endothelial cell culture 
media containing neuronal differentiation additives was flowed over the cells to promote 
differentiation. This procedure was shown to generate homogenous sized cell aggregates for 
research into embryoid body differentiation. Modifying the width of the microwell inserts 
was found to impact aggregate size and the subsequent differentiation status of the 
embryoid bodies generated. This research highlights the potential of in-well aggregate 
culture to perform research into cellular differentiation that would not be possible using 
conventional monolayer culture methods (Choi et al., 2010). 
Research by Futrega et al. assessed the use of a custom nylon microwell-mesh for the high-
throughput production of cartilage micro-tissues. Here, the authors develop a 6-well plate 
insert by casting PDMS sheets onto a polystyrene mould to generate square 2 x 2 mm, 0.8 
mm deep ‘V’ well disks. A nylon mesh was bonded onto the surface of the disk and bone 
marrow derived MSCs seeded onto the mesh at a concentration of 106 cells per mL of cell 
culture media. The plate containing the insert was then centrifuged briefly in order to pass 
individual cells through the nylon mesh pores and into the wells to form individual pellets. 
Pellets formed were unable to pass back through the mesh due to the pore size, allowing for 
media exchange without the risk of cell loss. Cells were then harvested by removing the 
mesh inserts leaving individual cartilage micro-tissues loosely attached and evenly spaced 
across the mesh. Each micro-tissue removed yielded approximately 5 x 103 cells with 240 
microwells per well of a 6-well plate. The chondrogenic differentiation of pellets generated 
via the microwell mesh culture technique was assessed and compared with pellets 
generated through a standardised pellet culture method. Cartilage-like micro-tissues were 
generated more rapidly in samples harvested from the microwell mesh when compared with 
control samples. This simple and scalable modification to standard cartilage pellet culture 




the challenges associated with cell handling and media exchanges due to the mechanism 
through which cells were entrapped within the mesh. These results provide a possible 
solution to some of the challenges associated with the use of liquid handling systems to 
automate the production and culture of 3D aggregate culture techniques (Futrega et al., 
2015). 
An alternative method for aggregate construction was presented by Park et al. from 
research evaluating the potential of using centrifugal forces within a microfluidic chip to 
generate cell aggregates. A PDMS-based aggregate culture microwell disk was developed 
and mounted onto a rotating platform to facilitate aggregate formation. Within this work a 
combination of multiple different cell types were applied to the microwells sequentially in 
order to generate a layered effect within the resulting aggregate. Preliminary assessment of 
aggregate formation was assessed microscopically. This work provides a novel adaptation of 
conventional centrifuge-based aggregate formation protocols through the use of a 
potentially scalable centrifugal microfluidic system. Further research is required to assess 
the scalability of the microfluidic system as well as its compatibility with extended aggregate 
culture periods and more complex cellular analysis techniques (J. Park et al., 2017). 
Lee et al. investigated the use of in-well aggregate culture techniques to generate in vitro 
hepatic disease models. Here, a custom PDMS microwell plate was developed and assessed 
with interlinking concave wells to promote aggregate formation and enable inter-well 
diffusion. This modification allowed the flow of nutrients, waste, cytokines and cell-cell 
interactions alongside the diffusion of oxygen across the entire plate. Hepatic cell aggregates 
were found to display increased albumin secretion when compared to identical aggregates 
generated within standard well plates and the diffusion of material between wells was 
demonstrated via both a labelled albumin assay and computer simulation. This work outlines 
a potential method to significantly enhance conventional aggregate culture techniques 
through further emulating elements of the in vivo environment, whilst retaining a 
standardised culture format compatible with traditional analysis techniques and high-
throughput processing systems (Lee et al., 2018). 
A number of limitations exist for different aggregate culture techniques. Preparation and 
seeding of cells for aggregate culture techniques requires both a significant amount of time 
and cells depending upon the particular technique employed. In addition, certain techniques 




effects, limiting aggregate formation. There are also practical considerations such as the 
time period required for cell aggregation prior to performing experiments (Bartosh et al., 
2010). Aggregates also demonstrate poor compatibility with a variety of non-destructive 
assays that are commonly used to characterise 2D culture platforms due to the reduced rate 
of diffusion through the tissue (McKee and Chaudhry, 2017). Finally, media exchange and 
aggregate imaging during culture are often more complex to perform when compared to 
samples generated using monolayer culture techniques (Joshi and Lee, 2015). 
Insert-based culture techniques have been developed as an alternative method to provide a 
3D culture environment, whilst circumventing some of the limitations associated with 
aggregate culture. Such systems generally employ a standard well-plate design coupled with 
an intermediary porous membrane suspended within each well. Polycarbonate and 
polyethylene terephthalate materials are commonly used to generate the membrane, with a 
range of pore sizes available to selectively allow for molecular transport studies, or cell 
growth, migration and interactions across the substrate. 
More recent designs have incorporated mechanisms to alter the membrane position within 
each well. This enables the gradual transfer of cells seeded onto the membrane towards the 
air liquid interface, a common procedure required for the production of in vitro skin models 
(Marx et al., 2018; Roger et al., 2019). Modifications have also been made to incorporate 
optional interlinked well designs to allow for media perfusion between multiple wells, as 
well as increase the compatibility of the insert culture format with current liquid handling 
systems and analysis equipment. As a result, insert-based culture techniques have been 
successfully incorporated in the construction of unique experimental models to assess cell 
migration and drug absorption (Restouin et al., 2009; Larson et al., 2012). These 
modifications also enable the use of insert-based culture systems within current high-
throughput screening (HTS) workflows. 
Due to the nature of the insert design it is possible to grow multiple cell types in a single well 
to assess cell interactions either with or without direct cell contact. Previous studies 
examining a combination of different cell types have demonstrated the versatility of such 
techniques for the construction of a wide range of different tissue models, as indicated in 









Cartilage 1.9 Corning 
Transwell® 
(Kubosch et al., 2016) 
Articular Joint 3.8 Reprocell 
Alvetex® 
(S. Li et al., 2015) 
Nasal Epithelium 1.9 Corning 
Transwell® 
(Luukkainen et al., 2018) 
Airway Mucosa 1.9 Corning 
Transwell® 





(Cozens et al., 2018) 
Trachea 3.8 Corning 
Transwell® 
(Kaartinen et al., 1993) 
Lung Cancer 1.9 Corning 
Transwell® 
(Hassell et al., 2017) 
Prostate Cancer 1.9 Corning 
Transwell® 
(Mosaad et al., 2018) 
Intestine 3.8 Corning 
Transwell® 
(Kämpfer et al., 2017) 
Cornea 1.9 Merck Millicell® (Mikhailova et al., 2014) 
Liver 9.5 Corning 
Transwell® 
(Kang et al., 2013) 
Kidney 3.8 Corning 
Transwell® 
(Vinaiphat, Charngkaew and 
Thongboonkerd, 2018) 
Kidney 1.9 Corning 
Transwell® 
(King et al., 2017) 
Skin 3.8 Reprocell 
Alvetex® 
(Roger et al., 2019) 






(Stone, England and O’Sullivan, 2019) 
 
Table 2.1 – Range of co-culture tissue models generated using insert-based culture 
techniques. 
Limitations of well-insert culture formats include the higher costs of insert-based plasticware 
products, limited compatibility with certain cell assays and increased complexity when 
sectioning or imaging models (Knight, 2013; Marx et al., 2018). However, despite these 
drawbacks, a range of previous research have demonstrated the potential for using insert-
based culture models to study osteoarthritis. This includes work by Greenberg et al. to 
generate a co-culture model within a 24-well plate insert system, where within each well 
base a canine synovium explant was suspended within media, alongside a cartilage explant 




interleukin-1β, and also contained different concentrations of hyaluronic acid. The 
concentrations of various biomarkers were then assessed within the culture media over 
time, alongside histological sectioning and analysis of the explant pairs. Two potential 
mechanisms of action for viscosupplementation were hypothesised as a result of the 
experimental outcomes. This work provides an early example of the use of a ‘well-in-well’ 
co-culture system for the evaluation of the effect of specific additives on the biochemical 
and histological markers of cultured tissue (Greenberg et al., 2006). 
A similar insert-based co-culture system was used by Osterman et al. to observe the effects 
of platelet rich plasma concentration on inflammation-related cartilage gene expression. The 
addition of platelet rich fibrin to the osteoarthritic cartilage and synovium co-culture was 
found to produce a range of anti-inflammatory effects on gene expression, however this was 
not found to be affected by platelet or leukocyte concentration. This paper provides further 
evidence of the potential of low-cost, scalable, well-based co-culture systems that utilise 
tissue explants and media additives to provide an early insight into the functionality of novel 
treatments for OA (Osterman et al., 2015). 
2.2.3 Analysis Techniques 
The experimental value of a disease model is critically influenced by the analysis techniques 
employed within experimental designs. A range of possible biomarkers have been previously 
reported within the literature for the evaluation of OA progression in vivo. Research by Bay-
Jensen et al. provides a comprehensive review of current biomarker research, as well as 
classifying each biomarker in accordance with the BIPED classification scheme, which 
incorporates the burden of disease, investigative, prognostic, efficacy of intervention and 
diagnostic classification elements. This research highlights a number of key biomarkers that 
have previously been identified within the literature as potential future targets for disease 
monitoring applications. In addition, it outlines the need for significant further work within 
the field of biomarker research to further classify and validate independent biomarker 
targets (Bay-Jensen et al., 2016). These challenges have important ramifications when 
designing in vitro OA disease models due to the limited predictive value of current 
biomarkers for tracking disease progression. 
Typical biomarkers used in the evaluation of OA tissue models include collagen I, II and X, 
aggrecan and SOX9. Expression is usually assessed by indirect immunofluorescence, enzyme-




2012; Mohanraj et al., 2014; Kubosch et al., 2016). This is due to changes in expression of 
these markers that occur during chondrogenesis (Diaz-Romero et al., 2005; Graceffa et al., 
2019). Additional characterisation using histological staining techniques to qualitatively 
assess sulphated glycosaminoglycan content and tissue architecture are also commonly 
performed. Finally, the use of non-destructive techniques such as proteomics to analyse the 
secretome of disease models has also been explored to increase analysis throughput 
(Clutterbuck et al., 2011). Careful consideration must be made to the sensitivity and 
specificity of each marker, as well as the compatibility of selected analysis techniques with 
HTS methodologies. 
2.2.4 Disease Modelling 
The functionality and replicative accuracy of in vitro models is also heavily influenced by the 
mechanism through which osteoarthritic processes are artificially induced. This is normally 
performed by either biochemical or mechanical methods.  
Cytokines are commonly used within biochemical models due to the key role that they play 
in the degradation of joint tissue and subsequent onset of osteoarthritis. These models are 
relatively well understood, are lower cost and can be readily configured to suit specific 
research requirements. However, it is also important to understand the tissue-wide effects 
of such factors across each of the cell types contained within the model, as well as any 
effects that the spatial arrangement of cells or culture conditions will have on signalling 
pathway activation (Johnson, Argyle and Clements, 2016). 
A wide range of different cytokines have trialled for use with OA models, yet only a small 
number of these have gained popularity. This is due to the fact that many cytokines are 
chondrocyte-derived. Successful candidates include pro-inflammatory cytokines IL-1β and 
TNF-α, as they are commonly used to induce further cytokine release due to their well-
recognise role in OA pathogenesis (Lin et al., 2009; Rahmati, Mobasheri and Mozafari, 2016). 
However, it is important to note that the cytokines are supplemented at a considerably 
higher concentration to what would normally be observed in vivo (Macrory et al., 2009; 
Gabriel et al., 2010; Murab et al., 2013). They also require significant incubation periods 
under controlled conditions in order to have their target effect. Yet despite these limitations, 
studies have indeed been performed in order to assess the effect of cytokine concentration 




An example of such work is by Murab et al., wherein the authors use a matrix composed of 
silk protein with sulfonated moieties, combined with non-covalently immobilised IL-1β and 
TNF-α cytokines to induce an OA-like cartilage microenvironment. MMP, TIMP and ADAMTS 
activity were shown to be upregulated 35-fold when compared with untreated controls, with 
gene expression profiles of treated cells displaying similarities to profiles observed in vivo 
from patients undergoing surgical intervention. This research therefore illustrates the potent 
effects of exogenous cytokine supplementation in order to deliver a local and continuous 
OA-like microenvironment on cultured tissue (Murab et al., 2013).  
An alternative method of biochemically replicating OA pathophysiological processes in vitro 
is through the incubation of the model with synovial fluid taken from a human donor in 
substitution for specific cytokine stimulation. Research by Hoff et al. evaluates the influence 
of OA-donor synovial fluid on the cytokine stimulation of primary human chondrocytes in 
vitro. In response to synovial fluid incubation, chondrocytes actively secrete cytokines such 
as VEGF. The conclusions of this work, which demonstrates the activation of pro-
inflammatory cytokines as a result of OA synovial fluid incubation, further complements 
wider research which hypothesises the presence and effects of a pro-inflammatory 
microenvironment on OA disease pathogenesis (Gaber et al., 2012).  
As an alternative to biochemically induced models, mechanically induced models utilise the 
application of a defined loading mechanism to directly induce cellular damage and activate 
signalling cascades that lead to the onset of degradative OA-like pathological processes. Such 
models are able to recapitulate the in vivo loading patterns that occur within a healthy joint, 
as well as the damage caused by non-physiological loading. 
Mechanically induced OA model examples include work by Ikenoue et al. whereby an in vitro 
human articular chondrocyte monolayer was subjected to intermittent hydrostatic load 
bearing forces. This work demonstrated that through intermittent hydrostatic loading of 1, 5 
and 10 MPa for 4 hours 4 times a day, aggrecan mRNA signal levels increased 1.4, 1.8 and 
1.9-fold respectively. In addition, at 5 and 10 MPa using the same loading regime, type II 
collagen expression was reported to increase. This experiment highlighted the significant 
effects of hydrostatic loading pressure and duration of application on cellular matrix protein 
expression, and by implication, cartilage matrix anabolism. It also further highlighted the 




pressure components to more accurately replicate the biological processes of OA (Ikenoue 
et al., 2003). 
The effect of mechanical stimulation on chondrocytes seeded within an agarose structure 
was researched by Pingguan-Murphy et al. Glycosaminoglycan synthesis in bi-axial-loaded 
chondrocytes was shown to increase when compared with unloaded and uni-axial loaded 
samples over the same period. The introduction of a free swelling recovery period between 
loading patterns further increased glycosaminoglycan production and total DNA content 
retrieved from samples, demonstrating an increase in cell proliferation. This paper therefore 
serves to further demonstrate the capabilities of a simple 3D cell seeded agarose system to 
determine the most fundamental effects of mechanical loading patterns on cell viability and 
ECM production (Pingguan-Murphy and Nawi, 2012). 
Load-based models require a higher cell count than their biochemically induced counterparts 
and are less flexible to changes in experimental methods. Generally, such models are also 
more complex to set up and maintain during experimentation than biochemically induced 
alternatives. Research has shown that both biochemical and mechanical induction methods 
initiate cytokine effects, leading to similar pathophysiological changes in the treated tissue 
(Johnson, Argyle and Clements, 2016). It is also important to consider the impact of the 
mechanism for inducing OA on the reproducibility and throughput requirements of the 
model, with biochemically induced methods considered to be more scalable to high-
throughput culture formats. 
2.2.5 High-Throughput Screening 
Current model platforms are labour intensive to setup, limiting the total screening 
throughput and experimental replication that be performed. The value of in vitro disease 
models for commercial research applications is therefore heavily influenced by their 
compatibility with HTS platforms. High-throughput screening represents a core technique for 
the analysis of potential therapeutics within the pharmaceutical sector, allowing for the 
analysis of more than 100,000 compounds per day (Michael et al., 2008). Such systems rely 
upon high levels of automation and miniaturisation to rapidly screen large libraries of new 
chemical and biological entities, and systems are commonly standardised to allow for 
comparisons to be made between experiments from extensive datasets. This methodology is 
currently used across a range of applications including drug discovery, pharmacological 




Mikiciuk-Olasik, 2012). The widespread adoption of HTS for a range of different research 
applications has resulted in new challenges such as the need to develop imaging systems, 
automated data analysis workflows, and liquid handling systems that can be operated at a 
continually increasing throughput (Taylor et al., 2002; Starkuviene and Pepperkok, 2007; 
Boutros, Heigwer and Laufer, 2015).  
Research by Astashkina et al. highlights the growing need for HTS devices in order to 
accommodate the increased number of potential drug candidates in development. Primary 
enablers of this technology include advances in protein characterisation and combinatorial 
small molecule chemical synthesis capabilities within the pharmaceutical sector. High-
throughput systems are able to challenge the increased economical and ethical constraints 
that are associated with the drug development process. 
The themes highlighted in this research provide key requisites for the design and 
development of a truly impactful OA model for drug screening and research applications. It 
also highlights the need for identifying accessible biomarkers that are compatible with high-
throughput system designs for the analysis of in vitro model functions in situ. Such markers 
must also perform predictably in vivo in order to evaluate the replicative accuracy of the 
model to that of the human disease, whilst also allowing for cross-model comparisons 
(Astashkina, Mann and Grainger, 2012). 
In order to generate HTS-compatible models, it is necessary to scale up manufacture through 
automating routine laboratory tasks. Commercially available liquid handling systems provide 
a method to automate dispensing functions within conventional HTS well-plate formats. A 
variety of actuation methods are employed within such systems and can be categorised into 
contact and non-contact dispensing.  
Contact dispensing, a dispensing system most commonly consisting of a series of solid pins 
or pipette tips, functions by submersing the dispensing system within a liquid. The 
dispensing system is then removed from the liquid and transferred to the substrate where 
direct contact is made, transferring retained liquid onto the substrate through surface 
tension or pneumatic effects.  
Non-contact dispensing avoids physical contact with the substrate by directly ejecting 




practical limitations of surface tension on minimum droplet volume can be overcome, 
enabling the deposition of material down to the picolitre-scale.  
Recent developments within the field of bioprinting have exploited a combination of non-
contact liquid handling methods, alongside additive manufacturing principles, in order to 
facilitate the deposition of cellular material. 
2.3 Bioprinting Technologies 
Bioprinting is a methodology used to co-process cells and biomaterials to generate 3D 
structures. Bioprinting techniques are commonly applied within the evolving field of 
biofabrication in order to generate a range of tissue models and cell-based therapies. A 
considerable overlap exists between the fields of biofabrication, tissue engineering and 
regenerative medicine as depicted in Figure 2.11. 
 
Figure 2.11 – Overlap between the fields of biofabrication and tissue engineering (TE) and 
regenerative medicine (RM). Reproduced from (Groll et al., 2016). 
2.3.1 Overview of Common Bioprinting Processes 
Bioprinting systems encompass a wide range of additive manufacturing technologies for 
tissue engineering applications. This includes material extrusion, material jetting and laser-























Figure 2.12 – Flow diagram showing the range of printing processes that have been 
explored for bioprinting applications. Adapted from (Gudapati, Dey and Ozbolat, 2016). 
In order to generate a tissue structure using bioprinting, a range of design, optimisation and 






Figure 2.13 – Step-by-step process from conceptualisation to functionalisation of a 
bioprinted product for tissue engineering applications. Adapted from (Murphy and Atala, 
2014). 
The first stage of production involves the development of a computer aided design file using 
medical scan data or digital design software to represent the product requiring manufacture. 
The file is then converted into a printer-readable stereolithography file format and loaded 
onto the machine, alongside configuration settings in order to initiate the build. Post-
processing is sometimes required following construction in order to achieve specific 
manufacturing properties or remove supporting structures. A nutrient and gaseous support 
system is also required to maintain cellular viability and functionality. 
It is crucial to select an appropriate bioprinting technology for the intended tissue 
engineering application in order to maximise the efficiency, reliability and accuracy of the 
1. Product Design
• Collection of scan data - computed tomography, magnetic resonance imaging, X-
ray
• Image segmentation, compression and stacking into 3D
• Conversion of data and optimisation within computer aided design package
• Generation of printer compatible stereolithography file format with suitable print-
specific metadata
2. Material Selection
• Cells - autologous, primary, cell line
• Biomaterials - natural polymers, synthetic polymers, extracellular matrix
• External liquid nutrient supplies, oxygen permeability barriers, suspension and 
carrier liquids





• Cell culture media supplementation or nutrient and waste transfer
• Cytokine or mechanical stimulation
• Monitoring and assessment of biological and mechanical functionality
5. Functionalisation or Implantation
• Activation of target cellular behaviour and device functionality
• Implantation into patient or activation in laboratory environment




bioprinting process. Each bioprinting technology possesses specific advantages and 
disadvantages and is capable of generating an end product with unique properties. It is 
therefore necessary to match the desired product properties to a specific manufacturing 
technique in order to most accurately replicate the intended design attributes within the 
printed product. Due to current process limitations, a design is often modified in accordance 
with the selected manufacturing technique to enhance compatibility and improve 
manufacturing outcomes. A breakdown of the most commonly researched bioprinting 
technologies for tissue engineering applications are outlined in Table 2.2. 
 Printing Technique  
 Material Jetting Microextrusion Laser-assisted References 
Cell Viability > 85 % 40 - 80 % > 95 % 
(Hopp et al., 2005; Xu et al., 
2005, 2006; Chang, Nam and 
Sun, 2008; Koch et al., 2018) 
Cell Density 
Low (106 - 107 
cells per ml) 
High 
Medium (108 
cells per ml) 
(Xu et al., 2005; Guillotin et al., 
2010; Mironov, Kasyanov and 
Markwald, 2011; Marga et al., 





30mPa/s to > 6 
x 107 mPa/s 
1- 300 mPa/s 
(Guillemot et al., 2010; Kim et 
al., 2010; Chang et al., 2011; 
Guillotin and Guillemot, 2011) 
Scalability High Medium Low 
(Roshanghias, Krivec and 
Baumgart, 2017; Kačarević et 
al., 2018; Da Conceicao Ribeiro 








(Smith et al., 2004; Campbell et 
al., 2005; Phillippi et al., 2008; 
Guillotin et al., 2010; Faulkner-
Jones et al., 2013) 
Cost Low Medium High 
(Kartmann et al., 2015; 














(Smith et al., 2007; Koch et al., 
2010; Michael et al., 2013; 
Murphy, Skardal and Atala, 
2013; Da Conceicao Ribeiro et 
al., 2019) 
 
Table 2.2 – Comparison between the key bioprinting processes that are commonly used 
within the field of biofabrication. Adapted from (Murphy and Atala, 2014). 
Material jetting technology is ideal for the construction of tissue models due the high 
accuracy and deposition speed associated with this process. In addition, a wide range of 
previous literature is available reporting its use within cell deposition applications. Systems 
based upon material jetting technology are also comparatively low cost in both construction 
and operation. A diagram representing a typical material jetting system layout is presented 





Figure 2.14 – Diagram depicting the various components of a typical material jetting 
printing platform. 
The inherent similarities between material jetting technologies, commercial graphics 
printing and surface lamination treatment processes is also advantageous in terms of prior 
research. A significant volume of process and ink optimisation research exists detailing 
methods to maximise jetting performance, thus providing potentially transferrable solutions 
to current bioprinting challenges (Wijshoff, 2018). 
Material jetting processes include both inkjet and valve-based printing equipment. Each 
actuation system can be operated in a continuous jetting (CJ) or drop-on-demand (DoD) 
configuration in order to deposit material onto a substrate. 
2.3.2 Inkjet Printing 
Inkjet printing systems encompass a range of different actuation techniques to generate 
pressure waves that propagate through ink contained within the printer nozzle. This includes 
acoustic, electrostatic, thermal and piezoelectric actuation methods (Xu et al., 2005; Kim et 
al., 2008; Khalate et al., 2012; Hadimioglu, Stearns and Ellson, 2016).  
Inkjet printing systems have been used across a wide variety of applications including 
graphics production, printed electronics, solder dispensing, additive manufacturing, display 
and solar panel production, pharmaceuticals, microarray and ELISA construction (Pierik et 




Wijshoff, 2018; C et al., 2019; Cader et al., 2019; Ganesan et al., 2019; Yus et al., 2019). 
Research into the use of inkjet printing techniques for cell printing applications most 
commonly uses thermal or piezoelectric methods.  
Continuous jetting approaches pump ink from the printer reservoir through an open-ended 
capillary tube to produce a stream of liquid. The liquid then separates into droplets as a 
result of Rayleigh instability, a process describing the break-up of a falling stream of fluid 
into droplets, thus minimising liquid surface area. A piezoelectric actuation device is used to 
vibrate the capillary, enabling modulation of the break-up of the fluid stream. An 
electrostatic field is then applied between the capillary and substrate, with an additional set 
of electrostatic deflection plates used to direct the positioning of each falling droplet. When 
printing is not required, the droplets are directed into a waste feed for recycling into the 
printer reservoir. Although such systems are widely used in a commercial setting, few 
bioprinting applications exist due to the high ink recycling rate required for printing. The 
requirement to continually recycle material increases the risk of contamination or cellular 
and material degradation during extended printing periods (Wheeler et al., 2014). 
With a DoD process, an actuation signal is selectively applied to generate single droplets on 
command. Ink is retained within the nozzle between print jobs due to a combination of 
surface tension effects at the nozzle tip and the application of low pressure within the ink 
reservoir. For thermally actuated devices, an electrical pulse is applied to activate a heating 
element within the nozzle of the printer. As this heat is transferred into the ink, a small 
quantity of material is vaporised, causing bubble formation and a subsequent change in 
pressure. This pressure pulse leads to droplet ejection from the nozzle, and subsequent 
collapse of the bubble provides a negative pressure to pull in additional ink from the printer 
reservoir. 
Within piezoelectric DoD processes, an electrical pulse is applied to piezoelectric material 
surrounding the capillary of the inkjet nozzle as indicated in Figure 2.15. This causes a 
change in shape of the material, resulting in the expansion and contraction of the attached 
capillary. The volume changes within the capillary generate pressure propagations within the 





Figure 2.15 – Actuation cycle of a piezoelectric inkjet device under a push-pull 
configuration. (A) Resting state. (B) Piezoelectric material activation leading to droplet 
ejection through an increase in liquid pressure. (C) Retraction of piezoelectric material 
following ejection resulting in a negative pressure. 
The waveform applied to a material jetting device represents the intensity, duration and 
polarity of the electrical signal applied to the actuator. It is important to consider both the 
rheological properties of the ink as well as the waveform parameters applied in order to 
achieve maximum printing performance. Previous research has demonstrated the impact of 
these characteristics on jetting performance for a wide variety of printing applications. In 
2013, Woo et al. investigated the relationship between inkjet printability and ink rheology 
when jetting silver nanoparticle conductive ink solutions to demonstrate the effect of 
various ink formulations on droplet ejection behaviour and positional accuracy. This research 
highlights the significant impact of ink composition on jetting characteristics (Woo et al., 
2013).  
Research by Kwon highlights a potential methodology for optimising the waveform design of 
a piezoelectric dispensing device through monitoring the meniscus motion. Within this 
research, custom software is developed to monitor the camera feed displaying the meniscus 
location at the tip of the jetting device nozzle. Data was generated on the meniscus motion 
in response to changes in the dwell time, velocity and polarity of the waveform applied to 
the printing device, which was then used to predict jetting performance, enabling 
subsequent algorithmic waveform optimisation. Results from this study demonstrated that 




performance of jetting waveforms. This work identifies a potential method to preliminarily 
screen and optimise an efficient waveform without requiring extensive jetting studies 
(Kwon, 2010). 
Wu and Hwang researched the effect of echo time on jetting performance when using a 
bipolar waveform design to deposit solder droplets. Here, a range of different echo times 
were applied and the properties of droplets deposited assessed and compared with 
simulated models of droplet formation. In combination, these methods were used to 
highlight the importance of echo time on droplet formation characteristics, as well as 
provide an optimised configuration for depositing solder droplets. This research highlights 
the complexity associated with waveform design, as well as the value of performing 
optimisation to achieve stable droplet formation (Wu and Hwang, 2015). 
Initial research into the application of inkjet printing technology within the fields of tissue 
engineering and biofabrication focused on the deposition of biocompatible materials. 
A review paper by Lemmo et al. in 1998 provides an early example of where the potential for 
using inkjet printing systems within high-throughput applications was considered. Early 
applications of this technology focussed on the deposition of proteins and genomic material, 
whereby much lower quantities could be dispensed when compared to conventional 
techniques (Lemmo, Rose and Tisone, 1998). 
Research by Roth et al. in 2004 explored the use of a commercially available thermal inkjet 
printing system for the deposition of collagen. Patterns of collagen were generated on the 
surface of a material repellent to cellular attachment using inkjet printing. Smooth muscle 
cells were then deposited manually onto the surface of the material and cultured over a 16 
day period. Cellular attachment was observed amongst surfaces where collagen had been 
deposited, allowing for the selective creation of cell patterns through the use of low cost 
printing equipment. This research provided an early indication of the potential of inkjet 
printing systems for tissue engineering applications (Roth et al., 2004). 
In regards to cell printing, Wilson and Boland provide an early example of where a thermal 
inkjet printing system was successfully used to deposit endothelial and smooth muscle cells. 
The selective deposition of cells and biomaterials was successfully demonstrated, with cells 
deposited at a concentration of 105 cells per mL in cell culture media. An average cell density 




following loading into the printer. A Live / Dead® cell viability assay was performed and a cell 
viability of 75 % was reported immediately following printing. This important research 
demonstrated the possibility of using inkjet printing systems to successfully deposit viable 
cells, whilst highlighting the potential implications of such technology for HTS applications 
and 3D tissue assembly in vitro (Wilson and Boland, 2003). As an additional output of this 
research, the nozzle head modifications developed by Wilson and Boland were patented for 
cell printing applications (Boland, Wilson and Xu, 2006). Further research into the 
applications of inkjet cell printing were then performed by Boland et al. to introduce the use 
of thermosensitive materials for multi-layered cell printing. This research used the same 
printing equipment combined with thermosensitive gels and bovine aortal endothelial cells. 
Multi-layered printing was demonstrated, with droplet stacking of individual gel layers to 
enable the construction of 3D structures. This research provides an early demonstration of 
the potential for combining cells and gels in order to construct 3D structures. It also 
represents an early example of where the potential impact of the cell and gel combination 
for tissue and organ construction was explored (Boland et al., 2003).  
In 2005, Xu et al. demonstrated that it was possible to jet Chinese hamster ovary cells using 
a modified thermal inkjet printer and corresponding cartridge system that had been 
commercially sourced from Hewlett Packard. These cells were suspended within phosphate 
buffered saline and printed onto a soy agar and collagen gel membrane at a concentration of 
2-5 million cells per mL. A high cell viability was observed, with less than 8 % of cells lysed 
during the printing process, demonstrating the potential for using low-cost, commercially 
available technology in a modified form to process living cells (Xu et al., 2005). 
More recent work by Xu et al. has combined multiple manufacturing processes in order to 
produce a single cell scaffold. This consists of electrospun polycaprolactone fibres in 
combination with inkjet-printed rabbit elastic chondrocytes, suspended within a fibrin-
collagen hydrogel. The resulting 5 layer tissue had a depth of approximately 1 mm, with 
cellular viability within the tissue reported to exceed 80 % following printing. This work 
indicates the potential of combining multiple manufacturing processes, each with specific 
advantages and limitations, in order to generate a single cell-laden structure with properties 





The effect of waveform parameters on cell printing performance was evaluated by 
Yamaguchi et al. in 2012. Using Sf9 insect cells, cells were deposited using a custom elliptical 
inkjet nozzle at a density of one cell per droplet in saline solution. Polymer beads were also 
independently deposited whilst the nozzle was simultaneously imaged to determine the 
positioning of each bead within the capillary in response to modifications to the jetting cycle. 
This research concluded that push-pull piezoelectric waveform designs provide superior cell 
jetting performance to pull-push methods, providing valuable information for future work 
where the optimisation of cell jetting waveform designs are required (Yamaguchi et al., 
2012). 
Research by Park et al. has also examined the precision and accuracy of a piezoelectric inkjet 
printing platform for the construction of complex cellular arrays and patterns. Within this 
work, the effect of the printing process on cellular viability and proliferation was assessed, 
with printed cells exhibiting no significant differences when compared to manually 
deposited samples. Positional accuracy data of cell printing performance was also presented 
in response to printing parameter modifications in order to determine an optimal printing 
configuration. A complex array of cells labelled with different dyes was generated, 
demonstrating the precision of the printing process for the creation of small-scale co-culture 
models. This research provides validation of the inkjet printing process for the precise 
deposition of an array of different cellular materials (J. A. Park et al., 2017). 
Research by Lorber et al. highlights the feasibility of using piezoelectric inkjet printing 
technology to jet a liquid medium, here containing adult rat ganglion cells, onto a substrate. 
In their 2014 publication, the authors use droplet analysis tests to determine droplet 
ejection characteristics of the cell-containing ink solution. Furthermore, high cell viability 
was reported following deposition, providing further evidence of the potential for using 
inkjet dispensing for cell deposition. This work also highlights some of the key limitations of 
using jetting technologies to process cells by reporting complications such as cells settling 
within suspension, adherence to the internal surfaces of the reservoir, and nozzle blockages 
during printing that were observed during the experiments performed (Lorber et al., 2014).  
These effects are a recognised limitation of the material jetting process and are commonly 
observed when applying this technology within bioprinting applications, despite the lack of 
reporting within subject literature (Chahal, Ahmadi and Cheung, 2012). Nozzle blockages are 




requirements of the nozzle to achieve high jetting accuracy. This can occur as a result of 
unfiltered solids within a suspension, crystallisation of ink components, cell adherence to the 
internal surface of the nozzle, and aggregation of cells into clumps. Collection of material on 
the outer surface of the nozzle can also impede droplet ejection and result in blockages or 
reduced jetting performance. These limitations occur alongside the more widely reported 
limitations surrounding ink viscosity and surface tension requirements to achieve stable 
droplet formation (Jang, Kim and Moon, 2009; McIlroy, Harlen and Morrison, 2013; Woo et 
al., 2013). 
2.3.3 Valve Printing 
In valve-driven systems, a solenoid activated by an electrical signal generates a magnetic 
field: this magnetic field then opens and closes the valve mechanism to control material 
flow. This is most commonly achieved through the movement of a plunger to block and 
unblock the path of fluid flow through the device in response to actuation signals from the 
printer controller as shown in Figure 2.16. A positive pressure is continually applied behind 
the valve to drive material through the device when opened. 
 
Figure 2.16 – Actuation cycle of a solenoid valve dispensing device under a drop-on-
demand configuration. (A) Resting state. (B) Valve opening leading to droplet ejection. (C) 




Continuous jetting approaches hold the valve in the open position during printing until the 
desired volume of liquid has been dispensed at a single coordinate. This approach reduces 
mechanical wear on the actuator and maximises the rate of material deposition. As a 
consequence, a continuous stream of material is deposited towards the substrate.  
Within a DoD configuration, the valve is sequentially opened and closed to repeatedly 
generate individual droplets of a consistent volume. A target volume is achieved through 
repeated deposition of droplets of a defined volume onto the substrate. This approach 
requires operating the valve under a higher duty cycle than CJ methods, and throughput is 
limited by the maximum actuation frequency of the valve. The deposition of individual 
droplets increases the precision of material delivery and has been previously combined with 
droplet impingement and reactive jetting processes to successfully generate 3D structures 
(Da Conceicao Ribeiro et al., 2019). 
Solenoid valves have been used across a wide range of engineering applications including 
pneumatic and hydraulic control as well as material dispensing (Razban and Davies, 1991; 
Moseler and Straky, 2000; Ahn and Yokota, 2005). More recent research has applied 
solenoid valve dispensing systems for liquid handling applications within biomedical research 
(Niles and Coassin, 2005; Bammesberger et al., 2013). This includes the application of valve 
deposition systems to the field of biofabrication for the deposition of cellular materials. 
A critical advantage of valve-based processes over inkjet printing technologies is the range of 
ink cell concentrations that can be deposited. Previous research by Ribeiro et al. used a 
solenoid valve in a DoD configuration to deposit MSCs at a concentration of up to 40 million 
cells per mL. Cells were deposited using a reactive jet impingement process, whereby two 
opposing valves directed a reactive mixture of collagen, alginate, fibrinogen, thrombin and 
cells contained within droplets at one another, to meet and react in mid-air, thus enabling 
the production of 3D gels. This research provides evidence of the flexibility of valve actuators 
to deposit high cell density solutions, as well as reporting a novel multi-jet configuration to 
enable in situ reactive printing for the production of 3D structures (Da Conceicao Ribeiro et 
al., 2019). 
Previous examples of where valve printing processes have been used to construct tissue 
models include research published in 2013 by Faulkner-Jones et al. Within this project, a 




fabrication printer, enabling the deposition of cellular material at a density of approximately 
5 cells per droplet. This printing device was then applied for the construction of embryonic 
stem cell aggregates via a hanging droplet cell culture method. Cellular viability was retained 
following printing and throughout the aggregate culture period. This research provides new 
evidence for the semi-automated production of size-controlled micro tissues (Faulkner-Jones 
et al., 2013). 
A printed human skin model was generated by Lee et al. in 2014 using a solenoid valve 
actuation system operating under a CJ configuration. The system was used to sequentially 
dispense layers of collagen, fibroblasts and keratinocytes onto a Transwell® membrane 
insert, with subsequent tissue organisation induced using an air-liquid-interface culture 
technique. Biological analysis revealed that cell viability was maintained following the 
printing process, with distinct epidermal and dermal tissue layers retained throughout the 
14 day culture period. This research provides a working example of where valve printing 
technology has been successfully applied for the production of an insert-based tissue model 
(Lee et al., 2014). 
In 2015, research by Ling et al. demonstrated the potential for using a custom solenoid 
valve-based printer to selectively deposit MCF-7 breast cancer cells for the manufacture of 
cell aggregates. Deposition volume was adjusted through modulating dispensing pressure 
and actuation pulse duration. Within this project, a gravimetric approach was applied to 
induce cell aggregation following deposition onto a printed concave gelatin microarray. 
Maintenance of cell viability following printing was confirmed using a Live / Dead® assay, 
with aggregate structure monitored over 7 days using microscopy. This research provides a 
further demonstration of the potential for using valve printing processes to scale up the 
manufacture of tissue aggregates (Ling et al., 2015). 
Work by Horvath et al. in 2015 applied valve printing technology for the fabrication of air-
blood barriers. Within this research, a commercial bioprinter was used to deposit a 
proprietary ECM substitute onto Millicell® insert membranes, followed by the sequential 
addition of endothelial, ECM and epithelial cells. Maintenance of cellular viability was 
reported following printing through quantitative evaluation of cellular proliferation and 
lactate dehydrogenase release. Bioprinted tissues displayed a flatter morphology than 
manually deposited samples when assessed using histological staining techniques, thus 




the versatility of valve printing techniques for the construction of tissue models that are 
comprised of a range of different cell types (Horvath et al., 2015). 
Further research by Min et al. in 2018 provides yet another example of bioprinted skin using 
a CJ valve deposition system in combination with sequential fibroblast, melanocyte, 
keratinocyte and collagen layering. A similar Transwell® membrane and air-liquid-interface 
was applied to promote and retain structural organisation of printed cells. Histological 
examination of the printed constructs was presented, demonstrating that the developed 
protocol was capable of generating skin tissue with clearly defined epidermal and dermal 
regions. Skin pigmentation as a result of melanocyte activity was also observed, further 
demonstrating the potential of valve printing processes for the production of in vitro tissue 
models (Min et al., 2018). 
2.3.4 Ink Composition 
The performance of each material jetting process is heavily influenced by the fluid properties 
of the ink being dispensed. A number of dimensionless quantities within the field of fluid 
mechanics have been used to predict fluid behaviour within a material jetting system. 
The Reynolds number is defined as being the ratio of inertial to viscous forces within a fluid 









𝑅𝑒 = Reynolds number 
𝜌 =  Density of fluid 
𝑢 = Velocity of fluid with respect to object 
𝐿 = Characteristic linear dimension 
𝜇 = Dynamic viscosity of fluid 
𝑣 = Kinematic viscosity of fluid 
 









The Weber number is used to analyse fluid flow in the presence of an interface between two 






𝜎 = Surface tension 
𝑊𝑒 = Weber number 
 
Equation 2.2 – Definition of Weber number used to characterise the ratio of surface to 
inertial forces within a fluid. 
The Ohnesorge number is used to describe the significance of viscous forces within a fluid to 









𝑂ℎ = Ohnesorge number 
 
Equation 2.3 – Definition of Ohnesorge number used to describe the significance of viscous 
forces within a fluid to inertial surface tension effects. 
The inverse of the Ohnesorge number (Z) has been used to define ink printability within DoD 
configurations (McKinley and Renardy, 2011). Initial research indicated that the Z factor of 
an ink must exceed 2 in order to achieve stable droplet formation (Fromm, 1984). More 
recent research has redefined the printable range as between 2 and 20 for practical ink 
designs through a combination of theoretical and practical experimental techniques (Reis 
and Derby, 2000; Jang, Kim and Moon, 2009; Liu and Derby, 2019). This research provides a 
marker for defining new ink properties in order to retain sufficient jetting performance. 
It is also important to consider the influence of ink composition, droplet ejection 
characteristics and substrate properties on droplet-substrate and droplet-droplet 
interactions, due to the recognised impact that they have on substrate splashing and 
subsequent printing accuracy (Stow and Hadfield, 1981; Perelaer et al., 2009; Jung, 2011; 




Previous research by Derby in 2010 constructed the parameter space shown in Figure 2.17 
to define ink printability within DoD systems by using the dimensionless quantities 
previously described. 
 
Figure 2.17 – Printability of inks plotted as a function of the Reynolds and Weber number 
for drop-on-demand printing processes. Reproduced from (Derby, 2010). 
Ink design therefore requires careful consideration of the impact of potential constituent 
materials on fluid rheology in order to maintain jetting performance. Traditionally, such 
designs have employed the use of specific chemicals that act as humectants, defoamers, 
surfactants or rheology modifiers to improve the stability and printability of ink solutions, as 
well as the properties of printed material (Hutchinson, 1978; Ramirez and Tumolva, 2018).  
Despite this, many materials commonly used to optimise the rheological properties of inks 
for commercial printing applications are not biocompatible with cellular material. This places 
greater restrictions on the level of ink optimisation that can be performed prior to printing. 
It is also important to consider the impact of solid cellular material suspended within a liquid 
ink on its overall printability. The distribution of suspended cells, individual cell size, and 
propensity of the cell type to aggregate can impact cell printing performance. Finally, the 
sensitivity of cells to shear forces induced by the jetting nozzle and potential reactivity of 




the printing process with each cell and material combination. A range of research has been 
published on various methods to minimise nozzle blocking and subsequently improve the 
performance of the material jetting process when depositing cell-containing solutions. This 
includes modifications to the printing devices and bioink composition used for cell 
dispensing. 
One example of a study into such effects is research by Parsa et al. in 2010 which evaluated 
the effect of using a combination of surfactants and stir-bar agitation on piezoelectric inkjet 
printing performance. Here, the authors use Pluronic® F68 at a concentration of 0.05 %, 
added to cell culture media to resuspend HepG2 hepatocyte cells at a density of 500,000 
cells per mL. Cells were loaded into a custom reservoir containing a stir-bar and 
corresponding external mixer circuit. Cells were then deposited with the stir-bar 
intermittently activated for approximately 5 seconds at 2 minute intervals over a 10 minute 
printing period to determine the impact of the stir-bar and surfactant on cell viability and 
metabolic activity. The addition of surfactant was not reported to have any significant 
impact on cell viability, with improvements in droplet ejection characteristics attributed to 
the differences in ink rheology. Stir-bar agitation was reported to reduce cell sedimentation, 
however inconsistencies in cell printing performance were still observed as a result of 
continual cell aggregation. This study therefore provides further evidence of the issues 
surrounding cellular aggregation and sedimentation when performing cell printing, requiring 
further research to evaluate additional methods to improve printing performance (Parsa et 
al., 2010). 
Chahal et al. carried out research into methods to reduce the effect of cell sedimentation 
and aggregation during the printing process. Within this work, Ficoll-PM 400® and Pluronic 
F127® were added to cell culture media at a concentration of 0 - 20 % and 0.25 % 
respectively to reduce the rate of cell sedimentation and ink surface tension. Cells were then 
resuspended in the ink at a concentration of 500,000 cells per mL and deposited using a 
piezoelectric inkjet dispensing device. Sedimentation velocity analysis revealed that 
increasing the ink Ficoll® concentration reduced the rate of cellular sedimentation. Cell 
deposition performance was also assessed over a 90 minute period by dispensing 30,000 
drops into individual wells of a 96 well plate. A significant reduction in variability of counted 
cells per well was reported in samples containing 5 or 10 % Ficoll® solution when compared 




reduced. The presence of Ficoll® was not found to have a significant impact on cellular 
metabolic activity when compared with untreated samples. This work provides a potential 
method to improve jetting performance through the inclusion of media additives that 
reduce cellular sedimentation and aggregation. Further research is required to evaluate the 
effects of the ink formulation on cellular viability and function to assess its suitability for 
bioink applications (Chahal, Ahmadi and Cheung, 2012). 
Research reported in a thesis by Tse in 2015 provides further evidence of the effect of cell 
sedimentation and aggregation on inkjet printing performance. Within this research, NG108 
mouse neuronal cells were sequentially deposited over a period of 100 minutes. A rapid 
reduction in the number of cells deposited was reported within the first 10 minutes of 
printing, with further deterioration in performance over a subsequent 40 minutes. Further 
printing resulted in negligible numbers of cells being deposited when compared with the 
earlier time points. The study was then repeated with the addition of intermittent gaseous 
aspiration cycles to the printer reservoir, with a small increase in printing performance 
reported following each aspiration cycle. This study highlights the difficulty in maintaining 
cell printing performance over extended printing periods when using inkjet printing 
technology. It also provides an early evaluation of the use of gaseous aspiration techniques 
to reduce cell sedimentation during printing. Although the aspiration protocol used was 
shown to have an initial effect on cell printing performance, this was not sufficient to fully 
restore initial performance. Additional issues were also reported surrounding droplet 
instability caused by the pressure changes induced as a result of the aspiration process. 
Further work is therefore required to assess the use of alternative techniques to reduce cell 
sedimentation during printing (Tse, 2015). 
Poly-l-lysine (PLL) is a polycation that is commonly used to coat cell culture plasticware in 
order to improve cellular adherence by ionically interacting with the negative charge of cell 
membranes. It has also previously been shown to promote chondrogenic differentiation of 
chondroprogenitor MSCs (San Antonio and Tuan, 1986; Woodward and Tuan, 1999). As a 
result, PLL has been studied as a potential material for the construction of hydrogels for 
cartilage tissue engineering applications (Clark et al., 2016). It has also been combined with 





Previous research by Ribeiro et al. employed PLL for the development of a temporary single 
cell coating process to reduce the cell agglomeration-induced nozzle blockages associated 
with material jetting technologies. The effect of the coating process was assessed on three 
cell types; neonatal human dermal fibroblasts, osteosarcoma cells and Ewing’s sarcoma cells 
across a concentration range of 10 - 100 µg / mL. A cell viability of 70 % was reported 
following coating at a PLL concentration of 10 µg / mL, with additional analysis performed to 
define the endocytic pathways involved in subsequent polymer internalisation. The effect of 
the coating process on cellular agglomeration was assessed via a combination of microscopy 
and cell printing approaches. Printing performance for the coated osteosarcoma cell samples 
was maintained over a 1 hour assessment period, with uncoated samples resulting in a rapid 
deterioration in jetting performance within a 20 minute period. This work highlights a 
potential method to improve the jetting performance of bioinks through temporary 
modification of the cell surface charge. Possibilities for future research include characterising 
the effects of the coating process on cellular functionality and agglomeration across 
additional cell types (Ribeiro et al., 2017). 
Taken as a whole, further research is therefore required to assess the potential of novel 
processing techniques such as those previously described, to improve material jetting 




Chapter 3. Methodology 
3.1 Cell Culture 
Y201 hTERT immortalised human Mesenchymal Stromal Cells (MSCs) (kindly donated by 
Professor Paul Genever, University of York) were obtained from passage 73, and cultured in 
high glucose (4.5 g / L) Dulbecco's Modified Eagle Medium (DMEM) (Thermo Fisher 
Scientific, USA) supplemented with 10 % foetal bovine serum (Thermo Fisher Scientific), 
5000 U / mL Penicillin / Streptomycin (Sigma-Aldrich, UK) and 2 mM L-Glutamine (Sigma-
Aldrich).  
TC28a2 human chondrocyte cells (Merck, USA) were obtained at passage 22, and were 
cultured in high glucose (4.5 g / L) DMEM / Ham’s F12 mix 1:1 v / v (Thermo Fisher Scientific) 
supplemented with 10 % foetal bovine serum (Thermo Fisher Scientific), 5000 U/mL 
Penicillin / Streptomycin (Sigma-Aldrich) and 2 mM L-Glutamine (Sigma-Aldrich).  
Cells were incubated at 37 °C, 5 % CO2 in a humidified atmosphere and passaged at ~70 % 
confluency through aspiration of media and washing with Phosphate Buffered Saline (PBS) 
(Sigma-Aldrich) (2.5 mL / 25 cm2) to remove residual serum. Trypsin-
ethylenediaminetetraacetic acid (0.05 %) (Sigma-Aldrich) (0.5 mL / 25 cm2) was added to the 
flask and incubated at 37 °C, 5 % CO2 until cells had detached from the flask surface. Cell 
culture media was added to the flask (> 1.0 mL / 25 cm2) to inactivate the trypsin and the 
suspension transferred to a centrifuge tube. The solution was centrifuged at 200 g for 5 
minutes and the resulting supernatant removed. The cell pellet was then re-suspended in 1 
mL of fresh cell culture media for cell counting. The volume of the cell-containing solution 
was adjusted accordingly with cell culture media to achieve the desired final concentration 
for reseeding into cell culture flasks. 
3.1.1 Cell Counting 
A trypan blue exclusion test was performed to determine the viable cell number during cell 
counting. Trypan blue dye is only able to stain cells with a disrupted cell membrane, causing 
the cytoplasm of non-viable cells to appear blue during examination. 
To perform a cell count a 20 µL aliquot of cell-containing solution was combined with an 
equal volume of 0.4 % trypan blue staining solution (Sigma-Aldrich). The viable cell number 
was determined by counting the number of unstained cells using a 0.1mm depth Neubauer 





Cells were trypsinised at ~70 % confluency using the procedures previously described and re-
suspended in a volume of freezing medium consisting of 10 % v / v dimethyl sulfoxide 
(Sigma-Aldrich) in foetal bovine serum to achieve a final concentration of 106 cells per mL.  
Cell suspension was then aliquoted into 1 mL cryopreservation tubes (Corning, USA) and 
placed in a dedicated freezing chamber (Thermo Fisher Scientific). The chamber was placed 
in a -80 °C freezer for 2-3 days to control the rate of cell freezing. Cryopreservation tubes 
were then transferred into liquid nitrogen for long-term storage at -196 °C. 
Samples were thawed via suspension of the cryogenic storage tube in a water bath at 37 °C 
until partially thawed. The sample was then immediately resuspended into a minimum of 10 
mL of cold fresh cell culture media and centrifuged at 200 g for 5 minutes. The supernatant 
was discarded and the pellet resuspended in cell culture media at the desired density for 
seeding into a cell culture flask. 
3.2 Metabolic Activity Assays 
Cells were seeded into the wells of a 96-well plate at a density of approximately 5,000 cells 
per well and incubated at 37 °C, 5 % CO2 for a minimum of 12 hours to facilitate cell 
attachment. 
3.2.1 MTT Assay 
Following treatment in desired experimental conditions, the cell supernatant from each well 
was removed and replaced with 100 µL of freshly prepared MTT (Sigma-Aldrich) working 
solution (0.5 mg / mL) in phenol-red free cell culture media (Thermo Fisher Scientific). Plates 
were incubated for a further 4 hours until formazan crystals had been produced. 
Supernatant was then removed from each well and replaced with 100 µL of propan-2-ol 
detergent solution (Fisher Scientific, USA). The plate was agitated for 30 minutes to 
solubilise the formazan crystals. The absorbance values for each well were then obtained 
using an ELx800 microplate reader (Biotek, USA) at 570 nm with a 630 nm reference 
wavelength recorded for normalisation. 
3.2.2 PrestoBlue® Assay 
Following treatment in desired experimental conditions, the cell supernatant from each well 
was removed and replaced with 100 µL of PrestoBlue® (Thermo Fisher Scientific) working 
solution previously prepared from the addition of 10 % v / v PrestoBlue® reagent to phenol-




for each plate were obtained using a FLUOstar® Omega microplate reader (BMG Labtech, 
Germany) using an excitation and emission filter of 544 nm and 620 nm respectively. 
3.3 Cell Viability Assay 
Cellular viability was assessed in response to different treatment conditions via the use of a 
Live / Dead® cell viability assay (Thermo Fisher Scientific). This assay contains a non-
fluorescent calcein acetoxymethyl compound that enters the cell membrane and is readily 
converted into a green fluorescent calcein dye via esterase enzymatic activity within living 
cells. Ethidium homodimer-1 is also contained within the assay and enters cells with 
damaged membranes. This compound binds to nucleic acids within the cell leading to a red 
fluorescence upon exposure to light. 
To perform the assay, each of the stock solutions were warmed to room temperature and 
diluted in PBS to produce a 2 μM calcein acetoxymethyl and 4 μM ethidium homodimer-1 
working solution. Adherent cells were washed extensively with PBS prior to the application 
of Live / Dead® working solution. The samples were then incubated for a period of 30 
minutes in a humidified atmosphere at 37 °C, 5 % CO2 prior to imaging. 
Imaging was performed using a DMLB fluorescence microscope (Leica Biosystems, Germany) 
at 10x magnification and images captured using a SPOT Advanced CMOS camera (Spot 
Imaging Solutions, USA) and corresponding microscopy software. A fluorescein filter was 
used to image the calcein fluorescence and Texas red filter for ethidium homodimer-1. 
3.4 Cell Imaging 
3.4.1 2D Sample Preparation 
For adherent cells grown in monolayer culture, three PBS washes were performed prior to 
fixation for 15 minutes in 4 % paraformaldehyde solution (Thermo Fisher Scientific). Fixed 
cells were then washed three times in PBS and stored at 4 °C in PBS prior to staining. 
3.4.2 3D Sample Preparation 
At several time points, samples were embedded in Tissue-Tek® optimal cutting temperature 
compound (Sakura Finetek, USA) and were snap frozen in liquid nitrogen. Samples were kept 
at -80 °C until use. Samples were cryosectioned by Xin Xu of the Newcastle Central Biobank 
using a CM1900 cryostat (Leica Biosystems, Germany) and sectioned at a thickness of 10 μm. 
Slides were kept frozen until analysis, where they were dried, sections restricted with a PAP 
pen (Sigma-Aldrich), washed in PBS and fixed for 30 minutes in 4 % paraformaldehyde 




3.4.3 Haematoxylin and Eosin Staining 
Optimal cutting temperature compound embedded sections were immersed in PBS for 
approximately 1 minute prior to staining. Samples were incubated in Mayer’s haematoxylin 
(Sigma-Aldrich) for 5 minutes prior to rinsing in running tap water for 2 minutes to blue 
haematoxylin stained nuclei. Samples were dehydrated through incubation in ethanol 
solutions of increasing concentration prior to immersion in eosin solution (Sigma-Aldrich) for 
30 seconds. Samples were further dehydrated and incubated in Histo-Clear® II (National 
Diagnostics, USA) for 5 minutes before being mounted in DPX (Sigma-Aldrich). Samples were 
imaged using an Axio Imager® (Carl Zeiss AG, Germany) upright microscope at 20x 
magnification. 
3.4.4 DAPI and Phalloidin Staining 
A combination of phalloidin–tetramethylrhodamine B isothiocyanate (Sigma-Aldrich) and 
mounting medium containing 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) were 
used to visualise the filamentous actin (F-actin) present within the cytoskeleton and cell 
nucleus respectively. Fixed cells were washed extensively in PBS prior to the addition of 1 μg 
/ mL phalloidin working solution prepared in PBS. Cells were then incubated for a period of 
20 minutes at room temperature prior to three washes in PBS. 
Coverslips were mounted to glass slides following the addition of mounting media containing 
DAPI and incubated for a further 5 minutes before imaging. Imaging was performed using an 
LSM800 point scanning confocal microscope (Carl Zeiss AG) at 20x magnification. 
3.4.5 Indirect Immunofluorescence Staining 
Fixed samples were permeabilised in 0.1 % Triton X (Merck) and washed in PBS 3 times for 5 
minute intervals. Samples were then blocked with an incubation of 2 % bovine serum 
albumin (Merck) for 30 minutes. Excess bovine serum albumin was removed and replaced 
with primary antibody solution. Primary antibodies were diluted in PBS to achieve a final 
concentration of 1/200 for Collagen II (ab34712, Abcam, UK) and 1/50 for Aggrecan (ab3778, 
Abcam). Samples were incubated for 2 hours at room temperature in the antibody solution 
before being washed 3 times for 5 minutes in PBS. Secondary antibody solution was then 
prepared using Alexa Fluor® 488 or 594 (Thermo Fisher Scientific) at a concentration of 
1/500 and added to the samples for a further 1 hour incubation. Samples were washed 3 
times in PBS and mounted in mounting medium containing DAPI. Imaging was performed 





3.5.1 System Configuration 
All printing experiments were performed using a JetLab® 4 XL (MicroFab, USA) printing work 
station combined with the JetDrive® printer drive electronics unit. Droplet ejection 
characteristics were assessed via the on-board stroboscopic camera in responses to printing 
parameter modifications. 
The device was cleaned by flushing 1 % v / v Micro-90 cleaning solution (Cole-Parmer, USA) 
followed by 70 % v / v ethanol (Fisher Scientific) through the reservoir, tubing and jetting 
device for a minimum of 10 minutes to remove potential sources of contamination prior to 
and following each use. The device was extensively flushed with sterile filtered de-ionised 
water immediately prior to use to remove any residual cleaning agents. 
3.5.2 Reservoir Configuration 
An in-house developed reservoir design and accompanying agitation system were utilised for 
all cell printing experiments. Two different systems were employed for printing experiments 
with each design incorporating a MINSTAC® 062 thread (the Lee Company, USA) to maintain 
compatibility with both the inkjet and valve actuation devices used. A continuous voltage of 
1.5 V was applied to the motor of either device via an external power supply unit (Elenco 
Electronics, USA) following ink loading to prevent cell sedimentation prior to or during 
printing. 
The initial design, referred to as ‘Agitator A’, incorporated a shaft-driven axial-flow impeller 
attached to an electric motor to minimise cell sedimentation within the 2 mL capacity ink 
reservoir shown in Figure 3.1. Ink loading was performed through the decoupling of the 
agitator and reservoir components. During printing, ink was fed directly into the actuation 






Figure 3.1 – Reservoir and agitator design ‘A’ used to minimise cellular aggregation during 
printing. (A) Reservoir and agitator following coupling. (B) View of threaded coupling 
between agitator and reservoir. (C) Motor, gearbox, driveshaft and impellor assembly. (D) 
Mounted reservoir and agitation system for printing. 
A revised design referred to as ‘Agitator B’ comprised of a 5 mL capacity reservoir shown in 
Figure 3.2. Agitation was achieved through the rotation of a gold-plated cylindrical 
neodymium magnet mounted to the inside of the reservoir. Movement was induced via an 
electrical motor coupled to an additional magnet external to the reservoir. This design 
reduced the minimum size of the agitator and isolated the reservoir contents in a sealed 
container during operation. Ink loading was performed via the removal of the clamped 
reservoir lid. Ink was fed into the actuation device via an orifice at the base of the reservoir 





Figure 3.2 – Reservoir and agitator design ‘B’ used to minimise cellular aggregation during 
printing. (A) View of gold-plated magnet suspended within reservoir. (B) External motor 
housing, lid clamping mechanism and pneumatic tubing connectors used to pressurise 
reservoir during printing. (C) Open reservoir configuration to allow for ink refilling. (D) 
Closed reservoir configuration for printing. 
3.5.3 Ink Preparation 
Cell culture medium was used as the bioink in each of the bioprinting experiments. The 
solution was heated to 37 °C and filtered using a 0.22 µm filter (Merck) prior to use. Cell 
pellets were then re-suspended within the culture media formulation and transferred to the 




3.5.4 Jetting Commands 
A range of different scripted command sets were produced in order to control the 
positioning stage, pressure output, drive waveform and image capture systems. All plate-
based cell printing experiments were performed using point-by-point, coordinate driven 
controls as shown in Figure 3.3. 
moveall 0 0 -35 
(move stage <X> <Y> <Z>) 
 
set zpos -35 
(Set printer movement height <Z>) 
 
set well on -38 





-0 0 1 10 0 





Figure 3.3 – Typical script layout for depositing material on a point-by-point basis using 
JetLab® printer control software. 
3.6 Statistical Analysis 
Data presented shows mean values ± standard deviation. All data were analysed using 
Prism® 8 statistical analysis software (GraphPad Software, USA) using two-way analysis of 
variance in combination with Tukey or Šídák multiple comparison tests. The Shapiro-Wilk 
test was used to assess normality prior to statistical analysis. 
Linear regression analysis was performed to identify trends within standard curve data and 






Cell proliferation assays were assessed via nonlinear regression analysis using an exponential 
(Malthusian) population growth model defined by the equation: 
𝑌 = 𝑌0 × 𝑒
𝑘𝑥 
Where: 
Y0 = Starting population 
𝑘 = Rate constant 
𝑥 = Population doubling time 
Equation 3.1 – Assessment of cell proliferation using the exponential (Malthusian) 
population growth model. 
An extra sum-of-squares F test was performed to compare the rate constant value of each 
sample group.  






Chapter 4. Single Cell Printing 
4.1 Introduction 
The aim of this chapter is to assess the suitability of an inkjet printing platform for the 
selective deposition of single cells. 
Within this chapter, the printing performance of a piezoelectric drop-on-demand inkjet 
printing device is characterised in response to critical printing parameters such as waveform 
design, signal dwell time and voltage and device backpressure.  
The biological effects of the inkjet printing process are characterised using mesenchymal 
stromal cell and chondrocyte cells, with the effects of this process determined by cell 
viability and function assessments. 
Single cell printing performance data is presented to demonstrate the suitability of the 
technique for high resolution bioprinting applications.  
Additional to this, an in-house developed poly-l-lysine cell coating protocol and reservoir 
agitation system are benchmarked to enhance inkjet cell printing performance over 
extended printing periods. 
4.2 Methodology 
4.2.1 Inkjet Printing Configuration 
MJ-AT-01 (standard) and MJ-ATP-01 (protected) threaded low temperature single-orifice 
piezoelectric jetting devices (MicroFab, USA) were used to deposit material from the printing 










Figure 4.1 – MJ-AT series piezoelectric inkjet actuation device configurations. Scale bar = 
10mm. 
The on-board pneumatic regulator was controlled via the JetDrive® control software to 
provide a negative backpressure of between -0.1 and -0.3 psi at the reservoir, depending 
upon ink levels present during printing. The pressure level was adjusted prior to each print 
job to ensure that the ink meniscus at the nozzle tip remained flush with the orifice. This was 
required to maximise jetting performance and prevent fluid leakage or impeded droplet 








Figure 4.2 – Inkjet nozzle prior to and following backpressure adjustment. Scale bar = 400 
μm. 
A range of different waveform designs were assessed in order to maximise the jetting 
performance of various bioink solutions. The function of these designs was to modify the 
actuation voltage intensity, polarity and duration applied to the piezoelectric actuator within 
the nozzle to modify droplet ejection. 
 A positive unipolar waveform configuration was developed that utilised a short ramp 
up period followed by a period of sustained applied voltage and equal ramp down 
period. 
 A bipolar waveform was developed that incorporated a positive trapezoid pulse 
similar to that of the unipolar waveform, followed immediately by a negative 
trapezoid pulse. 
 A tripolar waveform was developed that incorporated a similar pulse pattern to that 
of the bipolar waveform with the addition of a second trapezoid shaped positive 
pulse at the final stage of the waveform. 
All waveforms were developed with a resting voltage of 0 V and maximum positive voltage 
of 70 V. A jetting frequency of 1000 Hz was selected for all printing experiments. These 
parameters were selected to maximise printing throughput whilst adhering to manufacturer 
recommendations to minimise piezoelectric depoling during extended periods of operation. 





Figure 4.3 – Diagram of superimposed unipolar, bipolar and tripolar waveform designs 
used to apply an actuation signal to the piezoelectric inkjet actuation device. 
4.2.2 Characterisation of Printing Performance 
Droplet size and volume were calculated using the on-board stroboscopic camera in 
combination with the Aphelion® image processing software (ADCIS, France) incorporated 
within the JetDrive® printer control program. Droplets were dispensed from the inkjet nozzle 
and images captured using the stroboscopic camera following a strobe pulse generated 
synchronously with inkjet actuation. Adjustment of the timing delay of the strobe pulse 
following inkjet actuation enabled viewing of each stage of droplet ejection in response to 
different waveform configurations. Aphelion® image processing software was then used to 
identify the outline of the droplet across a series of sequential images. Droplet 
circumference, volume and velocity were calculated relative to the camera view scale and 
positional changes across the series of images. 
Cell printing performance was determined by depositing 50 droplets per coordinate onto a 
glass slide and normalising the total cell count to droplet number. Single cell printing 
performance was characterised by manually counting the number of cells contained within 
single droplets sequentially deposited onto a glass slide. Cells were counted immediately 
following printing using a DMLB microscope (Leica Biosystems, Germany). 
4.2.3 Polymeric Cell Coating 
Single cell coating was performed using the polycationic polymer poly-l-lysine (PLL) 




Fluorescein isothiocyanate (FITC) labelled PLL (Sigma-Aldrich, UK) of an equal molecular 
weight was used for cell coating studies. PLL was dialysed for 2 days using a cellulose 
membrane (Sigma-Aldrich) with a molecular weight cut-off of 14 kDa. PBS dissolution was 
then performed to achieve a stock concentration of 1 mg / mL. The solutions were sterilised 
through filtration with a 0.22 µm pore size polyethersulfone filter (Sigma-Aldrich) and 
diluted to a desired final concentration using Hank’s balanced salt solution. PLL-coated cell 
imaging was performed using an LSM800 point scanning confocal microscope (Carl Zeiss AG, 
Germany) at 40x magnification. 
A PrestoBlue® assay was performed to assess the impact of PLL concentration on cellular 
metabolic activity. Mesenchymal stromal cells and chondrocyte cells were seeded at a 
density of 5,000 cells per well into a 96 well plate and incubated overnight to facilitate 
attachment. The media was then aspirated and replaced with media containing PLL at each 
specified concentration. Samples were incubated for a period of 15 minutes prior to washing 
with Hank’s balanced salt solution (Sigma-Aldrich). Cell culture media was added to each 
well and the cells incubated for the desired time points before performing a PrestoBlue® 
metabolic activity assay as previously described. 
To PLL coat the cells, a 200 µL cell suspension was prepared at a cell density of 107 cells per 
mL and the required concentration of coating solution added to achieve a final volume of 1 
mL. As shown in Figure 4.4, the solution was agitated and incubated for 15 minutes at 37 °C, 
5 % CO2 to allow for cell coating. The coated cells were centrifuged at 200 g for 5 minutes 
and re-suspended in Hank’s balanced salt solution twice to remove unattached polymer 
within the solution. Cells were re-suspended in cell culture media to achieve the desired 





Figure 4.4 – Diagram depicting the stages of an in-house developed poly-l-lysine cell 






4.3.1 Waveform Optimisation 
An initial series of experiments were performed in order to evaluate the performance of the 
inkjet printing device for depositing cell culture media. The first experiment compared the 
effect of a range of different waveform designs on droplet formation characteristics using 
the on-board stroboscopic camera. Figure 4.5 displays the droplet ejection behaviour 
resulting from each of the three waveform designs assessed.  
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Figure 4.5 – Sequential droplet ejection images for each waveform design captured using 
the JetLab® on-board stroboscopic camera using an incremental strobe delay of 50 μs. Cell 
culture media was deposited at a jetting frequency of 1000 Hz and actuation voltage of 20 
V. Scale bar = 400 μm. 
All three waveforms were found to be capable of ejecting droplets of cell media under 
normal conditions. The tripolar configuration was found to be the least versatile, with jetting 




reduced when using a unipolar waveform design, irrespective of other waveform 
parameters. 
Droplet ejection performance was found to be highly dependent upon waveform design, 
with tripolar waveform configurations particularly susceptible to jetting instability. Ink 
accumulation around the nozzle orifice as well as air ingestion and entrapment within the 
nozzle was observed during extended jetting periods, resulting in jetting failure as depicted 
in Figure 4.6. 
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Figure 4.6 – Sequential droplet ejection images captured using the JetLab® on-board 
stroboscopic camera using an incremental strobe delay of 20 μs. Cell culture media was 
deposited at a jetting frequency of 1000 Hz and actuation voltage of 20 V. Scale bar = 400 
μm. 
Further assessment of the impact of voltage and dwell time on droplet formation 
characteristics was performed using the unipolar and bipolar waveform designs. An 
approximate minimum voltage of 20 V and dwell time of 4 μs was required to achieve 
droplet ejection across both unipolar and bipolar waveform designs as shown in Figure 4.7. 
Unipolar droplet ejection characteristics exhibited two discrete regions of stable droplet 
formation. Bipolar droplet ejection characteristics exhibited a single region of stable droplet 














































Figure 4.7 – Heat map showing the effect of jetting parameters on droplet ejection 
characteristics when dispensing cell culture media.   = Stable droplet formation.   = 





Figure 4.8 highlights the impact of each waveform design on droplet formation 
characteristics. Droplet volume and velocity were quantified using the on-board image 
analysis software. 
The bipolar waveform design was observed to generate droplets of a higher velocity and 
volume in comparison to the unipolar design, irrespective of the dwell time applied to the 
actuation signal. An optimal dwell time configuration was determined to be 18 μs for the 
unipolar waveform and 30 μs for the bipolar waveform to consistently generate single 
droplets at a high ejection velocity and volume. 





























































































Figure 4.8 – Influence of dwell time on primary droplet ejection properties for unipolar and 
bipolar waveform designs at an actuation voltage of 40 V / -40 V. (A) Unipolar droplet 
ejection velocity. (B) Bipolar droplet ejection velocity. (C) Unipolar droplet ejection volume. 
(D) Bipolar droplet ejection volume. Data represents mean values ± SD. N=3. 
Further comparison between the unipolar and bipolar waveform designs under the defined 
dwell time parameters highlighted a correlation between actuation voltage and droplet 
velocity, irrespective of waveform design. Figure 4.9 indicates that the bipolar waveform was 




configuration across each voltage configuration assessed. Droplet volume remained stable 
across a larger voltage range for the bipolar waveform design. 



















































Figure 4.9 – Effect of actuation voltage on primary droplet ejection velocity and volume for 
unipolar and bipolar waveform designs at a dwell time of 18 and 30 μs respectively. Data 




An additional study was performed to assess the influence of inkjet nozzle orifice size on 
droplet ejection characteristics. Data within Figure 4.10 displays a negative correlation 
between nozzle size and droplet velocity across the three nozzle diameters tested. Droplet 
volume was shown to increase in response to increases in the nozzle orifice diameter. 
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Figure 4.10 – Influence of nozzle orifice diameter on droplet ejection characteristics when 
depositing cell culture medium using a bipolar waveform design at an actuation voltage of 
70 / -70 V and dwell time of 30 μs. Data represents mean values ± SD. N=6. 
4.3.2 Cell Deposition Performance 
Following material jetting characterisation, a range of further characterisation steps were 
performed to compare the effect of unipolar and bipolar waveform designs on cell printing 
performance. For these studies it was necessary to increase the minimum actuation voltage 
applied to the jetting device to 40 V in order to maintain printing performance. 
The data in Figure 4.11 highlights the impact of waveform design on cell printing 
performance. The bipolar waveform design was shown to deposit approximately 0.5 cells 
per droplet across the three dwell times assessed. The unipolar waveform design failed to 




































Figure 4.11 – Effect of waveform design and dwell time on inkjet cell printing performance 
when depositing MSCs at a concentration of 106 cells per mL. Data represents quartile 
values ± min / max values. N=6. 
The impact of cell ink concentration was also assessed across each dwell time configuration 
for the bipolar waveform design as shown in Figure 4.12. The cell density per droplet was 
shown to increase as expected in response to increases in the cell ink concentration loaded 
into the printer. An increase in variability was also observed in response to an increase in cell 






































Figure 4.12 – Effect of cell concentration on inkjet printing performance across a range of 
different bipolar waveform dwell times. MSCs were deposited at a concentration of 106 
cells per mL. Data represents quartile values ± min/max values. N=6. 
An important consideration when studying the cell printing performance of the inkjet 
actuation device was the period in which the device had been inactive prior to commencing 
printing. A significant increase in cell density was temporarily observed following periods of 
inactivity where cells had been retained within the reservoir of the printing system. 
The data presented in Figure 4.13 provides a quantification of this effect through comparing 
the cell printing performance of the inkjet system immediately following a purging cycle 
versus a sustained resting period. Cell density per printed droplet was observed to remain 
relatively stable over the course of a series of 10 subsequent actuation cycles where 
previous actuation immediately prior to the printing command had taken place. However, a 
temporary increase in cell density per droplet was observed where the printer had been 

































Figure 4.13 – Impact of nozzle purging on cell printing performance immediately prior to 
dispensing. Data represents mean values ± SD. N=3. 
To determine the maximum possible resolution of the inkjet printing platform, a further 
experiment was performed using the previously defined printing parameters. 
The sequential droplet deposition data displayed in Figure 4.14 highlights the frequency of 
achieving 1 cell per droplet for the MSC and chondrocyte cell types at ink concentrations of 1 
and 2 million cells per mL.  
At an ink concentration of 1 million cells per mL, a similar number of droplets contained 
either a single cell or none. Less than 10 per cent of droplets ejected contained more than a 
single cell for either cell type. At a concentration of 2 million cells per mL, an approximate 
cell density per droplet of 1 was achieved in the highest proportion of droplets assessed, 
with a smaller proportion of additional droplets containing either no cells or multiple cells, 
correlating with a Poisson probability distribution. No significant difference in cell density 
per droplet was observed when comparing the jetting performance of MSC and chondrocyte 
cell types. A cell density equivalent to approximately 1 cell per droplet was achieved at an 




























































































































































Figure 4.14 – Inkjet cell dispensing performance using an optimised bipolar waveform. Cell 




million cells per mL. Cell density per droplet for the MSCs (C) and chondrocytes (D) at an ink 
concentration of 2 million cells per mL. Frequency distribution graphs showing the 
percentage of droplets containing different MSC (E) and chondrocyte (F) concentrations. 
(G) Normalised cell density per droplet for each cell type. N=50. 
Figure 4.15 provides a sequential droplet ejection image array of cells deposited using the 
bipolar waveform design. A single primary droplet was ejected from the nozzle orifice with 
minimal ligand formation, preventing the formation of additional satellite droplets. 
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Figure 4.15 – Deposition of MSCs at a concentration of 106 cells per mL in cell culture media 
using a bipolar waveform design. Images were captured using a sequential strobe delay of 
50 μs. Scale bar = 400 μm. 
4.3.3 Biological Impact Assessment 
Following assessment of cell deposition performance, it was necessary to characterise the 
effects of the printing process on cellular viability and function. A combination of 
morphological analysis and cell viability, proliferation and metabolic activity assays were 
used to characterise the cellular effects of the printing process.  
Figure 4.16 displays the results of the Live/Dead® cell viability assay performed on cell 
samples deposited via the inkjet printing process versus manually pipetted controls. The 
ratio of live to dead cells, labelled green and red respectively, was maintained between 
manually seeded control samples and printed cells both immediately following and 24 hours 
after printing for both cell types. Cells appear smaller whilst in suspension immediately 
following printing, with cell adherence to the culture vessel surface and subsequent cell 

















Figure 4.16 – Live / Dead® microscopy images displaying the viability of cells processed 
using the inkjet actuation device relative to manually pipetted control samples 




An MTT metabolic activity assay was performed to assess the impact of the printing process 
on the overall metabolic activity of each cell type following seeding. No significant difference 
in metabolic activity was observed between printed and manually seeded cells at each time 











































Figure 4.17 – MTT metabolic activity assay displaying the effect of the inkjet printing 
process on cellular metabolic activity when compared with manually seeded cells over a 3 




Confocal microscopy was used to assess the morphology of each cell type prior to and 
following printing. The fluorescence microscopy data presented in Figure 4.18 and Figure 
4.19 compares the effect of the printing process on cell morphology immediately after 
printing and after a subsequent incubation period. No discernible difference in cell 
morphology or adherence rate was observed for either cell line when compared with 















Figure 4.18 – Influence of inkjet printing process on cell morphology for the MSC line. Cell 
nuclei were visualised using DAPI (blue) and F-actin using phalloidin (red) staining. Scale 














Figure 4.19 – Influence of inkjet printing process on cell morphology for the chondrocyte 
cell line. Cell nuclei were visualised using DAPI (blue) and F-actin using phalloidin (red) 




An additional study was performed to further analyse the effect of the inkjet printing 
process on cell viability through monitoring the rate of cell growth following printing. The 
data in Figure 4.20 displays the population growth rate and cell viability of MSC and 
chondrocyte cell types subjected to the inkjet printing process. No significant difference in 
population doubling time was observed when comparing samples of cells deposited via 
manual and inkjet printing techniques. 


































































































 MSC Chondrocyte 
Control Printed Control Printed 
Y0 (x104) 3.97 3.43 6.26 5.87 
K (Hours-1) 0.023 0.021 0.029 0.025 
Doubling Time (Hours) 29.58 32.87 24.17 28.17 
 
Figure 4.20 – Effect of inkjet printing process on the proliferation rate of MSC and 
chondrocyte cell lines in comparison to manually seeded cells. (Left) Live cell number 
assessed via a trypan blue exclusion test. (Right) Percentage of live cells counted at each 
time point. (Bottom) Parameters obtained from nonlinear regression analysis using an 





4.3.4 Cell Aggregation 
A deterioration in printing performance was observed when jetting cellular material for 
extended periods of time. This resulted in failed print jobs, and in some cases required full 
disassembly and cleaning of the printing device. This was despite the production of droplets 
of uniform consistency using the optimised printing parameters previously defined.  
The deterioration in performance was caused by the agglomeration of cells within the 
printer reservoir leading to blockage of the nozzle orifice. Figure 4.21 displays the nozzle 
prior to, during and following extended periods of jetting. The accumulation of cells within 
the nozzle was observed via the on-board camera, which showed the progressive blocking of 
the orifice over the course of the print. Microscopic analysis following printing showed the 
presence of large agglomerates of cells within the nozzle orifice, preventing further material 
flow from the nozzle. 
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Figure 4.21 – Nozzle blockage and cell sedimentation captured using the JetLab® on-board 
stroboscopic camera (top) and via a microscope (bottom) when depositing cells at a 




It was therefore necessary to assess potential modifications to the printing process in order 
to reduce the rate of cellular agglomeration and minimise the possibility of nozzle blockages 
occurring. This included the use of agitation systems to minimise the rate of cell 
sedimentation during extended periods of printing, as well as the coating of cell membranes 
with poly-l-lysine to prevent cellular agglomeration. 
4.3.5 Polymeric Cell Coating 
The effect of the cell coating process on cellular viability and metabolic activity was assessed 
in order to determine the most appropriate poly-l-lysine concentration for cell coating. 
Fluorescence microscopy images from the Live / Dead® assay shown in Figure 4.22 indicate 
an equal proportion of live to dead cells across both cell lines up to a PLL concentration of 50 
μg / mL. A significant reduction in live cell number immediately following and 24 hours after 
the coating process was observed across samples exposed to PLL concentrations of 50 and 
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Figure 4.22 – Effect of PLL coating concentration on cellular viability of the MSC and 
chondrocyte cell lines immediately following and 24 hours after coating. Scale bar = 200 
μm. 
Metabolic activity data displayed in Figure 4.23 quantifies the effect of PLL coating 
concentration on cellular metabolic activity across a range of time points. A significant initial 
reduction in metabolic activity was observed for the MSC and chondrocyte cell lines in 
response to polymer concentrations in excess of 25 μg / mL. Although metabolic activity was 
shown to increase over the 72 hour incubation period, this was not sufficient to match the 
activity of untreated MSCs. A partial recovery in metabolic activity over 72 hours was 
observed for chondrocyte cells exposed to a PLL concentration of 50 μg / mL or greater. 
Below this concentration, no significant difference in metabolic activity was observed 
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Figure 4.23 – Effect of PLL coating concentration on cellular metabolic activity for the MSC 
and chondrocyte cell lines. Data represents mean values ± SD. N=6. 
Confocal microscopy was performed on samples coated with FITC-conjugated PLL to identify 
the efficiency and stability of the single cell coating process, as well as its subsequent 
degradation and internalisation. FITC-PLL fluorescence intensity and coating efficiency was 




at concentrations of 50 μg / mL or higher in the MSCs, as shown in Figure 4.24. At lower 
concentrations, speckling of FITC-PLL was visible on the cell surface. Following a 24 hour 
incubation period all cells displayed speckled areas of PLL. 
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Figure 4.24 – Cell coating efficiency of FITC-conjugated PLL (green) at various 
concentrations for the MSC line. Cells were imaged immediately following and 24 hours 
after coating. Cell nuclei were visualised using DAPI (blue) and F-actin using phalloidin 
(red) staining. Scale bar = 50 μm. 
Chondrocyte cells exposed to the coating process demonstrated speckling across the full 
concentration range assessed, with none of the tested concentrations sufficient to fully coat 
the cell membrane, as shown in Figure 4.25. Evaluation of the cells 24 hours following 




  Chondrocyte 
  Day 0 Day 1 












































    
Figure 4.25 – Cell coating efficiency of FITC-conjugated PLL (green) at various 
concentrations for the chondrocyte cell line. Cells were imaged immediately following and 
24 hours after coating. Cell nuclei were visualised using DAPI (blue) and F-actin using 
phalloidin (red) staining. Scale bar = 50 μm. 
4.3.6 Printer Reservoir Agitation 
The performance of two separate agitation systems was assessed in terms of both the level 
of cellular dispersion retained within the reservoir over time as well as cellular function in 
response to the agitation process. 
Figure 4.26 demonstrates the impact of sedimentation on cellular dispersion across each 
continually agitated reservoir design in comparison to both non-agitated samples and those 
agitated manually using a pipette. A rapid reduction in cellular dispersion was observed in 




period assessed. Cellular dispersion remained stable across the full time course where 
agitation within the reservoir was employed, irrespective of agitator design.  
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Figure 4.26 – Effect of continuous reservoir agitation on cellular dispersion and metabolic 
activity at a concentration of 106 cells per mL. (A) MSC count. (B) Chondrocyte cell count. 
(C) MSC metabolic activity. (D) Chondrocyte metabolic activity. Data represents mean 
values ± SD. N=6. 
Assessment of cell metabolic activity for each sample revealed a significant reduction in the 
metabolic activity of non-agitated samples within the first 30 minutes of incubation across 
each cell type assessed. A greater metabolic activity range was recorded for agitator A when 
compared with manually agitated samples. Agitator B was shown to provide a minimal 
impact on metabolic activity when compared with manually agitated samples. 
A minimum agitator ink volume of approximately 1.5 mL was required for agitator B to 
function. This was caused by the movement of the magnetic stirrer in and out of liquid 






Figure 4.27 – Bubble formation in Agitator B. (A) Foam generated within reservoir during 
agitation under low ink volumes. (B) Foam in ejected material following jetting. 
An additional experiment was performed to determine the impact of the reservoir agitation 
system on cell printing performance. Figure 4.28 compares the printing performance of the 
inkjet system under agitated and non-agitated conditions. A gradual reduction in cell 
number deposited per droplet was observed under non-agitated conditions over the first 60 
minutes of printing followed by a nozzle blockage preventing further deposition. Consistent 
deposition performance was maintained within the agitated sample group throughout the 2 
































Figure 4.28 – Effect of agitation system on inkjet dispense performance over time when 
depositing MSCs. Data represents mean values ± SD. N=6. 
 
4.4 Discussion 
4.4.1 Waveform Optimisation 
Initial experimentation with the inkjet actuation device highlighted the importance of 
developing printing parameters optimised to the ink’s rheological properties. Significant 
variation in droplet velocity, volume and directionality occurred in cases where droplet 
ejection characteristics varied as a result of satellite formation or the sequential ejection of 
multiple droplets per actuation pulse. These effects negatively implicated both the accuracy 
and printing resolution that could be achieved. As a consequence, partially ejected material 
accumulated around the tip of the nozzle, leading to a further reduction in printing accuracy 
and a progressive deterioration in jetting performance. Additionally, minor variations within 
the manufacturing tolerances of the piezoelectric element, orifice diameter or glass capillary 
length also affected the pressure oscillations and subsequent jetting performance of each 
inkjet device. It was therefore necessary to tailor the waveform design and printing 
parameters to both each jetting device and the bioink composition used in order to 




Cell culture media has a high surface tension and low viscosity, resulting in a theoretically 
low degree of printability when defined through fluid properties (Wasan and Papoutsakis, 
1995; Jang, Kim and Moon, 2009). A significant amount of energy was therefore required 
during printing to overcome the surface tension forces and initiate droplet ejection from the 
ink volume contained within the nozzle. Due to the comparatively low viscosity, once droplet 
ejection had been initiated a reduced trailing ligand was generated following the ejection of 
the primary droplet, with the high surface tension reducing droplet ejection velocity. This 
resulted in a reduced operational range for actuation voltage intensity and waveform dwell 
time settings. Ejected droplets also displayed a less stable trajectory, resulting in reduced 
depositional accuracy when impacting the substrate. 
It was therefore necessary to experiment with a range of custom waveforms in order to 
improve droplet formation and ink deposition. It was possible to reduce the jetting 
frequency down to 100Hz for material deposition. Although droplet ejection characteristics 
could be further improved at reduced jetting frequencies, printing speed was substantially 
reduced, resulting in an excessively compromised jetting throughput. 
A jetting frequency of 1000Hz was selected for printing experiments in order to maximise 
the inkjet deposition rate whilst adhering to the operational range of the actuation device 
used. Jetting frequencies beyond 1000Hz increase the risk of damage to the piezoelectric 
actuator within the nozzle and provide a reduced total waveform duration between 
actuations, further limiting potential configuration options. 
Waveforms were developed that utilised the lowest possible voltage in order to achieve 
stable droplet ejection. A consistent voltage and jetting frequency was used across each of 
the waveform designs assessed to allow for direct comparisons to be made solely on the 
effects of the waveform dwell time and signal polarity. 
Images in Figure 4.5 outline the sequential droplet deposition images captured when 
employing unipolar, bipolar and tripolar waveforms. This study was performed to identify 
the most robust and reliable configuration for material deposition. Considerable ink 
accumulation and air ingestion was observed when using a tripolar waveform, resulting in 
jetting failure as shown in Figure 4.6.  
Quantification of the effect of unipolar and bipolar waveform designs on droplet ejection 




shown to generate droplets of a higher velocity and volume when compared with unipolar 
waveform designs, alongside operating across a greater parameter range. An optimal dwell 
time for each waveform was defined as 18 μs and 30 μs for the unipolar and bipolar 
waveforms respectively to maximise droplet velocity and volume. Further characterisation 
data presented in Figure 4.9 demonstrated that the bipolar waveform design was capable of 
achieving a higher droplet ejection velocity than the unipolar design, alongside reduced 
variability in ejection volume where actuated under the optimal dwell time previously 
defined. 
In combination, these results indicate that the bipolar waveform design is most suitable for 
depositing cell culture media, through operating across the widest parameter range and 
ejecting droplets of a higher velocity and volume when compared to unipolar and tripolar 
configurations. These observations reinforce previous findings within the literature whereby 
waveform designs were compared for the ejection of material using a similar piezoelectric 
inkjet printing device (Kwon, 2009). 
The effect of nozzle orifice diameter on printing performance was also assessed, with 
droplet volume positively correlating with nozzle diameter in response to a reduced ejection 
velocity, as shown in Figure 4.10. This reinforces prior research recognising the relationship 
between orifice diameter and printing performance (Miers and Zhou, 2017). 
4.4.2 Cell Deposition Performance 
The inclusion of cells within the liquid ink solution produced a colloidal dispersion, which 
altered the rheological properties of the ink and led to variations in inkjet printing 
performance. 
The minimum actuation voltage required to successfully deposit material was higher when 
jetting solutions containing cells than when jetting cell culture media alone, irrespective of 
waveform design. In addition, droplet ejection characteristics were found to be more 
sensitive to dwell time adjustments where cell-based inks were used. It was therefore 
necessary to further evaluate the parameters previously defined in order to maximise cell 
deposition performance. 
The bipolar waveform design was shown to be more robust when depositing cell-containing 




was demonstrated in Figure 4.11 when assessing the cell density of dispensed material in 
response to changes in dwell time for each of the waveform designs.  
A target cell density of 1 cell per droplet was achieved following further optimisation of the 
ink concentration and dwell time configuration. A significant increase in cell density per 
droplet was observed in response to increasing the ink concentration from 1 to 2 million 
cells per mL, as shown in Figure 4.12. Variability in cell density per droplet was found to 
increase in response to an increase in the cell concentration within the ink, representing a 
trade-off between deposition density and resolution when using the inkjet printing process. 
Idle time between print jobs was also found to have a significant impact on inkjet cell 
deposition performance. The use of purge cycles immediately prior to printing was shown in 
Figure 4.13 to reduce the variability in cell density per droplet obtained, as well as providing 
a mechanism to clear partial nozzle blockages. These findings reflect previous observations 
in other fields where inkjet printing techniques have been extensively studied for high-
volume material printing applications (Lund and Ward, 1998; Pawlowski and Childers, 2001; 
Park, 2013). They also provide a valuable mechanism that can be employed to reduce the 
performance issues commonly associated with inkjet printing platforms. 
The efficiency of the single cell printing configuration was also demonstrated via the 
sequential deposition of individual droplets. The majority of droplets printed were found to 
contain single cells, with a minority containing 0, 2 or 3 cells. The frequency distribution of 
cells per droplet, displayed in Figure 4.14, correlated with Poisson distribution probability 
modelling. These observations reflected previous research exploring the potential for single 
cell printing via inkjet deposition technologies, whereby a similar distribution of ejected cells 
per droplet was observed (Liberski, Delaney and Schubert, 2011; Moon et al., 2011; Yusof et 
al., 2011). 
4.4.3 Biological Impact Assessment 
The biological impacts of the inkjet printing process were characterised using a combination 
of cell viability, metabolic activity and proliferation assays, as well as morphological analysis. 
The Live / Dead® assay data reported in Figure 4.16 showed no significant difference in the 
ratio of live to dead cells between manually seeded and printed samples for both cell types 
studied. This result indicated that the inkjet printing process does not induce any immediate 




The data presented in Figure 4.17 compared the metabolic activity of cells printed using the 
inkjet printing platform with manually seeded cell controls using an MTT assay. No 
significant differences in metabolic activity were observed for the MSC or chondrocyte cell 
lines when comparing manually deposited and inkjet printed samples. These results provide 
evidence of the suitability of the inkjet printing process for cell deposition applications. 
The morphology of cells processed using the inkjet printing technique were compared with 
manually seeded cells in Figure 4.18 and Figure 4.19 for the MSC and chondrocyte cell lines 
respectively. Cell adherence and growth was shown to be similar for both seeding 
techniques, with no discernible differences in cell morphology observed over the assessment 
period.  
Proliferation studies comparing the growth rate of manually seeded and printed MSC and 
chondrocyte cells displayed a similar percentage of viable cells at each time point, with a 
small variation in the number of cells counted immediately following seeding. No significant 
difference in the rate of population growth following seeding was observed between printed 
and manually seeded cells, as reported in Figure 4.20, indicating that the cell printing 
process had no significant effect on cell growth kinetics following seeding. 
Taken together, these findings indicate that the inkjet printing process can be used to 
deposit MSC and chondrocyte cells without significantly affecting cellular viability or 
function, highlighting the biocompatibility of the printing process for cell deposition 
applications. These findings provide further evidence of previous observations within the 
literature that examined the impact of inkjet printing on cellular viability and function using 
alternative cell types (Saunders, Gough and Derby, 2008; Cui et al., 2010). 
4.4.4 Cell Aggregation 
Nozzle blockages previously reported within the literature were observed when printing for 
extended periods of time, as shown in Figure 4.21 (Chahal, Ahmadi and Cheung, 2012; Tse, 
2015; Tse et al., 2016). This significantly reduced the reliability of the printing process by 
regularly interrupting the printing job. It was not possible to alleviate this issue through 
modifications to the jetting parameters used, or the use of alternative nozzles with a larger 
orifice diameter. The passage of cellular clumps through the nozzle was also found to impair 
the flow of material through the nozzle chamber during actuation-induced pressure 




when compared with the ejection characteristics observed when depositing cell culture 
media.  
These effects had a considerable impact on the scale at which cell printing could be 
performed when using inkjet dispensing devices. Two separate techniques were researched 
as potential methods to reduce cellular agglomeration and improve process reliability. This 
included both the use of an agitation system within the reservoir compartment of the 
printer, as well as the process of coating individual cells with a polycation prior to printing. 
4.4.5 Polymeric Cell Coating 
The effect of the poly-l-lysine cell coating process on cellular viability and metabolic activity 
was studied to identify an optimal concentration range for cell printing applications.  
The Live / Dead® assay data reported in Figure 4.22 displayed a significant reduction in cell 
viability in response to concentrations exceeding 50 μg / mL for both the MSC and 
chondrocyte cell lines. Analysis of the metabolic activity of each cell type following coating 
revealed a significant reduction in metabolic activity across samples exposed to PLL 
concentrations exceeding 25 μg / mL for the MSCs, and 50 μg / mL for the chondrocyte cell 
line, as shown in Figure 4.23. 
The efficiency of the PLL cell coating process was assessed by fluorescence microscopy, as 
shown in Figure 4.24 and Figure 4.25 for the MSC and chondrocyte cell lines respectively. 
FITC-conjugated PLL cell coating efficiency was shown to increase with PLL concentration for 
the MSC cell line, with a minimum concentration of 50 μg / mL required to fully coat the 
membrane of the cells. PLL coating efficacy was reduced in the chondrocyte cell line, with 
speckled coating observed across the full concentration range assessed. A reduction in FITC-
PLL signal intensity following a 24 hour incubation period indicated that the PLL was 
internalised within the cell over time. The reduction in speckling area and increased point 
intensity of the fluorophore highlighted potential polymer consolidation by internal cellular 
processes.  
In combination, this data provides evidence of a dose-dependent response to the PLL 
concentration used for cell coating. This reflects the observations of previous research 
whereby low PLL concentrations were found to have a negligible impact on the viability of 
other cell types, with higher concentrations reducing cellular viability and function (Ribeiro 




applications to reduce cellular agglomeration where a low polymer concentration was used. 
Further research is required to characterise the biocompatibility of the PLL coating process 
on additional cell lines, as well as benchmark its impact on inkjet printing performance. 
4.4.6 Printer Reservoir Agitation 
A combination of two in-house agitation systems were developed and evaluated to reduce 
the rate of cell sedimentation and agglomeration during extended printing periods. Gravity-
induced cell sedimentation occurred during printing, leading to cell sedimentation at the 
base of the reservoir. Subsequent cell agglomeration and attachment to the interior surfaces 
reduced the concentration of cells within suspension, leading to a reduction in printing 
performance irrespective of reservoir outflow positioning.  
The data reported in Figure 4.26 indicated that both designs were capable of greatly 
reducing the rate of cellular sedimentation within the reservoir chamber when assessed over 
a 120 minute incubation period, providing agitation performance comparable to that of 
manually agitated samples. This represented a significant improvement over the use of a 
regular reservoir design during cell printing experiments. When comparing each agitator 
design against manually agitated cells, agitator design B was shown to provide the smallest 
variation in metabolic activity for each cell type. Despite this, it was important to consider 
the working volume of each agitation system due to the bubble formation that occurred 
during operation at low volumes, as depicted in Figure 4.27. These effects were not 
observed within agitator design A, making this design more suitable for low volume 
applications. 
The impact of the agitation system on inkjet printing performance was also benchmarked in 
Figure 4.28. Agitated samples were shown to prevent a deterioration in printing 
performance over a 120 minute testing duration. This contrasted with the results obtained 
for the non-agitated samples printed, whereby a significant deterioration in performance 
occurred over the first 60 minutes of printing, leading to the blockage of the inkjet nozzle. 
Although nozzle blockages still occurred during normal use when using the agitated reservoir 
system, the frequency of blockages was significantly reduced. This data highlights the value 
of employing an agitation system in order to reduce cellular sedimentation and 
agglomeration, thus providing a mechanism to improve the reliability of the inkjet printing 
process. These findings have important implications within the field of biofabrication to 





Within this chapter, an inkjet printing process was explored for the selective deposition of 
biological material for high-accuracy bioprinting applications. 
 A bipolar waveform design was developed to enable the deposition of biological 
material at the picolitre-scale 
 Single cell printing was achieved, with the cell density per droplet correlating with a 
Poisson probability distribution 
 The inkjet process was shown to not have any significant effect on cellular viability, 
metabolic activity, morphology or proliferation rate when assessed using the MSC 
and chondrocyte cell types, demonstrating its suitability for cell printing applications 
 A novel polycationic cell coating system was benchmarked, with a PLL concentration 
of up to 25 μg / mL shown to not affect cellular viability or metabolic activity 
 A custom reservoir agitation system and purging process was successfully 
demonstrated to reduce the rate of cellular sedimentation and subsequent 





Chapter 5. Aggregate Construction using Valve-based Bioprinting 
5.1 Introduction 
The aim of this chapter is to investigate the application of a valve-actuated bioprinting 
process for the production of 3D cell aggregates. The material jetting performance of a drop-
on-demand valve-based printer is characterised through evaluation of the effect of various 
actuation parameters, such as waveform and backpressure, on printing accuracy, resolution, 
throughput and reliability. 
Cell printing performance is also assessed, with additional studies conducted to determine 
the biocompatibility of the printing process with mesenchymal stromal cell and chondrocyte 
cell lines. 
A combination of 3D aggregate culture methods are utilised to construct tissue models of 
each cell type using the valve printing technique. Biological characterisation is performed to 
determine the impact of the printing process on model morphology, cellular organisation 
and phenotypic marker expression. 
5.2 Methodology 
5.2.1 Valve Printing Configuration 
Lee VHS Series 24 V solenoid valves, connected via a 0.62 MINSTAC® fitting to a 0.25 mm 
jewelled orifice dispensing nozzle (The Lee Company, USA), were used to deposit material 
for all valve-based bioprinting experiments, as shown in Figure 5.1. An adjustable spike-and-
hold driver (The Lee Company) was used to convert the JetDrive® waveform output into a 
valve-compatible signal to control device actuation. An external power supply (ISO-Tech, UK) 
was connected to the spike-and-hold driver to provide the additional power source required 
for actuation. This setup provided a continuous 24 V supply to the spike driver terminal and 










Figure 5.1 – VHS series valve actuator with 0.25 mm diameter jewelled orifice nozzle and 
accompanying spike-and-hold driver. Scale bar = 10 mm. 
The MicroFab CT-PT4 standalone pneumatics controller box was used to generate a 
backpressure of between 100 and 400 mmHg at the reservoir, depending upon ink levels 
present during printing. The pressure level was manually adjusted to achieve accurate and 
reliable material ejection characteristics. An external pneumatics system was required due 
to the limited pressure output capability of the on-board pneumatics system designed for 
use with inkjet devices. 
A simple trapezoid shaped unipolar waveform, shown in Figure 5.2, was used to provide a 5 
V actuation signal and 0 V resting signal to the external spike-and-hold driver using the 
JetDrive® control software. A dwell time of 200 µs and actuation signal frequency of 500 Hz 





Figure 5.2 – Diagram of actuation signal waveform generated to operate the valve via an 
intermediary spike-and-hold controller. (A) Unipolar waveform of drive signal applied to 
spike-and-hold controller. (B) Spike-and-hold controller output signal applied to valve. 
5.2.2 Characterisation of Printing Performance 
Characterisation of droplet volume via gravimetric methods was performed by selectively 
depositing material onto a substrate in response to changes in total droplet number or 
printing parameters. The substrate mass was then immediately measured using an Explorer® 
analytical balance (Ohaus, USA). 
Droplet volume was determined via the following equation: 
𝐷𝑟𝑜𝑝𝑙𝑒𝑡 𝑉𝑜𝑙𝑢𝑚𝑒 (𝑛𝐿) =  
𝐿𝑖𝑞𝑢𝑖𝑑 𝑀𝑎𝑠𝑠 (𝑔) × 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝐶𝑒𝑙𝑙 𝐶𝑢𝑙𝑡𝑢𝑟𝑒 𝑀𝑒𝑑𝑖𝑎 × 106
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐷𝑟𝑜𝑝𝑙𝑒𝑡𝑠
 
Equation 5.1 – Determination of mean droplet volume using the liquid mass, density of cell 
culture media and printed droplet number. 
Fluorometric characterisation of droplet volume was performed using fluorescein sodium 
salt (Sigma-Aldrich, UK) prepared to a stock concentration of 1 M in PBS. A 100 µM 
fluorescein working solution was prepared in PBS for the generation of standard curves and 
for dispensing within valve performance tests. Fluorescence values for each plate were 




excitation and emission filter of 485 nm and 520 nm respectively. Droplet volume was 
interpolated from standard curve data. 
For low ink cell density studies, the cell printing performance was characterised by manually 
counting the number of cells contained within single droplets sequentially deposited onto a 
glass slide. Cells were counted immediately following printing using a DMLB microscope 
(Leica Biosystems, Germany). 
For high ink cell density studies, a volume of material was deposited into the individual wells 
of a multi-well plate and a 10 µL aliquot transferred to a 0.1 mm depth Neubauer chamber 
haemocytometer (Hawksley, UK) for cell counting. Cell concentration was calculated by 
normalising the cell count to the calculated droplet volume previously determined. 
5.2.3 Hanging Droplet Aggregate Culture 
Mesenchymal stromal cells and chondrocyte cells were seeded via either manual dispensing 
or valve deposition onto the inside surface of petri dish lids (Corning, USA) across a range of 
densities. The lids were then carefully rotated and placed onto the petri dish base. The base 
of the petri dish was partially filled with PBS to provide an additional source of humidity 
during incubation at 37 °C, 5 % CO2. Gravity-induced cell aggregation occurred within 24 
hours of culture and a partial media change was performed every 2 days to minimise 
aggregate disruption.  
5.2.4 In-Well Aggregate Culture 
Mesenchymal stromal cells and chondrocyte cells were seeded at varying densities via either 
manual dispensing or valve deposition into individual wells of non-adherent U-bottomed 96-
well plates (Fisher Scientific, USA) in medium containing 0.25 % methyl cellulose (Sigma-
Aldrich). Cells self-aggregated within 12 hours and a partial media change was performed 
every 2-3 days to minimise aggregate disruption. 
5.2.5 Aggregate Imaging 
Aggregate size and morphology was assessed using a Leica DMLB bright-field microscope at 
5x magnification and images captured using a SPOT Advanced CMOS camera (Spot Imaging 
Solutions, USA) and corresponding microscopy software. Aggregate size was measured 




5.2.6 Conditioned Media Formulation 
A differentiation-inducing media formulation was prepared for the MSC aggregates via the 
addition of supplements to basal cell culture media prepared as previously described. A 
breakdown of the composition of the media formulation is shown in Table 5.1. 
Supplement Manufacturer Concentration 
L-Ascorbic acid-2-phosphate Merck 50 µg / ml 
Dexamethasone Merck 100 nM 
L-Proline Merck 40 µg / ml 
ITS+1 Merck 1 % 
TGF-ß3 Thermo Fisher Scientific 10 ng / ml 
 
Table 5.1 – Chondrogenic conditioned media formulation for MSCs. 
5.3 Results 
5.3.1 Material Deposition Performance 
An initial study was performed to determine the impact of waveform dwell time and 
backpressure on the deposition performance of the valve actuation device when dispensing 
cell culture media. Figure 5.3 displays the gravimetric assessment of valve ejection volume 
across a range of printing parameters. The volume of media dispensed was shown to 
positively correlate with the waveform dwell time applied. Pressure behind the valve was 
shown to have a minimal impact on dispense volume per actuation cycle at lower dwell 
times with greater variation observed above 300 μs. Droplet ejection was not achieved 
below a dwell time of 150 μs. A dwell time of 200 μs at a pressure of 200 mmHg was shown 
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Figure 5.3 – Influence of waveform dwell time and backpressure applied to the valve on 
dispense volume when printing cell culture media. Data represents mean values ± SD. N=3. 
Fluid ejection characteristics for the valve were observed using the on-board stroboscopic 
camera. Sequential ejection images displayed in Figure 5.4 show a significant droplet 
generated within the actuation cycle followed by a tailing ligand. Satellite and ligand 
formation were observed irrespective of the applied printing parameters. 
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Figure 5.4 – Sequential droplet ejection images captured using the JetLab® on-board 
stroboscopic camera at an incremental strobe delay of 100 μs. The valve was used to 
dispense cell culture media at a dwell time of 200 μs and backpressure of 200 mmHg. Scale 
bar = 1 mm. 
An additional study was conducted to assess the impact of actuation cycle number on 
material ejection volume. Figure 5.5 shows a high degree of linearity between ejection 
volume and actuation cycle number. Linear regression analysis revealed a droplet volume of 
61 nL, identified via the gradient of the line of best fit across the actuation cycle range 
assessed. The percentage coefficient of variation was calculated for each actuation cycle 






































































Figure 5.5 – Linearity of material ejection when printing cell culture media at a dwell time 
of 200 μs and pressure of 200 mmHg. (A) Dispense volume per droplet was calculated via 
the measurement of dispensed material mass. The gradient of the linear regression trend 
line corresponds to a droplet volume of 61 nL. (B) Coefficient of variation data calculated 




Further characterisation of valve dispense performance was performed using a fluorometric 
method as shown in Figure 5.6. A calibration standard curve (A) was prepared across a wide 
concentration range to determine a suitable working concentration range of fluorescein 
solution. A linear range was identified (B) for experimental work below a fluorescein 
concentration of 6 μM.  
A high degree of linearity was observed between the fluorescence values of the samples and 
the number of droplets of fluorescent material added to each sample (C). Percentage 
coefficient of variation calculations across each sample group demonstrated a volume 
dispensing precision of below 9 % (D). 
Droplet volume calculated for each droplet deposition number was shown to be stable 
across the range of 1-20 drops assessed, with an average droplet volume of approximately 
54 nL achieved (E). 
Comparisons between the fluorescence intensity of material deposited using the valve 
printing processes versus manual pipetting across a range of target volumes revealed a 
variation in the level of dispersion between samples (F). Samples generated using the valve 
printing process displayed a reduced degree of fluorescence intensity variation when 
compared with those generated using a pipette. A significant difference in fluorescence 
intensity between valve deposited and manually pipetted samples was observed at the 
highest deposition volume assessed. 
The effect of sample positioning within the valve printing script was also assessed using 
normalised fluorometric data (G). An elevated Z-score was observed at the first deposition 
coordinate followed by a period with minimal variation. A reduction in Z-score was observed 
at the final deposition coordinate for each print run. 
Comparisons between the dispense performance of two independent valve actuators 
displayed an increasing variation in the fluorescence intensity of dispensed samples in 























































































































































































































Figure 5.6 – Fluorometric evaluation of valve deposition performance. (A) Fluorescein 
standard curve data of serial dilution from 100 μM. (B) Linear region of standard curve 
data displaying a linear regression trend line. (C) Linearity of droplet ejection from the 
valve measured via the fluorescence intensity of ejected material. (D) Percentage 
coefficient of variation calculations for replicates of samples at each droplet dispense 
number. (E) Calculated per droplet volume deposited from the valve across a droplet 




between fluorescence values obtained from samples dispensed using a pipette and valve 
across a range of target volumes. (G) Z-score of normalised valve printing data showing 
well positioning bias amongst replicates within each volume request. (H) Comparison 
between jetting performance of 2 independent valves. Data represents mean values ± SD. 
N=12. 
5.3.2 Cell Deposition Performance 
The effect of each printing parameter on cell deposition performance was assessed when 
dispensing MSC and chondrocyte cells. An increase in cell density per droplet was observed 
in Figure 5.7 for both cell lines in response to increases in the dwell time applied to the 
actuation signal. This effect was diminished beyond a dwell time of 500 μs. A minimum dwell 
time of 200 μs and 150 μs was required in order to deposit cellular material for the MSC and 























































Figure 5.7 – Influence of waveform dwell time and backpressure applied to valve on cell 
density per droplet when printing MSC and chondrocyte cell lines at a concentration of 106 




Significant cell sedimentation was observed within the actuation device and device-reservoir 
coupling during extended printing periods. A further study presented in Figure 5.8 was 
performed to quantify the effect of applying a purge cycle prior to printing on cell density 
per sequentially dispensed droplet. A rapid initial reduction in the cell density per droplet 
was observed for the non-purged sample until stable printing performance was achieved. 
The addition of a purge cycle immediately prior to printing was shown to reduce the 
variability in cell density during printing by replacing stationary material within the nozzle 
with ink contained within the reservoir. 






















Figure 5.8 – Cell density of sequentially dispensed single droplets with and without the 
addition of a purge cycle prior to printing. Data represents mean values ± SD. N=3. 
The performance of a custom reservoir agitation system was benchmarked in Figure 5.9 for 
the valve printing process. Printing performance in the absence of an agitation device was 
shown to deteriorate over a 60 minute printing period resulting in printing failure. The 
incorporation of an agitation system within the reservoir was shown to prevent a 
deterioration in printing performance with a stable cell density per droplet observed over 

























Figure 5.9 – Effect of a reservoir agitation system on valve cell printing performance over 
time. Data represents mean values ± SD. N=6. 
An assessment of the impact of ink cell density on printing performance was performed to 
determine the operational range of the valve printing process. Figure 5.10 displays the 
impact of ink cell concentration on the cell printing performance for MSCs over a 30 minute 
period. A positive correlation was observed between the ink cell concentration and cell 
density per droplet. Total printing period was shown to have an increasing impact on cell 







































Figure 5.10 – Influence of ink cell concentration on cell deposition performance over a 30 
minute period. The valve was configured to operate with a dwell time of 200 μs and 
backpressure of 200 mmHg. Data represents mean values ± SD. N=6. 
Data in Figure 5.11 provides a comparison between the printing performance of the MSC 
and chondrocyte cell lines across a range of ink cell concentrations. A linear relationship 
between cell concentration and printing density was observed for both cell lines, with an 
increasing variation in cell density per droplet observed at higher ink cell concentrations. Cell 
type was shown to have an increasing influence on the reliability of the printing process at 







































Figure 5.11 – Effect of ink cell concentration on cell deposition performance for MSC and 
chondrocyte cells printed in cell culture media at a dwell time of 200 μs and backpressure 
of 200 mmHg. Cell number per sample was normalised to a mean droplet volume of 54 nL. 
Data represents mean values ± SD. N=6. 
5.3.3 Biological Impact Assessment 
A range of experiments were conducted to determine the impact of the valve deposition 
process on cellular viability and function for the MSC and chondrocyte cell lines. 
Data presented in Figure 5.12 displays the results of a Live / Dead® cell viability assay 
comparing the samples deposited via the valve printing process versus manual pipetting. A 
similar ratio of live to dead cells is observed across both cell lines in either sample group 
immediately following printing. An increase in cell number is observed at day 1 across both 
sample groups, with cells readily adhering to the substrate and maintaining viability. Cells 
appear smaller whilst in suspension immediately following printing, with cell adherence to 

















Figure 5.12 – Live / Dead® microscopy images displaying the viability of cells deposited 
using the valve printer relative to manually pipetted control samples immediately 




PrestoBlue® metabolic activity data presented in Figure 5.13 displays the impact of the valve 
printing process on cell metabolism when compared to manual pipetting techniques. No 
initial effect on the metabolic activity of either cell line was observed across each sample 
group immediately following seeding. A significant difference between manually seeded and 
printed samples was observed for both cell lines 24 hours following printing, however this 
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Figure 5.13 – PrestoBlue® metabolic activity assay comparing the metabolic activity of MSC 
and chondrocyte cell types following printing versus manually pipetted control samples. 





Fluorescence microscopy was used to compare the morphology of cells deposited using the 
valve printing process with manually seeded cells. No discernible differences in cell 
adherence rate or morphology were observed for either cell line displayed in Figure 5.14 and 
Figure 5.15, when compared to manually seeded control cells. Cell confluency was shown to 
















Figure 5.14 – Influence of valve printing process on cell morphology for the MSC line. Cell 
nuclei were visualised using DAPI (blue) and F-actin using phalloidin (red) staining. Scale 















Figure 5.15 – Influence of valve printing process on cell morphology for the chondrocyte 
cell line. Cell nuclei were visualised using DAPI (blue) and F-actin using phalloidin (red) 




A comparison between the proliferation rates of cell seeded using the valve printing process 
versus manual seeding techniques is shown in Figure 5.16. No significant difference in cell 
viability or proliferation rate was observed for cells seeded via each technique. 






























































































 MSC Chondrocyte 
Control Printed Control Printed 
Y0 (x104) 3.61 2.05 2.98 2.88 
K (Hours-1) 0.026 0.030 0.039 0.034 
Doubling Time (Hours) 26.74 22.84 17.77 20.40 
 
Figure 5.16 – Effect of valve printing process on the proliferation rate of MSC and 
chondrocyte cell lines in comparison to manually seeded cells. (Left) Live cell number 
assessed via a trypan blue exclusion test. (Right) Percentage of live cells counted at each 
time point. (Bottom) Parameters obtained from nonlinear regression analysis using an 
exponential growth model of cell proliferation data. Data represents mean values ± SD. 
N=6. 
An investigation was performed to assess the potential for using the valve printing process 
to seed cells for the production of cell aggregates. The suitability of the valve printing 
process was assessed by comparing the aggregate formation of printed MSC and 




5.3.4 Hanging Droplet Aggregate Culture 
The hanging droplet culture technique was initially employed for the production of cellular 
aggregates across a range of cell seeding densities over a 9 day incubation period. 
MSC aggregates were successfully generated across the cell seeding density range assessed 
in both manually deposited and printed samples within the first 24 hours of culture, as 
shown in Figure 5.17. Aggregates remained intact throughout the 9 day incubation period 
with subsequent cellular outgrowth and debris accumulation occurring during the later time 
points. Secondary aggregate formation was observed in the printed samples, reducing the 
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Figure 5.17 – Comparison between MSC aggregates seeded via manual pipetting and 
valve-based deposition when using the hanging droplet culture method. Cells were seeded 
across a range of cell seeding densities and imaged over a 9 day incubation period. Scale 
bar = 400 μm. 
Chondrocyte hanging droplet aggregate formation was observed in Figure 5.18 across all 
samples, however aggregate compactness and stability was significantly reduced when 




the first 24 hours of culture, alongside a reduction in primary aggregate density over the 
course of the incubation period. Progressive cellular outgrowth and a reduced degree of 
aggregation were also observed across both manually seeded and valve printed samples, 
irrespective of the initiating cell seeding density. These effects were most significant at the 
highest cell seeding density of 5,000 cells per hanging droplet. 
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Figure 5.18 – Comparison between chondrocyte aggregates seeded via manual pipetting 




seeded across a range of cell seeding densities and imaged over a 9 day incubation period. 
Scale bar = 400 μm. 
Bubble formation was observed in samples generated using the printing technique due to 
the air gap between the jetting device and substrate during printing. This is highlighted in 
the image in Figure 5.19 taken immediately following the seeding of hanging droplets.  
 
Figure 5.19 – Bubble formation within valve printed hanging droplet arrays. MSCs were 
deposited at a concentration of 106 cells per mL in cell culture media. Scale bar = 1 cm. 
Figure 5.20 displays images of arrays of hanging droplets printed across a range of valve 
backpressures. An increase in pressure applied to the valve was shown to increase the 
degree of droplet splashing, resulting in additional bubble formation and irregular droplet 
volumes. The removal of foetal bovine serum from the cell culture media altered the surface 
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Figure 5.20 – Effect of backpressure applied to the valve and media composition on bubble 
formation within printed droplets of cell culture media. Arrows indicate droplet splattering 
and foam formation respectively. Scale bar = 1 cm. 
5.3.5 In-Well Aggregate Culture 
An in-well gravimetric culture technique was also assessed for the production of MSC and 
chondrocyte aggregates across a higher cell seeding density range.  
Images in Figure 5.21 display the morphology of aggregates generated by seeding MSCs 
using the valve printing process versus manual seeding techniques. MSC aggregates were 
formed within the first 24 hours of seeding for both manually seeded and printed samples 
across the full range of cell seeding densities assessed. Cells further condensed over the 
remainder of the time course, with minimal cell outgrowth or secondary aggregate 






















































     
Figure 5.21 – MSC aggregates generated using the in-well aggregate culture technique 
across a range of cell seeding densities. Scale bar = 400 μm. 
Quantification of aggregate diameter in Figure 5.22 revealed a reduction in aggregate 
diameter over the first 3 days of culture as cells condensed, with no further change in 




positively correlate with aggregate size throughout the 9-day incubation period. No 
significant difference in aggregate size was observed between manually seeded and printed 
aggregates in each cell seeding density sample group.  

























Figure 5.22 – MSC aggregate diameter measurements generated using the in-well 
aggregate culture technique across a range of cell seeding densities. Cells were seeded 
using either manual (solid lines) or printed (dotted lines) methods. Data represents mean 
values ± SD. N=3. 
Figure 5.23 displays the morphology of chondrocyte aggregates generated using the valve 
deposition technique. Cells aggregated within the first 24 hours of culture across each of the 
cell seeding densities assessed, irrespective of seeding method. Cellular debris was observed 
from day 3 and was most pronounced in samples with a higher cell seeding density. This 























































     
Figure 5.23 – Chondrocyte aggregates generated using the in-well aggregate culture 
technique across a range of cell seeding densities. Scale bar = 400 μm. 
Quantification of aggregate diameter in Figure 5.24 displayed a similar pattern of cell 
condensation over the first 3 days of culture via a reduction in aggregate diameter. Cell 




the diameter of aggregates seeded at 10,000 cells per well. A statistically significant 
difference in the size of printed versus manually seeded aggregates was observed at day 1 
when seeding cells at a density of 30,000 cells per well. Cell seeding technique was not 
observed to significantly impact aggregate size across other time points or cell seeding 
densities. 


























Figure 5.24 – Chondrocyte aggregate diameter measurements generated using the in-well 
aggregate culture technique across a range of cell seeding densities. Cells were seeded 
using either manual (solid lines) or printed (dotted lines) methods. Data represents mean 
values ± SD. N=6. 
An additional set of experiments were performed to assess the stability and biological 
properties of the aggregates generated over an extended culture period. 
Figure 5.25 shows the morphology and diameter measurements of chondrocyte aggregates 
generated at a cell seeding density of 60,000 cells per well. Aggregate size remained stable 
following an initial cell condensation period within the first 7 days. A significant amount of 
cellular debris accumulated within the base of the wells surrounding each aggregate during 
extended culture. No significant difference in aggregate morphology or diameter was 
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Figure 5.25 – Comparison between chondrocyte aggregates seeded via manual pipetting 
and valve-based deposition when using the in-well culture method. Cells were seeded at a 
density of 60,000 cells per well and incubated over a 21-day period. (A) Bright-field 
microscopy images showing aggregate morphology during culture. Scale bar = 400 am. (B) 
Quantification of aggregate diameter. Data represents mean values ± SD. N=6. 
A combination of histological and indirect immunofluorescence staining was employed to 
biologically characterise the aggregates generated. 
Haematoxylin and eosin staining of sectioned aggregates displayed in Figure 5.26 revealed 
no significant differences in tissue morphology or cellular organisation as a result of the 
printing process. An increase in eosinophilic staining was observed within the central region 
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Figure 5.26 – Haematoxylin and eosin staining of chondrocyte cell aggregates generated 
using the valve printing process versus manually seeded controls. Cells were cultured in 
DMEM / F12 media over a 21-day culture period. Scale bar = 500 μm. 
Indirect immunofluorescence microscopy data shown in Figure 5.27 displays no discernible 
variations in collagen II or aggrecan expression between aggregates seeded using the valve 
printing technique and manual methods. A low level of marker expression was observed 
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Figure 5.27 – Immunostaining data comparing the collagen II (COLII, green) and aggrecan 
(AGCN, red) content of chondrocyte cell aggregates generated using the valve printing 
process versus manually seeded controls. Cells were cultured in DMEM / F12 media over a 





Figure 5.28 presents the aggregates generated from MSCs seeded at a density of 60,000 cells 
per well over a 21-day incubation period. Cells were treated with both basal and 
chondrogenic media formulations to evaluate the influence of differentiation-inducing 
media on cell phenotype within the aggregate culture format. A similar pattern of cell 
condensation was observed within aggregates during the first 7 days of culture, with 
aggregate size remaining stable throughout the remaining time points. Secondary aggregate 
formation was also observed during extended periods of culture. No significant differences 
were observed in aggregate size or morphology between printed and manually seeded cells 
under basal media formulations. Chondrogenic media formulations were shown to have a 
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Figure 5.28 – Comparison between MSC aggregates seeded via manual pipetting and 
valve-based deposition when using the in-well culture method. Cells were seeded at a 
density of 60,000 cells per well and incubated in basal and chondrogenic media 




morphology during culture. Scale bar = 400 μm. (B) Quantification of aggregate diameter. 
Data represents mean values ± SD. N=6. 
Haematoxylin and eosin staining of the sectioned MSC aggregates in Figure 5.29 revealed no 
significant differences in tissue structure in response to the cell seeding method. A similar 
pattern of sample degradation was observed in response to the sectioning process with 
variations in section size caused by section positioning within the tissue. 
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Figure 5.29 – Haematoxylin and eosin staining of MSC aggregates generated using the 
valve printing process versus manually seeded controls over a 21 day culture period in 
basal and chondrogenic media formulations. Scale bar = 500 μm. 
Indirect immunofluorescence staining was performed on the MSC aggregates displayed in 
Figure 5.30 and Figure 5.31 for basal and chondrogenic media formulations respectively. No 
discernible difference in collagen II or aggrecan protein expression was observed between 
the printed and manually seeded aggregates under either media formulation. An elevation in 
aggrecan expression was observed at 21 days for samples exposed to basal media 
formulations and 7 days for samples exposed to chondrogenic media formulations. Basal 




exposed to chondrogenic media formulations displaying peak collagen II expression within 
the first 7 days of culture. 
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Figure 5.30 – Immunostaining data comparing the collagen II (COLII, green) and aggrecan 
(AGCN, red) content of MSC aggregates generated using the valve printing process versus 
manually seeded controls over a 21 day culture period in basal media. Cell nuclei were 
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Figure 5.31 – Immunostaining data comparing the collagen II (COLII, green) and aggrecan 
(AGCN, red) content of MSC aggregates generated using the valve printing process versus 
manually seeded controls over a 21 day culture period in chondrogenic media. Cell nuclei 





5.4.1 Material Deposition Performance 
An initial investigation was performed to assess the impact of various printing parameters on 
valve deposition performance. A gravimetric approach was used to determine droplet 
volume via the measurement of material mass following deposition. 
Experimental research displayed in Figure 5.3 showed a strong correlation between the 
waveform dwell time applied to the valve and the volume of material dispensed per 
actuation cycle. A minimum operational dwell time of 150 μs was required in order to 
achieve droplet ejection, with a dwell time of 200 μs required to prevent material build-up 
on the nozzle during printing. Backpressure applied to the valve during jetting was shown to 
have a minimal effect on material ejection characteristics under shorter dwell time 
configurations, with 200 mmHg providing the greatest linearity in dispense performance 
over the dwell time range assessed. A low pressure range was assessed within this research 
to minimise potential pressure related damage to cellular material during bioprinting 
experiments. It is possible that this range was insufficient to cause substantial variations in 
material ejection volume per valve actuation cycle due to the considerably larger range of 
operational pressures that the valve was designed to function across. 
A pressure of 200 mmHg and dwell time of 200 μs was selected in order to maximise the 
resolution of the valve printing process whilst maintaining printer reliability. Under this 
configuration, a droplet volume of approximately 50 nL was achieved.   
Observation of the fluid ejection characteristics from the valve displayed the ejection of a 
large droplet volume with a substantial tailing ligand, as shown in Figure 5.4. Partial ligand 
recombination was observed during droplet flight, with a small number of satellite droplets 
forming as a result of ligand destabilisation. A lack of granularity in the control of droplet 
ejection characteristics was observed when comparing the valve printing process to previous 
research using inkjet printing devices. This was due to the limited waveform modifications 
that could be achieved when employing a spike-and-hold driver and ‘ON/OFF’ actuator 
versus the dynamically adjustable piezoelectric actuator within an inkjet system. As a result, 
it was not possible to further adjust droplet volume or prevent satellite formation, limiting 
the accuracy and maximum resolution of the printing process. 
Figure 5.5 displayed the correlation between actuation cycle number and total dispensed 




linearity was observed between dispense volume and the total number of droplet ejections 
requested. A droplet volume of approximately 61 nL was defined for the printing 
configuration assessed, based upon linear regression analysis. A coefficient of variation 
percentage (CV) was calculated for measurements at each droplet ejection cycle number to 
determine the precision of the printing process across different target volumes. The CV 
ranged from 2-11 %, with the highest variation in dispense volume occurring at the lowest 
dispensed volume. A CV of below 7 % was calculated across droplet volumes above the 
minimum dispense volume. The precision of the valve printing system corroborated with the 
literature values reported for state-of-the-art liquid handling systems when dispensing 
similar fluids under a gravimetric calibration methodology (Taylor et al., 2002; Stangegaard 
et al., 2011; Bessemans et al., 2016). This data demonstrates the precision of the valve 
dispensing device in a DoD configuration to deposit material across a wide volume range. 
A recognised limitation of the gravimetric measurement technique is the high minimum 
droplet mass required for measurements using a conventional microbalance. Due to the low 
per actuation cycle volume dispensed by the valve, it was necessary to deposit a large 
number of droplets and divide the final mass by this number to identify an average droplet 
mass. As a consequence, this approach prevented comparisons from being made between 
the volumes of individual droplets dispensed. In addition, material lost as a result of 
splashing or evaporation was not accounted for within droplet measurements, and all 
measurements were dependent upon the accuracy and precision of the balance used. It is 
hypothesised that these effects contributed to the increased CV observed when depositing a 
low number of droplets. Despite these limitations, gravimetric methods remain a common 
standard for the calibration of printing devices and liquid handling systems (Faulkner-Jones 
et al., 2013; Bessemans et al., 2016). 
An additional experiment was performed, as shown in Figure 5.6, to determine the volume 
of individual droplets based upon the detection of printed fluorescent material. This 
technique required interpolation of material volume via fluorescent readings from a 
standard curve, having been previously validated within the literature to assess the 
dispensing performance of liquid handling systems at the nanolitre-scale (Rodríguez-Puente, 
Linacero-Blanco and Guasch, 2013). Data was obtained on the printing performance of the 




A droplet volume of approximately 54 nL was identified using the fluorometric approach. 
This technique enabled the calculation of dispense volumes down to the single droplet scale, 
providing further characterisation of the deposition process. A high degree of linearity was 
observed when depositing 1-20 droplets per well, indicating that the sequential actuation of 
the valve had no significant effect on per droplet volume. In addition, CV calculations for 
each sample group revealed a consistent dispensing precision of below 9 %. This data 
contrasts with the findings of earlier gravimetric studies by indicating that the precision of 
the valve dispensing system remained stable across the low droplet cycle range. This finding 
represented a critical factor for the operation of the valve printing processes in a DoD 
configuration, whereby variations in actuation cycle represent the primary method to adjust 
dispense volume. Retaining the DoD approach was considered essential in the optimisation 
of the printing process to maximise compatibility with 3D bioprinting applications, where 
structures are generated from the sequential stacking of individual droplets at a specified 
coordinate (Da Conceicao Ribeiro et al., 2019). 
These results corroborate with research conducted by Bammesberger et al. to compare the 
performance of commercial non-contact valve and positive displacement micro dispensing 
systems using fluorometric detection methods. The jetting performance of state-of-the-art 
valve dispensing devices was assessed across a target droplet volume range of 50 nL to 1 μL 
under a continuous jetting mode, whereby total dispense volume was controlled through 
adjusting the dwell time of the actuation signal. Jetting precision and volume working range 
of the system benchmarked within this research was shown to remain competitive with the 
commercial systems assessed, whilst retaining a DoD printing approach. The precision and 
accuracy of the DoD valve printing device was also shown to be superior to the results 
reported for positive displacement systems (Bammesberger et al., 2013).  
Comparisons between the dispensing performances of the valve actuator versus a 
conventional manual pipette demonstrated that the valve was capable of reproducibly 
dispensing larger volumes across the 0.5-2.5 μL range. A reduced variability in fluorescence 
intensity across samples at each target range demonstrated the high degree of precision that 
could be achieved when using the valve printer to dispense liquids in a DoD configuration. At 
the highest deposition volume, a significant difference in fluorescent intensity of samples 
generated using each seeding technique was observed. Due to the nature of the DoD jetting 




droplets significantly impact total dispensed volume where a large number of actuation 
cycles are requested. It is hypothesised that this variation in deposition performance was 
caused by the cumulative error associated with droplet volume calculations when 
performing large numbers of actuation cycles, representing an inherent limitation of the 
DoD valve actuation approach. Potential approaches to control such errors within future 
work include the independent calibration of DoD dispensing devices across separate working 
volume ranges. This would ensure that printing performance is retained for both high 
accuracy and high volume jetting applications. 
Assessment of the intra-well fluorescence revealed a positive and negative bias towards the 
first and last coordinates within a print job respectively, indicating that additional 
fluorescent material was deposited at the first coordinate and reduced material at the final 
coordinate. There are a number of potential causes for such effects, including jetting 
hardware associated errors and plate edge effects. Multi-well plate edge effects are 
commonly associated with fluorometric assays due to variations in the temperature and 
evaporation rate between regions of the multi-well plate (Lundholt, Scudder and Pagliaro, 
2003). In addition, variations in fluorescence intensity readings across the plate or 
inaccuracies in plate reading hardware can cause placement-related variation in well 
readings. A range of potential methods are available to reduce such effects, and further 
work will be required to determine the cause of this observation due to the significant 
reduction in calculated valve precision when comparing datasets inclusive of edge wells 
(Jean-Philippe et al., 2012; Chen et al., 2017; Shterev et al., 2018). 
Additional research highlighted the intra-valve variability between two identical actuation 
devices. Due to the DoD nature of this process, small variations in droplet volume between 
printing devices can lead to substantial variations in total dispensed volume where high 
numbers of actuation cycles are employed. This data emphasises the importance of 
independently calibrating printing protocols to each jetting device used due to inherent 
variations in actuator performance. This is of particular importance where multi-valve 
systems are employed to increase printing throughput (Faulkner-Jones, 2015; Da Conceicao 
Ribeiro et al., 2019). These results reinforce previous studies within the literature 
highlighting the high variability in printing precision amongst independent actuators within a 




In combination, this data demonstrates the suitability of using the valve in a drop-on-
demand configuration to selectively and reliably deposit material across a wide volume 
range by solely adjusting the actuation cycle number applied during printing. 
5.4.2 Cell Deposition Performance 
Analysis of the effect of valve printing parameters on cell deposition performance was 
shown for the MSC and chondrocyte cell lines in Figure 5.7. Pressure was observed to have a 
minimal impact on cell density per droplet, reinforcing previous observations in Figure 5.3 
where material deposition performance was characterised. Increases in dwell time were 
shown to have a diminishing effect on cell dispense performance beyond a dwell time of 500 
μs. It was hypothesised that the changes in ejection behaviour under higher dwell times 
could have been caused by sedimentation or material flow effects through the valve, where 
larger volume displacements were requested. 
An additional experiment was performed to characterise this effect by comparing the cell 
density of sequentially deposited droplets in the presence or absence of a valve purging 
process immediately prior to printing. Data in Figure 5.8 displayed a rapid reduction in cell 
density per droplet in response to each sequential ejection cycle until a stable droplet 
density was achieved. Stable cell density per droplet was maintained where a purge cycle 
was employed immediately prior to printing, reflecting previous observations in Figure 4.13 
for the inkjet printing platform. This data highlights the importance of using purge cycles 
when depositing cellular material contained within a liquid suspension to maximise process 
precision. 
A deterioration in jetting performance was observed in response to extended printing 
periods. Data presented in Figure 5.9 provides a comparison between the cell printing 
performances of the valve using a standard reservoir configuration versus a custom reservoir 
agitation system. The incorporation of a custom agitation system was shown to minimise 
degradative effects by maintaining cell printing performance over a 2-hour assessment 
period. This reflects previous research presented in Figure 4.26 which compared the printing 
performance of an inkjet actuator with and without the use of a reservoir agitation system. 
In combination, these results signify the importance of maintaining adequate processes to 
account for the presence of cell suspensions within DoD bioprinting techniques in order to 




could be used to precisely and reliably print cells using a DoD dispensing method under 
appropriately optimised jetting parameters. 
Additional experiments were performed to determine the impact of ink cell density on valve 
printing performance. Data shown in Figure 5.10 compared the printing performance of the 
valve across a cell density range of 1-20 million cells per mL at 0, 15 and 30 minute 
increments. Cell density per droplet was shown to correlate with increasing ink cell 
concentration as anticipated, with a greater variation in cell density per droplet observed at 
higher ink cell concentrations. Printing period was also shown to have a significant impact on 
cell density per droplet at the higher cell concentrations, indicating a deterioration in jetting 
performance. 
These results corroborate with previous observations within the literature whereby cell 
printing at concentrations of up to 40 million cells per mL have been reported using valve 
printing processes (Da Conceicao Ribeiro et al., 2019). The ability to process high cell 
densities using valve printing techniques represents a major advantage over alternative DoD 
processes, whereby greater limitations are placed on the ink properties and maximum cell 
density that can be reliably printed (Cui et al., 2010; Parsa et al., 2010; Chahal, Ahmadi and 
Cheung, 2012). 
Data in Figure 5.11 compared the valve printing performance when depositing MSC and 
chondrocyte cell lines across a concentration range of 1-10 million cells per mL. An 
increasing variation in cell density per droplet was observed in response to increases in the 
ink cell concentration, with the cell type having a greater influence on cell density per 
droplet at higher concentrations. It is hypothesised that the trade-off between printing 
reliability and ink cell concentration could be caused by the changing rheological 
characteristics of the ink, leading to variations in valve ejection volumes per actuation cycle. 
Additional considerations for further research include the effect of cell size and 
concentration on the rheological properties of the fluid, as well as quantification of the error 
associated with calculating and processing high cell density solutions using standard tissue 
culture techniques. 
5.4.3 Biological Impact Assessment 
A crucial factor when considering different bioprinting technologies or printing parameters is 




assays were employed to determine the biological effects of the valve printing process on 
the MSC and chondrocyte cell types.  
A Live / Dead® assay was performed to compare the ratio of live to dead cells in printed and 
manually seeded samples. Cellular viability was maintained immediately following and 24 
hours following printing for both cell lines, as indicated in Figure 5.12, demonstrating that 
the printing process had no significant effect on membrane integrity or cellular viability.  
Characterisation of the impact of the printing process on the metabolic activity of each cell 
type was performed using a PrestoBlue® assay as shown in Figure 5.13. A significant 
difference in metabolic activity was observed 24 hours following cell seeding for both cell 
lines, indicating potential short-term changes in cell metabolism in response to the 
deposition process. No significant difference in metabolic activity was observed immediately 
following cell seeding or after an extended incubation period for either cell line. This data 
indicates that the valve printing process induces a temporary variation in cellular 
metabolism as a result of the associated mechanical forces during deposition, however 
recovery and function is restored following a short period of culture. 
Morphological analysis was performed over a range of time points following printing to 
identify any potential effects on cell adherence or morphology. Comparisons between 
manually pipetted and valve printed samples, shown in Figure 5.14 and Figure 5.15, revealed 
no visible differences in the rate of cell adherence or subsequent morphology for either cell 
line. A progressive increase in cell confluency was observed over the 72 hour culture period 
irrespective of seeding method, indicating the suitability of the valve printing process for cell 
seeding applications. 
A cell proliferation study, shown in Figure 5.16, was conducted to quantitatively compare 
the rate of growth between valve printed and manually seeded MSC and chondrocyte cells. 
No significant differences were observed between the population growth rate of manually 
seeded and valve printed cell samples, indicating that the valve deposition process did not 
significantly impact cellular growth kinetics following seeding. In addition, no significant 
differences were observed between the percentage cell viability of manually deposited and 
printed cells for either cell line at each time point. 
In combination, these findings indicate that the valve deposition process is highly suitable for 




morphology, viability, metabolic activity or cell proliferation over extended culture periods 
were observed as a result of the printing process. These findings strengthen previous 
observations within the literature that demonstrate the biocompatibility of the valve 
deposition process with a range of cell types, enabling the production of hepatic and breast 
cancer aggregates alongside skin and alveolar tissue models (Lee et al., 2014; Faulkner-Jones 
et al., 2015; Horvath et al., 2015; Ling et al., 2015). 
The application of 3D cell culture techniques for in vitro research has become increasingly 
common due to the more replicative cellular environment that is induced when compared to 
traditional monolayer culture (McMurtrey, 2016; Nath and Devi, 2016; Melissaridou et al., 
2019). In addition, advancements within the field of cellular therapies has enabled the 
development of aggregate-based surgical procedures to treat diseases such as osteoarthritis 
(National Institute for Health and Care Excellence, 2017; Ong et al., 2018). The suitability of 
the valve printing process for the production of MSC and chondrocyte tissue aggregates was 
assessed using a combination of gravity-induced aggregate culture techniques. 
5.4.4 Hanging Droplet Aggregate Culture 
A hanging droplet aggregate culture technique was assessed for the production of MSC 
aggregates. Data presented in Figure 5.17 revealed outgrowth of aggregates produced via 
manual pipetting during later time points. This was most pronounced in aggregates seeded 
at higher cell densities. These observations were hypothesised to have been caused by cell 
proliferation following aggregate formation and condensation, resulting in a loss of model 
stability. 
Aggregates generated using the valve printing process were shown to be less stable in 
culture than manually seeded cells, with a significant reduction in aggregate density 
accompanied by increased cellular debris over the 9-day incubation period. In addition, a 
considerable number of secondary aggregates were observed shortly following cell seeding. 
Subsequent analysis of the technique using chondrocytes in Figure 5.18 revealed a low rate 
of cell aggregation for both manually seeded and valve deposited samples, leading to the 
formation of secondary aggregates. Poor aggregate stability was also observed, with a 
considerable amount of cell outgrowth occurring throughout the course of the incubation 
period. One potential cause for the increased rate of cellular outgrowth when compared 
with the MSC aggregates is the more rapid rate of cell proliferation that is characteristic of 




A combination of factors inherent to the valve deposition process could have contributed to 
the poor rate of cellular aggregation within the printed samples. This includes bubble 
formation, shown in Figure 5.19, which occurred as a result of the air-liquid-interface 
present during printing, as well as the greater dispersion of cells within the liquid substrate 
when dispensed from above versus directly within the droplet. 
The effect of pressure and media formulation on bubble formation within the printed 
droplets was assessed in Figure 5.20. An increase in backpressure resulted in an increase in 
bubble formation alongside droplet splattering on substrate impact. These effects further 
reduced the resolution of the printing process and increased the variability in droplet 
volume within printed arrays. The removal of foetal bovine serum from the media 
formulation was shown to reduce the number of bubbles generated during printing. This 
was due to the recognised effects of protein concentration on the surface tension and 
subsequent bubble formation within liquids (Zhang, Handa-Corrigan and Spier, 1992). It was 
not feasible to further reduce the backpressure of the valve whilst maintaining reliable 
printing performance. In addition, changes to the protein composition of the media would 
negatively influence cellular growth and function due to the critical role that proteins play in 
cellular processes. 
Further limitations of this technique were observed during culture. This includes challenges 
surrounding media exchange when using conventional and automated liquid handling 
methods, as well as model sensitivity to mechanical shocks. These limitations have been 
previously been reported within the literature (Breslin and O’Driscoll, 2013; Joshi and Lee, 
2015). 
It was therefore necessary to assess the suitability of an alternative in-well aggregate culture 
technique for the production of MSC and chondrocyte aggregates. 
5.4.5 In-Well Aggregate Culture 
An in-well aggregate culture technique was selected due to its compatibility with well-plate 
based biological analysis techniques. In addition, the well-plate format provided a high 
sample density to culture large numbers of aggregates for high-throughput applications. 
Data presented in Figure 5.21 displayed microscopy images of aggregates generated across a 
range of cell seeding densities via both manual pipetting and valve deposition processes. 




within 24 hours, irrespective of the seeding method employed. No visible differences in the 
size, shape or stability of aggregates were observed when comparing the manually seeded 
and valve deposited samples over the 9-day culture period. Quantification data presented in 
Figure 5.22 revealed no significant differences between the sizes of aggregates generated 
using either seeding method, with cell seeding density correlating with aggregate size as 
anticipated. A gradual reduction in aggregate size over the first 3 days of culture was 
observed indicating cell condensation. Cultures remained stable throughout the remaining 
time period, with minimal cell outgrowth or secondary aggregate formation. These results 
support previous research by Pennock et al., who demonstrated the impact of cell seeding 
concentration on primary MSC aggregate size and density across a 7 day in-well culture 
(Pennock et al., 2015). These findings demonstrate the suitability of the in-well culture 
technique for the production of MSC aggregates, as well as the compatibility of the culture 
format with the valve printing process. 
Evaluation of the in-well aggregate culture methodology with chondrocyte cells, reported in 
Figure 5.23 and Figure 5.24, revealed a similar pattern of cell aggregation and condensation 
over the first 3 days of culture. No significant differences in the morphology or density of 
aggregates were observed between manual and valve seeded samples. A reduced aggregate 
size was observed within the lower cell seeding densities assessed leading to subsequent 
secondary aggregate formation. These observations indicate that a higher cell number is 
required for chondrocyte cells to reliably generate single aggregates. Aggregate outgrowth 
was observed irrespective of cell seeding density or technique. It is hypothesised that this 
was due to the more rapid rate of proliferation that is characteristic of the chondrocyte cell 
line, as indicated within previous experiments. 
Both cell types were shown to be compatible with the in-well culture technique across a 
wide range of cell seeding densities. A seeding density of 60,000 cells per well was selected 
for further experiments to minimise the number of cells required, whilst retaining reliable 
aggregate formation. 
Further research was performed to determine the impact of extended culture on the 
stability of the aggregate model for each cell type, alongside any potential biological effects 
of the printing process. Figure 5.25 displays the morphology of chondrocyte cells cultured 




aggregate formation and condensation followed by a period of stable culture was observed, 
with cellular debris collecting within each well over the later time points. 
Haematoxylin and eosin staining of sections, shown in Figure 5.26, displayed an increase in 
eosinophilic staining within the central region of the aggregate across all sample conditions, 
indicative of an upregulation in ECM production or reduction in cellular viability. A reduction 
in cell nuclei frequency within the central region of the aggregates was also observed. This is 
characteristic of literature observations reporting a necrotic core induced by localised 
hypoxia within the central zone of larger aggregates that are comprised of higher cell 
densities (Huang et al., 2017; Riffle et al., 2017). 
Indirect immunofluorescence staining in Figure 5.27 displayed a low degree of aggrecan and 
collagen II protein expression amongst both manually seeded and printed samples across the 
time points assessed. No discernible differences in marker localisation or intensity was 
observed between printed and manually seeded aggregates. These results indicate that the 
printing process did not significantly affect the cellular phenotype or tissue structure of the 
aggregates generated. 
Figure 5.28 displays the morphology of MSC aggregates maintained over a 21-day period. 
Aggregates were treated with both basal and chondrogenic media formulations to identify 
any differentiation inducing effects of the culture format on MSC phenotype when 
compared with cells differentiated using standardised protocols. The addition of pro-
chondrogenic compounds to cell culture media resulted in an increased aggregate size 
following the initial cell condensation period, compared to samples incubated in a basal 
media formulation. It was hypothesised that this was caused by an elevation in the rate of 
MSC proliferation, or nuclear hypertrophy, in response to chondrogenic differentiation-
inducing media stimuli. Previous research has indicated chondrogenic differentiation of 
MSCs induces an intermittent elevation in proliferation rate within a high density culture 
format, resulting in similar increases in aggregate size (Shimizu, Yokoyama and Asahara, 
2007; Dexheimer, Frank and Richter, 2012). 
Haematoxylin and eosin staining of sectioned MSC aggregates, presented in Figure 5.29, 
revealed no obvious differences in tissue structure between manually seeded and printed 
aggregate models under basal or chondrogenic media stimulation. Variations in aggregate 




degradation during the cryosectioning process. These artifacts have been previously 
reported within the literature and are inherent of the sectioning process (Pampaloni, Ansari 
and Stelzer, 2013). 
Indirect immunofluorescence of collagen II and aggrecan content was presented in Figure 
5.30 and Figure 5.31 for the MSCs treated with basal and chondrogenic media formulations 
respectively. No visible differences in signal intensity or marker localisation were observed 
between manually seeded and printed aggregates under either media formulation. An 
increase in aggrecan and collagen II expression was observed over the 21-day culture period 
for cells exposed to basal media formulations, indicating potential chondrogenic 
differentiation of the MSCs as a result of the aggregate culture method. High density culture 
has been previously reported within the literature to promote chondrogenic differentiation 
of MSCs (Shimizu, Yokoyama and Asahara, 2007; James et al., 2015; Lu et al., 2017). Peak 
aggrecan and collagen II signal intensity was observed on day 7 within aggregates treated 
with the chondrogenic media formulation, indicating that the chondrogenic media 
supplements had a significant effect on MSC differentiation status, irrespective of the 3D 
culture format. 
Both collagen II and aggrecan are extensively used within the literature as markers of the 
chondrogenic phenotype for chondrocyte and MSC cell types (Das et al., 2008; Chen et al., 
2009; Karlsen, Shahdadfar and Brinchmann, 2011). Despite this, previous research has 
reported conflicting outcomes on their suitability as markers to monitor chondrogenesis 
(Mwale et al., 2006; Karlsen, Shahdadfar and Brinchmann, 2011; Yeung et al., 2018).  
These findings present an opportunity to further research the influence of cell seeding 
density on the formation of a necrotic region within each aggregate, as well as the region’s 
impact on cellular phenotype, using a more comprehensive range of chondrogenic markers 
and over a longer culture period. 
In addition, advancements within the field of fluorescence microscopy provide an alternative 
method to assess cell marker expression and tissue organisation by using whole-mount 
microscopy techniques. Recent research has demonstrated the potential of using such 
techniques to study tissues of a similar size and shape to those generated within this 
research, thus avoiding the challenges in sample preparation and processing throughput 




includes the use of light sheet fluorescence microscopy to enable whole-mount tissue 
imaging, whereby an illumination system excites fluorophores within a narrow focal plane. A 
detection lens is placed perpendicularly to the light sheet to reduce out-of-focus light, thus 
enabling the collection of high definition images within a single plane of tissue. Recent 
research has successfully applied this technology to study tissue architecture and drug 
penetration within aggregate culture formats (Smyrek and Stelzer, 2017; Lazzari et al., 2019). 
Nevertheless, this research has demonstrated the compatibility of the in-well aggregate 
culture technique with valve printing systems for scaling up the production of 3D aggregate 
tissues. This has applications for both in vitro osteoarthritis research and potential 
aggregate-based cellular therapies. These findings build upon previous research into other 
tissue types, whereby the compatibility of valve printing processes with in-well and hanging 
droplet aggregate culture techniques were assessed (Faulkner-Jones et al., 2013; Ling et al., 
2015) 
5.5 Conclusions 
Within this chapter, the bioprinting performance of a valve-based DoD printing process was 
benchmarked to construct 3D aggregate tissue models. 
 A combination of printing parameters were optimised to enable the reliable 
deposition of material at the nanolitre-scale 
 Cell printing was demonstrated across an ink concentration range of 1-20 million cells 
per mL, through the sequential deposition of droplet volumes of approximately 54 nL 
 The suitability of the valve process for cell printing applications was demonstrated 
through results which show no significant effects on cellular viability or function 
when compared to manual seeding techniques 
 An in-well aggregate culture platform was successfully reproduced using the valve 
printing process, providing a method to automate the construction of 3D aggregate 






Chapter 6. Production of a Bioprinted Co-culture Model of 
Osteoarthritis 
6.1 Introduction 
The purpose of this chapter is to apply the valve printing process that was previously 
benchmarked in order to construct a co-culture model which could be used for osteoarthritis 
research. 
Within this chapter, the valve printing process is used to sequentially deposit mesenchymal 
stromal cell and chondrocyte cell lines onto a microplate insert membrane. A range of 
biological tests are performed to characterise the impact of cell co-culture on tissue 
structure and organisation, versus single cell type cultures, over a 14-day incubation period. 
This includes cell proliferation and metabolic activity assays, cell tracking, histological 
staining and indirect immunofluorescence staining of phenotypic markers of 
chondrogenesis. 
6.2 Methodology 
6.2.1 Plate Configuration 
The Transwell® 96-well plate permeable support system (Corning, USA) was selected for co-
culturing MSCs and chondrocyte cell lines. This system featured 96 interconnected 
polycarbonate well inserts with a 0.4 μm pore size alongside a dedicated receiver plate. This 
platform was selected due to its robotics friendly design to maximise compatibility with the 
bioprinting equipment. 
It was necessary to separate the Transwell® insert into smaller segments to enable the 
acquisition of each sample group from a single plate at each time point. A Laserscript® 
LS3020 laser cutting device and accompanying Lasercut® software (HPC Laser Limited, UK) 
was used to compartmentalise the Transwell® inserts prior to cell seeding to enable rapid 
collection and isolation of samples. 
6.2.2 Cell Seeding  
The Transwell® inserts were pre-soaked in cell culture media prior to cell printing to 
promote cell attachment. Each cell type was then sequentially seeded onto the base of each 
of the Transwell® inserts to achieve a cell seeding density equivalent to 1 million cells per 
cm2 using the valve deposition parameters defined within the previous chapter. Co-culture 
samples were generated by seeding an equivalent number of chondrocytes, immediately 




A target volume of 80 μL per insert well was maintained across all samples in accordance 
with the manufacturer’s recommendations. Cells were cultured in high glucose DMEM / 
Ham’s F12 mix 1:1 v / v supplemented with 10 % foetal bovine serum (Thermo Fisher 
Scientific, USA), 5000 U / mL Penicillin / Streptomycin (Sigma-Aldrich, UK) and 2 mM L-
Glutamine (Sigma-Aldrich) using the Transwell® independent 96-well receiver plate. 
Cell culture media was added to each isolated well of the Transwell® receiver plates to 
achieve a target volume of 235 μL. Media was changed daily using the well-specific feeder 
ports during culture. 





























Figure 6.1 – Flow diagram displaying an overview of the cell printing, culture and analysis 
procedures for each model. 
6.2.3 Sample Retrieval 
Samples were isolated at each time point via removal of the insert from the Transwell® 
receiver plate. Membranes were separated from the insert using a scalpel and immediately 




6.2.4 Cell Tracker Staining 
CellTracker® Red and CellTracker® Green dyes (Thermo Fisher Scientific) were used to label 
MSC and chondrocyte cell samples respectively prior to printing. Cell tracker solutions were 
prepared to a final concentration of 25 µM in cell culture media. Pelleted cells were 
resuspended in the CellTracker® solutions and incubated for 45 minutes at 37 °C. Following 
centrifugation, the supernatant from each sample was removed and cells resuspended in cell 
culture media at the required density for printing. At the desired time points the Transwell® 
membranes were removed from the insert mounts, fixed for 30 minutes in 4 % 
paraformaldehyde solution (Thermo Fisher Scientific) and washed 3 times in PBS (Sigma-
Aldrich). Whole samples were mounted onto glass slides using DPX (Sigma-Aldrich) prior to 
imaging. Imaging of samples labelled with CellTracker® dyes was performed using an 
LSM800 point scanning confocal microscope (Carl Zeiss AG, Germany) at 20x magnification. 
6.2.5 Cell Proliferation Assay 
Cell proliferation was assessed using the 5-ethynyl-2’-deoxyuridine (EdU)-Click 594 cell 
proliferation assay (Baseclick, Germany). Samples were seeded and cultured in media 
containing 10 µM EdU for 48 hours prior to processing at each time point. Day 1 samples 
were incubated in EdU for 24 hours. Transwell® inserts were then snap-frozen and sectioned 
as previous described. Sections were stained with the EDU-Click kit according to 
manufacturer’s instructions and mounted in mounting medium containing DAPI nuclear 
counterstain (Sigma-Aldrich). Imaging was performed using an LSM800 point scanning 
confocal microscope (Carl Zeiss AG) at 20x magnification. 
6.2.6 Metabolic Activity Assay 
Following culture, the supernatant from each well was removed and replaced with 235 µL of 
PrestoBlue® working solution previously prepared via the addition of 10 % v / v PrestoBlue® 
reagent to phenol-red free cell culture media. Plates were incubated for 2 hours prior to the 
collection of supernatant. Fluorescence values were obtained using a FLUOstar® Omega 
microplate reader (BMG Labtech, Germany) using an excitation and emission filter of 544 nm 
and 620 nm respectively. 
6.3 Results 
6.3.1 Haematoxylin and Eosin Staining 
Haematoxylin and eosin staining of the sectioned tissue models is displayed in Figure 6.2. 
Tissues comprising of multiple cell layers on the upper surface of the Transwell® insert 




Separation of the membrane from the tissue structure was observed indiscriminately of 
sample conditions as a consequence of the sectioning process. A reduction in cell density 
was observed on the apical surface of each tissue, with the exception of the chondrocyte 
models and co-culture models at day 14. Co-culture sections displayed an overall increase in 
tissue thickness during culture when compared to single cell conditions. Distinct cell layering 
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Figure 6.2 – Haematoxylin and Eosin staining of printed Transwell® insert cultures 
generated from MSC, chondrocyte and cell co-cultures over a 14 day culture period. Scale 
bar = 100 μm. 
6.3.2 Indirect Immunofluorescence Staining 
Indirect immunofluorescence staining of collagen II and aggrecan protein expression is 
presented in Figure 6.3, Figure 6.4 and Figure 6.5 for the MSC, chondrocyte and co-culture 
samples respectively. An increase in collagen II expression was observed within the 
chondrocyte and co-culture samples when compared to the tissue generated solely from 
MSCs, with a comparatively low expression of aggrecan observed across all samples. An 
increase in tissue thickness and cellular organisation was also observed within the 
chondrocyte and co-culture samples at day 3 and 14, corroborating with previous 
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Figure 6.3 – Immunostaining data comparing the collagen II (COLII, green) and aggrecan 
(AGCN, red) content of MSCs printed onto the Transwell® inserts over a 14 day culture 
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Figure 6.4 – Immunostaining data comparing the collagen II (COLII, green) and aggrecan 
(AGCN, red) content of chondrocyte cells printed onto the Transwell® inserts over a 14 day 
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Figure 6.5 – Immunostaining data comparing the collagen II (COLII, green) and aggrecan 
(AGCN, red) content of the MSC and chondrocyte cell co-culture printed onto the 
Transwell® inserts over a 14 day culture period. Cell nuclei were visualised using DAPI 
(blue) staining. Scale bar = 100 μm. 
6.3.3 Cell Tracker Staining 
Analysis of the localisation of MSC and chondrocyte cell types on the surface of the co-
culture model is displayed in Figure 6.6. Both MSCs and chondrocytes were retained 
throughout the 14 day culture period. A reduction in signal intensity for each cell line was 
observed over the first 3 days, with a subsequent increase in chondrocyte cell number and 
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Figure 6.6 – Immunofluorescence microscopy of printed MSC (green) and chondrocyte (red) 
cells on the surface of the co-culture over a 14 day culture period. Cells were labelled using 
CellTracker® fluorescent dyes prior to printing. Scale bar = 100 μm. 
6.3.4 Cell Proliferation Assay 
An EdU cell proliferation assay was conducted to identify regions of proliferation within the 
insert-based tissues generated from MSC, chondrocyte and cell co-cultures. Indirect 
immunofluorescence data presented in Figure 6.7, Figure 6.8 and Figure 6.9 displays the 
proportion and location of proliferating cells within the MSC, chondrocyte and co-culture 
models respectively. Proliferation was maintained within all three models across the full 14 
day culture period assessed. No discernible differences in the proportion of proliferating 
cells were observed between individually cultured and co-cultured cells. Proliferation was 
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Figure 6.7 – Immunofluorescence detection of proliferating cells via EdU incorporation 
within MSCs printed onto the Transwell® inserts over a 14 day period. Cell nuclei were 
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Figure 6.8 – Immunofluorescence detection of proliferating cells via EdU incorporation 
within chondrocyte cells printed onto the Transwell® inserts over a 14 day period. Cell 
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Figure 6.9 – Immunofluorescence detection of proliferating cells via EdU incorporation 
within MSC and chondrocyte co-cultures printed onto the Transwell® inserts over a 14 day 
period. Cell nuclei were visualised using DAPI (blue) staining. Scale bar = 100 μm. 
6.3.5 Metabolic Activity Assay 
A PrestoBlue® metabolic activity assay was performed to determine the metabolic activity of 
each cell line in comparison to the co-culture model over time. No significant difference in 
metabolic activity was observed between each cell culture condition at any of the time 
points assessed in Figure 6.10. A significant reduction in metabolic activity was observed 



































Figure 6.10 – PrestoBlue® metabolic activity assay for the printed MSC, chondrocyte and 
cell co-culture models over a 14 day incubation period. Data represents mean values ± SD. 
N=3. 
6.4 Discussion 
A bioprinted tissue model was constructed using the valve jetting process previously 
optimised in chapter 5. Tissues consisting of printed MSC, chondrocyte and MSC-
chondrocyte cell co-cultures were generated and compared over a 14 day period. 
A rapid reduction in the pH of cell culture media contained within each well was observed 
due to the combined high cell densities and low media volume of generated cultures. 
Although daily media exchange was performed, it is hypothesised that these effects 
significantly affected biological conditions within the culture. 
Nutrient and waste diffusion gradients are of specific importance within 3D culture formats 
due to the recognised role that they play in cellular viability, activity and migration. Previous 
studies have demonstrated the significant effects of nutrient diffusion within high density 3D 
cultures on cellular activity (Bock and Mrowietz, 2001; Keenan and Folch, 2007; Knight, 




Current strategies reported within the literature to reduce such effects include seeding cells 
at lower densities, performing more frequent media exchanges and using high-volume well 
plates. These methods collectively increase the availability of nutrients within the media and 
reduce the rate of waste product build-up (Knight, 2013; Mikhailova et al., 2014; Cozens et 
al., 2018). Reducing the cell density of the culture for OA disease models provides limited 
usefulness due to the important contribution that high cell densities have on tissue 
formation, differentiation and subsequent in vitro replication of current OA cell-based 
surgical procedures (Foldager et al., 2012; Mennan et al., 2018; Armoiry et al., 2019; Wang 
et al., 2019). In addition, modifications to the frequency of media exchange or plate size 
reduce the maximum throughput and density of model cultures, limiting their value for 
commercial scale HTS applications. 
Further research is therefore required to assess the suitability of novel methods to improve 
media exchange within high density culture environments. Exploratory research has 
investigated the potential for using active perfusion-based plate designs to allow for 
continual media exchange, thus avoiding the build-up of nutrient and waste gradients, as 
well as providing a continual source of material for real-time cell activity monitoring (Huang 
et al., 2015; Ma et al., 2018; Parrish et al., 2018). Such systems are currently implemented at 
the expense of compatibility with standard tissue culture plasticware, as well as plate 
handling and analysis equipment. Research by Huang et al. proposes a novel 24-well culture 
platform with a custom microfluidic lid to circumvent such issues (Huang et al., 2015). 
6.4.1 Haematoxylin and Eosin Staining 
Histological analysis of sectioned tissues was reported in Figure 6.2. Cells were shown to 
adhere to the membrane within the first 24 hours of culture, generating tissues consisting of 
multiple layers of cells. Over the remaining time points, an increase in tissue thickness and 
cell density was observed for the chondrocyte and cell co-cultures, with MSC tissues 
retaining a similar thickness. Additional tissue organisation at the final time point was 
observed in the co-culture, indicating the formation of multiple cell layers. 
Variations in nuclei size were also observed within the chondrocyte and cell co-cultures 
following tissue formation. These changes are characteristic of nuclear blebbing, a process 
whereby structural changes such as chromatin condensation and fragmentation lead to the 
formation of distinct regions within the nucleus (Cataldi et al., 1994). Nuclear blebbing was 




the co-culture, cells undergoing nuclear blebbing transitioned from being evenly dispersed 
within the tissue to becoming localised on the upper surface region. These results indicate 
that the co-culture of MSC and chondrocyte cell types promotes in vivo cellular 
differentiation and organisation when compared to single cell cultures of either cell type. 
These findings support a range of existing literature indicating a potential relationship 
between the co-culture of MSC and chondrocyte cell types versus single cell cultures for the 
production of cartilage tissues (Hwang et al., 2011; Meretoja et al., 2012, 2014; Yang, Lee 
and Barabino, 2012; Dahlin et al., 2014; Li et al., 2016). This has potentially significant 
implications on the cellular therapies under development for the treatment of OA 
(Richardson et al., 2017; Wang et al., 2019). 
The process of cryosectioning was also observed to significantly impact the quality of the 
tissue yield. Insert membranes readily separated from the tissue upon thawing to room 
temperature, resulting in tissue tearing and inconsistencies in tissue thickness. Furthermore, 
small variations in blade cutting force, blade integrity, or adhesiveness of the tissue or 
polycarbonate membrane impacted sample quality and led to membrane separation. These 
challenges represent inherent limitations of the sectioning process and have been reported 
within the literature for similar insert-based cultures (Knight, 2013; Pampaloni, Ansari and 
Stelzer, 2013; Marx et al., 2018).  
Additionally, variations in cell seeding technique have also been shown to affect the 
distribution of tissue on the membrane surface, with dispersed versus concentrated 
pipetting techniques having been reported to effect tissue localisation (Knight, 2013). Due to 
the nature of the bioprinting process, material is deposited onto the membrane at a 
significant ejection velocity and within a specified region, potentially impacting tissue 
formation. 
6.4.2 Indirect Immunofluorescence Staining 
Indirect immunostaining microscopy comparing the protein expression of collagen II and 
aggrecan within the sectioned tissue models was displayed in Figure 6.3, Figure 6.4 and 
Figure 6.5 for the MSC, chondrocyte and cell co-culture samples respectively. An elevation in 
collagen II expression was observed within the chondrocyte and co-culture samples over 
time. Collagen represents the most abundant structural macromolecule within cartilage 
ECM, of which the majority is type II collagen (Sophia Fox, Bedi and Rodeo, 2009). These 




co-culture models that would normally be found within cartilage tissue. An elevation in 
aggrecan expression was observed in MSC and co-culture tissues when compared to tissues 
comprised solely of chondrocyte cells. 
These findings corroborate with data presented within the previous chapter, whereby the 
effect of aggregate culture on MSC and chondrocyte expression of collagen II and aggrecan 
was studied. An opportunity for further work is provided to study the biological effects of 
the co-culture using a wider range of cellular markers. This could include SOX9, a 
transcription factor upregulated during chondrogenesis, alongside markers previously 
discussed to define the MSC population within the model (Dominici et al., 2006; Hino et al., 
2014; James et al., 2015).  
Additionally, a similar pattern of variations in nuclear size and shape was observed within 
indirect immunofluorescence stained samples that is characteristic of nuclear blebbing. This 
was visualised through DAPI nuclear binding within apoptotic cells, prior to the subsequent 
membrane damage and cell lysis that is characteristic of apoptosis (Eidet et al., 2014). These 
findings support the previous observations within Figure 6.2 of haematoxylin and eosin 
stained tissue sections. 
These results provide an opportunity for further research in a number of areas. This includes 
the use of whole-mount microscopy techniques to analyse tissue composition, the 
incorporation of a wider range of cellular makers to assess tissue changes, as well as an 
assessment of the effect of the different bioprinting protocols on tissue formation (Smyrek 
and Stelzer, 2017; Lazzari et al., 2019). 
6.4.3 Cell Tracker Staining 
A combination of green and red CellTracker® fluorescent dyes were used to label MSC and 
chondrocyte cells respectively prior to printing. Cell tracking was performed to determine 
the ratio and localisation of each cell type within the co-culture model over time. 
Immunofluorescence images presented in Figure 6.6 confirmed the presence and 
maintenance of both cell types within the co-culture throughout the 14 day incubation 
period. A reduction in signal intensity was observed within the first 3 days, representing the 
degradation of the fluorophore and its reduced retention within proliferating cells. 
An increase in chondrocyte cell number and subsequent signal intensity was observed 




smaller increase in signal intensity observed for the MSCs. It is hypothesised that the 
variations in proliferation rate that were previously quantified had resulted in a discernible 
change in the ratio of MSC to chondrocyte cells within the model. It is also possible that the 
presence of MSCs within the co-culture caused an elevation in the rate of chondrocyte 
proliferation. This is supported with previous findings whereby the presence of MSCs was 
shown to stimulate chondrocyte proliferation (Wu et al., 2011). An opportunity for further 
validation work could include the application of techniques such as fluorescence-activated 
cell sorting to quantitatively assess the cellular composition of the co-culture tissue. 
Additionally, a greater proportion of surface-level chondrocyte cells were present within the 
model when compared to MSCs. In combination with the layered tissue structure observed 
within Figure 6.2, this data indicates that the chondrocyte cell population formed a surface 
layer above the MSCs within the tissue models generated, contrasting the initial post-
printing cellular organisation. This is supported by previous research indicating the 
organisational potential of MSCs when co-cultured with other cell types (Wu et al., 2011; 
Marshall, Barnes and Genever, 2018). Further research is required to more comprehensively 
assess the changes in cellular localisation and composition using advanced microscopy 
techniques such as optical sectioning. 
This data provides an important validation step to confirm the maintenance of a cell co-
culture within the tissues generated, as well as indicating a time frame for the maintenance 
of a 50:50 ratio of MSC and chondrocyte cell types. 
6.4.4 Cell Proliferation Assay 
Immunofluorescence microscopy images indicating the regions of proliferation within the 
MSC, chondrocyte and co-culture models were presented in Figure 6.7, Figure 6.8 and Figure 
6.9 respectively, via EdU incorporation within cellular DNA during replication. 
Proliferation was shown to be maintained across all sample groups throughout the full 14 
day assessment period, with cellular composition having no discernible effect on 
proliferation activity. Proliferating cells were shown to be localised towards the membrane 
side of the tissue. These results imply that the tissue was polarised, and actively proliferating 
from the membrane level, with non-proliferative cells transferred to the apical surface. This 
data corroborates with the histological staining previously presented in Figure 6.2, whereby 





Additionally, a distinct reduction in nuclei size and sphericity was observed towards the 
uppermost surface of the co-culture tissue at day 14, in combination with an increase in 
fluorophore intensity within localised nuclear regions, indicative of nuclear blebbing. These 
observations further support the hypothesis that cells were transferred from a proliferative 
region at the base of the tissue to the apical layer, whereby they underwent maturation and 
subsequent controlled cell death. These results indicate potential structural organisation of 
the micro-tissue into distinct layers based upon cellular density, size and maturation status, 
mimicking the structural variations of hyaline cartilage tissue outlined in Figure 2.3. 
Previous research using insert-based 3D culture platforms has demonstrated that cellular 
migration through dense tissues or pore structures promotes the formation of nuclear 
blebbing and membrane rupture, indicating a possible mechano-regulatory role on cell cycle 
phase (Pfeifer et al., 2018; Xia et al., 2019). These findings provide evidence of physical 
changes to cellular structure and organisation in response to high density culture conditions, 
indicating a potential mechanism through which the nuclear blebbing observed was induced. 
6.4.5 Metabolic Activity Assay 
Data showing the results of a PrestoBlue® metabolic activity assay of each culture condition 
were presented in Figure 6.10. Cellular composition was not shown to significantly affect 
tissue metabolic activity, with a reduction in metabolic activity observed over the first 7 days 
of culture in all samples. These results contrast with the findings of previous research 
presented within this thesis, whereby a significant difference in metabolic activity was 
observed between the MSC and chondrocyte cell lines during routine 2D culture, as shown 
in Figure 4.17 and Figure 5.13. 
A number of factors could have contributed to the overall reduction in cellular metabolic 
activity. This includes a reduction in cell number or viability due to increasing resource and 
space constraints. In addition, a reduction in cellular metabolic activity is commonly 
observed in response to a reduced rate of cellular proliferation or substrate adherence 
during culture (Liberio et al., 2014). However, such effects would contrast with previous 
findings whereby the proliferation and adherence of each cell type was maintained 
throughout culture. 
It is therefore likely that the metabolic activity assay selected provided poor compatibility 
with the 3D culture format. Previous research has demonstrated that a range of commonly 




representation of cellular activity when applied to 3D culture conditions. This is due to the 
requirements for rapid diffusion, internalisation, conversion and subsequent externalisation 
and diffusion of reagents to provide an indicator of internal cellular processes (Mosmann, 
1983; Quent et al., 2010; Walzl et al., 2014; Uzarski et al., 2017).  
Within a 3D culture platform, the rate of compound diffusion is rapidly reduced in response 
to increasing tissue thicknesses, with upper bounds placed on tissue thickness where 
vasculature networks are absent (Malda et al., 2004; Zhou, Cui and Urban, 2008; Cai et al., 
2015; McMurtrey, 2016). This is further compounded within an insert-based model, 
whereby diffusion through the membrane is required to ensure that the full cellular 
composition is represented, with the porous membrane reducing compound diffusion rates 
(Bock and Mrowietz, 2001). Under normal conditions, a progressive increase in cell density 
and adherence onto the insert would be anticipated, further reducing its permeability for 
cell-based assays. These findings therefore provide an opportunity for further research to 
assess the effectiveness of commonly used cell-based assays within the 3D culture 
environment to identify the most appropriate biological markers. In addition, further 
research is needed to optimise assay protocols to 3D platforms in order to provide a more 
robust and reproducible system to monitor cellular changes during 3D tissue culture. 
In combination, this research demonstrates the suitability of valve deposition processes for 
the construction of tissue models for in vitro OA research applications. These results 
complement wider literature in this area, whereby bioprinting technologies were 
successfully combined with insert culture formats to generate models of alternative tissue 











Within this chapter, a DoD valve printing process was applied for the construction of 3D 
tissue models. 
 A combination of MSC, chondrocyte and cell co-cultures were successfully printed 
onto an insert-based platform using the valve printing process, providing a method to 
automate the manufacture of 3D tissue models 
 Cellular proliferation and composition within each model was maintained across the 
14 day culture period, with histological assessment demonstrating the formation of 
dense tissues within chondrocyte and co-culture models 
 Further work is required to fully ascertain the effect of the cell co-culture on tissue 





Chapter 7. Discussion 
7.1 Summary of Results 
The research presented in this thesis focussed on the characterisation of piezoelectric inkjet 
and valve-based drop-on-demand printing technologies, alongside their application in the 
construction of 3D tissue models for osteoarthritis research. 
7.1.1 Single Cell Printing 
The jetting performance of a piezoelectric inkjet printing device was characterised in 
response to changes across a range of critical printing parameters. A printing configuration 
was defined to enable reliable material deposition at the picolitre-scale. Cell printing 
performance was evaluated under this configuration, with a resolution achieved to enable 
the selective deposition of biological material at the single cell level, whilst maintaining 
cellular viability. 
Cellular agglomeration and nozzle blockages previously reported within the literature were 
observed when jetting cellular material for extended time periods. These effects reduced the 
reliability and performance of the printing process. Cell deposition performance was 
improved through the development and application of an in-house designed reservoir 
agitation system to maintain cellular dispersion within the ink solution. A poly-l-lysine cell 
coating protocol was also evaluated to reduce cellular agglomeration, with a working range 
of up to 25 μg / mL defined based upon compatibility with the MSC and chondrocyte cell 
types studied. 
7.1.2 Valve Cell Printing 
A solenoid valve dispensing system was evaluated under a drop-on-demand actuation 
configuration to deposit biological material at the nanolitre-scale. The impact of printing 
parameter effects on dispensing performance were quantified, using a combination of 
gravimetric and fluorometric analysis techniques, to determine an optimal configuration for 
reliable printing. 
Cell printing performance was demonstrated with the dispensing process exhibiting no 
significant effects on cellular viability or biological activity. In addition, jetting was reliably 
achieved across a concentration range of 1-20 million cells per mL, demonstrating the 




7.1.3 Tissue Model Production 
The suitability of aggregate and insert-based 3D culture platforms were assessed for the 
construction of printed tissue models.  
An in-well aggregate culture protocol was successfully replicated using the valve printing 
process to generate high density cultures of MSC and chondrocyte cell types. The model 
format was retained across a 21 day culture period, with biological analysis confirming that 
the printing process had no significant effect on aggregate morphology, size or cell protein 
expression of chondrogenic markers. 
The insert-based culture platform was generated using the valve printing device to culture 
MSC, chondrocyte and MSC-chondrocyte co-cultures. Tissues were generated and retained 
over a 14 day culture period, exhibiting continual proliferation. Histological analysis revealed 
the formation of distinct cellular layers within the chondrocyte and co-culture samples, with 
both cell types retained within the model at 14 days. 
In combination, these findings demonstrate the compatibility of the valve printing process 
with aggregate and insert-based 3D culture formats. 
7.2 Implications of Research 
7.2.1 Considerations for Cell Printing 
A wide range of drop-on-demand bioprinting processes have been reported for cell printing 
applications within the literature. Most commonly, these publications have focussed on the 
biological applications of inkjet printing, where the authors have taken care to ensure the 
efficient modelling and optimisation of printing parameters to improve cell printing 
performance (Xu et al., 2005; J. A. Park et al., 2017). Yet despite this, limited research exists 
on the practical limitations of dispensing cellular material within a liquid solution (Kwon, 
2009; Parsa et al., 2010; Yusof et al., 2011; Chahal, Ahmadi and Cheung, 2012; Tse, 2015). 
Within this work, the effects of cellular materials on droplet ejection, printing density and 
jetting reliability have been investigated, and the implications these factors have on 
bioprinting systems have been reported. This includes challenges surrounding the 
maintenance of cellular suspensions within a reservoir, as well as the agglomeration of 





A combination of three independent methodologies have been assessed and presented as 
potential mechanisms to improve printing performance. This includes the use of purge 
cycling between print runs, the development of an in-house designed reservoir agitation 
system to reduce cell sedimentation, and benchmarking of a polycationic cell coating 
process to minimise cellular agglomeration. Each of these strategies provide a valuable 
alternative to current bioprinting approaches in order to maximise print performance, and 
alleviate the issues that are inherent when processing cell-containing solutions over 
extended periods of time. As a result, this research serves as an important reference when 
developing or refining novel bioprinting approaches to account for cell ink effects, thus 
maximising the potential applications of such techniques within the fields of tissue 
engineering and regenerative medicine. 
7.2.2 Liquid Handling Applications of Valve Deposition Technology 
The emergence of the fields of biofabrication and high-throughput screening have increased 
demand for reliable, low-volume dispensing apparatus for applications within tissue 
engineering and drug discovery research. Commercially available non-contact liquid handling 
systems are often designed to feature pneumatic actuation methods. These systems 
generally employ disposable tips to hold and transfer material between plates, making 
printing performance heavily dependent on tip-to-tip manufacturing tolerances. In addition, 
physical limitations are placed on the minimum volume that can be practically transferred 
per actuation cycle due to the considerable impact of surface tension, material viscosity and 
component mixing on dispensing performance. 
A growing number of systems have begun to employ solenoid valve actuated dispensing 
devices to circumvent such issues and provide a significant improvement in minimum 
dispense resolution. Despite this, such systems commonly require the valve open time to be 
adjusted to change droplet volume. As a result, they offer less control over material ejection 
characteristics, generating a continual stream of material under large volume requests. 
These systems therefore provide a poor method to bioprint structures in 3D, where spatial 
control of material volume is required, and in many cases in situ contact or curing reactions 
are applied to generate layered structures (Sturgess et al., 2017; Da Conceicao Ribeiro et al., 
2019; Zimmermann et al., 2019). 
In this thesis, the versatility of a valve deposition process for material and cell deposition 




drop-on-demand configuration. In addition, the ability to process cellular material across a 
wide concentration range represents a significant advantage over alternative techniques 
such as inkjet printing, whereby jetting performance is limited to lower cell concentrations 
(Cui et al., 2010). The ability to process high cell ink concentrations is of particular 
importance for bioprinting applications within the field of tissue engineering due to the high 
cell density of natural tissues. Comparisons between gravimetric and fluorometric analysis 
techniques also highlighted the challenges associated with quantifying deposition 
performance at the nanolitre-scale to assess printing accuracy and reproducibility, as well as 
providing potential methods for circumvention. 
These results provide an important validation step to ensure that valve printing performance 
can be maintained when using actuation cycle number to control total dispense volume. In 
addition, biological characterisation data demonstrated the biocompatibility of the valve 
deposition process to deposit MSC and chondrocyte cell types, without significantly 
implicating cellular viability or function. 
7.2.3 Scaling Up Aggregate Production 
The emergence of cellular therapies for the treatment of osteoarthritis provides a valuable 
alternative to conventional surgical procedures. Ongoing clinical trials have demonstrated 
the potential of such therapies across a range of implantation formats, of which aggregate 
culture and surgical implantation are being developed at the clinical and commercial scale 
(National Institute for Health and Care Excellence, 2018; Armoiry et al., 2019; Wang et al., 
2019). In addition, aggregate culture has gained increased attention within recent literature 
due to the improved recapitulation of the 3D environment of living tissue, thus providing a 
more replicative environment when compared to the commonly employed monolayer 
culture techniques for in vitro research (McMurtrey, 2016; Nath and Devi, 2016). 
Current methodologies to generate tissue aggregates are labour intensive, thus limiting the 
scale at which cultures can be generated (Foty, 2011; Leung et al., 2015). Within this 
research, a valve-based dispensing system was successfully applied to generate 3D 
aggregates of MSC and chondrocyte cell types using a gravity-induced culture method. The 
printing process was shown to have no significant effect on aggregate size, morphology, or 
expression of key chondrogenic cell markers, when compared with manual seeding 
techniques using an in-well culture format. This approach therefore provides a potential 




whilst simultaneously reducing labour requirements. As a result, such technologies could 
provide improvements to the roll-out and cost-effectiveness of existing cellular therapies, 
alongside increasing the potential throughput of in vitro OA research platforms. 
7.2.4 Bioprinting of Osteoarthritis Tissue Models 
Recent strategies to improve the performance of emerging osteoarthritis cell therapies 
include the combination of MSC and chondrocyte cell types to promote cartilage formation 
on implantation. However, few studies exist to provide evidence of the potential impact of 
MSCs on chondrocyte tissue formation in both in vitro and in vivo formats (Li et al., 2016; 
Kim et al., 2019; Wang et al., 2019). In addition, there is a growing demand for novel disease 
models that can be used for early-stage high-throughput screening applications due to the 
high costs and low success rates that are characteristic of the therapy development process 
(Dimitri, 2011; DiMasi, Grabowski and Hansen, 2016). 
It is therefore imperative that in vitro platforms are developed to better model the cellular 
microenvironment within the joint, thus enabling improved early-stage testing of potential 
compounds or cellular therapies for the treatment of osteoarthritis. Within this research, a 
combination of MSC, chondrocyte and MSC-chondrocyte co-culture tissues were generated 
within an insert-based culture format to study cell-cell interactions and provide a platform 
for high-throughput screening. Models were constructed using a valve printing process in a 
96-well plate format to maximise throughput and scalability. Biological characterisation data 
demonstrated that the model remained viable over the full 14 day assessment period 
through continual cell proliferation and the maintenance of both cell types, as well as 
elucidating a potential mechanism of cellular organisation within the co-cultured tissue. 
This work provides a platform for assessing the effect of cell co-cultures on tissue formation, 
as well studying tissue responses to external pathological stimuli such as cytokines IL-1β and 
TNF-α, which are implicated in OA pathophysiology (Rahmati, Mobasheri and Mozafari, 
2016). Following the induction of an OA phenotype, this model may also provide a platform 
to assess treatment response during the early stages of the drug discovery process.  
7.3 Future Research 
A number of areas for further research are highlighted within this work. This includes the 
scaling up of inkjet or valve-based actuation systems to enable simultaneous printing across 
multiple actuation channels. Such modifications could include the use of a microfluidic or 




separate reservoir systems could be designed to enable the simultaneous delivery of 
multiple different cell types within a single model. Further development of the drive 
electronics systems would be required to enable the application of independent actuation 
parameters to each device according to print and ink specifications. These modifications 
would increase the throughput of the device to match that of commercial non-contact 
dispensing systems, as well as enable the simultaneous deposition of multiple materials into 
each well of a multi-well plate. As a result, such changes would significantly improve the 
commercial applicability of the printing platform. 
Further development of the printing platform could also include upgrades to the on-board 
image acquisition and analysis systems to integrate image-based automated cell counting. 
This would provide a rapid and automated method to calibrate and benchmark printing 
performance prior to each print job in order to ensure printing reliability. 
In addition, the demonstration of single cell printing capabilities presented using the inkjet 
deposition system in chapter 4 provides a unique method to scale down the size of disease 
models, opening up new opportunities to research intercellular interactions and responses 
to external stimuli. Further research could incorporate this printing technology to deposit 
multiple cell types within a microfluidic chamber or culture format that is an order of 
magnitude smaller than conventional high density multi-well plates. Decreasing model size 
would confer increased model densities and subsequently higher-throughput platforms for 
in vitro research. It would also significantly reduce reagent and cell requirements, lowering 
associated development and maintenance expenses. When combined with appropriate 
analysis techniques, such models could provide an opportunity to study interactions at the 
single cell level, thus providing unique research opportunities that would be difficult to 
achieve at an equivalent scale and throughput when using conventional liquid handling 
processes. 
Further research is also required to identify biomarkers and analysis techniques that could 
be used to study tissue models at a greater screening throughput. Within both the aggregate 
and insert-based models, a key challenge throughout the project has been the low 
throughput and complexity of conventional sectioning, staining and imaging processes. In 
addition, phenotypic markers of cellular differentiation have provided a limited 
understanding of cellular changes within the tissue. Culture formats were also primarily 




samples were required to determine cellular changes over time with a reduced analytical 
throughput. Further research could incorporate whole-mount microscopy techniques, more 
comprehensive biomarker screening, or non-destructive supernatant analysis techniques, to 
provide an analysis methodology that is able to more comprehensively and rapidly monitor 
cellular changes within the tissue models. 
The exchange of cell culture media represented a continual challenge when culturing high 
cell densities within high-throughput compatible culture formats. Due to the recognised role 
that nutrient and waste diffusion gradients have on cellular functionality, it is essential to 
select culture formats, media formulation and exchange procedures to minimise any 
variabilities in culture conditions. In addition, the collection and management of media 
exchange provides a valuable opportunity for further study, when coupled with the 
requirements to provide non-destructive sample analysis techniques such as supernatant 
analysis. Further research should be performed to explore the potential of using novel media 
exchange methods to automate the media exchange process, as well as to provide an 
additional sample stream for real-time analysis. This may incorporate modifications to well 
volumes, perfusion-based systems or microfluidic devices. 
Finally, a number of additional areas of interest exist in relation to the specific 3D culture 
formats explored within this research. This includes the impact of initiating cell seeding 
densities and ratios on model stability and function, as well as methods to induce and 
monitor OA-like pathophysiological processes within the tissues generated. Such methods 
could include the use of cytokine induction within the cell culture media formulation, as well 
as mechanical methods to initiate tissue instability or damage, in order to recapitulate 
specific pathophysiological conditions that are characteristic of OA. 
7.4 Conclusion 
The research presented within this thesis has demonstrated the versatility of inkjet and 
valve-based drop-on-demand processes for cell printing applications. Each technique was 
characterised to determine the influence of jetting parameters on printing performance.  
Single cell printing was achieved using the inkjet printing process, enabling the deposition of 
material at the picolitre-scale, thus providing unique opportunities for the development of 




Valve printing performance was demonstrated over a concentration range of 1-20 million 
cells per mL to enable the deposition of material at the nanolitre-scale, providing a versatile 
method to dispense high cell density solutions. 
Both printing processes were successfully applied for the deposition of mesenchymal 
stromal and chondrocyte cell types without significantly affecting cellular viability or 
function, with a combination of intermittent nozzle purging, polycationic cell coating, and 
reservoir agitation systems presented to maximise cell jetting performance. These results 
demonstrate the suitability of drop-on-demand processes for bioprinting applications, as 
well as providing potential mechanisms to reduce cell printing performance issues that are 
inherent within droplet-based bioprinting processes. 
Aggregate and insert-based 3D culture formats were then replicated using the valve printing 
technology to generate tissue models for in vitro osteoarthritis research applications. These 
models provide the first examples of DoD bioprinted platforms to study the underlying 






Chapter 8. References 
Ahn, K. and Yokota, S. (2005) ‘Intelligent switching control of pneumatic actuator using 
on/off solenoid valves’, Mechatronics, 15(6), pp. 683–702. doi: 
10.1016/j.mechatronics.2005.01.001. 
Aijian, A. P. and Garrell, R. L. (2015) ‘Digital Microfluidics for Automated Hanging Drop Cell 
Spheroid Culture’, Journal of Laboratory Automation, 20(3), pp. 283–295. doi: 
10.1177/2211068214562002. 
Amin, A. K. et al. (2009) ‘Chondrocyte survival in articular cartilage: The influence of 
subchondral bone in a bovine model’, Journal of Bone and Joint Surgery - Series B, 91(5), pp. 
691–699. doi: 10.1302/0301-620X.91B5.21544. 
Anderson, G. D. et al. (1996) ‘Selective Inhibition of Cyclooxygenase (COX)-2 Reverses 
Inflammation and Expression of COX-2 and Interleukin 6 in Rat Adjuvant Arthritis’, J. Clin. 
Invest, 97(11), pp. 2672–2679. 
Armoiry, X. et al. (2019) ‘Autologous Chondrocyte Implantation with Chondrosphere for 
Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a 
NICE Single Technology Appraisal’, PharmacoEconomics, 37(7), pp. 879–886. doi: 
10.1007/s40273-018-0737-z. 
Armstrong, S. J. et al. (1993) ‘Moderate exercise exacerbates the osteoarthritic lesions 
produced in cartilage by meniscectomy: a morphological study’, Osteoarthritis and Cartilage, 
1(2), pp. 89–96. doi: 10.1016/S1063-4584(05)80023-8. 
Astashkina, A., Mann, B. and Grainger, D. W. (2012) ‘A critical evaluation of in vitro cell 
culture models for high-throughput drug screening and toxicity’, Pharmacology & 
Therapeutics, 134(1), pp. 82–106. doi: 10.1016/j.pharmthera.2012.01.001. 
Atala, A. et al. (2012) ‘Hybrid printing of mechanically and biologically improved constructs 
for cartilage tissue engineering applications’, Biofabrication. IOP Publishing, 5(1), p. 015001. 
doi: 10.1088/1758-5082/5/1/015001. 
Bammesberger, S. et al. (2013) ‘Quantitative characterization of non-contact 





Bartosh, T. J. et al. (2010) ‘Aggregation of human mesenchymal stromal cells (MSCs) into 3D 
spheroids enhances their antiinflammatory properties’, Proceedings of the National 
Academy of Sciences of the United States of America, 107(31), pp. 13724–13729. doi: 
10.1073/pnas.1008117107. 
Basso, N. and Heersche, J. N. M. (2006) ‘Effects of hind limb unloading and reloading on 
nitric oxide synthase expression and apoptosis of osteocytes and chondrocytes’, Bone, 39(4), 
pp. 807–814. doi: 10.1016/j.bone.2006.04.014. 
Bay-Jensen, A. C. et al. (2016) ‘Osteoarthritis year in review 2015: soluble biomarkers and 
the BIPED criteria’, Osteoarthritis and Cartilage, 24(1), pp. 9–20. doi: 
10.1016/j.joca.2015.10.014. 
Bellido, M. et al. (2011) ‘Improving subchondral bone integrity reduces progression of 
cartilage damage in experimental osteoarthritis preceded by osteoporosis’, Osteoarthritis 
and Cartilage, 19(10), pp. 1228–1236. doi: 10.1016/j.joca.2011.07.003. 
Berenbaum, F. (2013) ‘Osteoarthritis as an inflammatory disease (osteoarthritis is not 
osteoarthrosis!).’, Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. W.B. 
Saunders, 21(1), pp. 16–21. doi: 10.1016/j.joca.2012.11.012. 
Bessemans, L. et al. (2016) ‘Automated Gravimetric Calibration to Optimize the Accuracy and 
Precision of TECAN Freedom EVO Liquid Handler’, Journal of Laboratory Automation, 21(5), 
pp. 693–705. doi: 10.1177/2211068216632349. 
Bhadriraju, K. and Chen, C. S. (2002) ‘Engineering cellular microenvironments to improve 
cell-based drug testing’, Drug Discovery Today, 7(11), pp. 612–620. doi: 10.1016/S1359-
6446(02)02273-0. 
Bhosale, A. M. and Richardson, J. B. (2008) ‘Articular cartilage: Structure, injuries and review 
of management’, British Medical Bulletin, 87(1), pp. 77–95. doi: 10.1093/bmb/ldn025. 
Birgersdotter, A., Sandberg, R. and Ernberg, I. (2005) ‘Gene expression perturbation in 
vitro—A growing case for three-dimensional (3D) culture systems’, Seminars in Cancer 
Biology, 15(5), pp. 405–412. doi: 10.1016/j.semcancer.2005.06.009. 
Bock, O. and Mrowietz, U. (2001) ‘Development of a new method of analysing chemotactic 




Methods. Elsevier, 48(3), pp. 257–268. doi: 10.1016/S0165-022X(01)00157-9. 
Boland, T. et al. (2003) ‘Cell and organ printing 2: Fusion of cell aggregates in three-
dimensional gels’, Anatomical Record - Part A Discoveries in Molecular, Cellular, and 
Evolutionary Biology, 272(2), pp. 497–502. doi: 10.1002/ar.a.10059. 
Boland, T., Wilson, W. and Xu, T. (2006) ‘Ink-jet printing of viable cells’. United States: United 
States Patent and Trademark Office. Available at: 
https://patents.google.com/patent/US7051654B2/en. 
Bondeson, J. et al. (2008) ‘The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in 
osteoarthritis: A review’, Clinical and Experimental Rheumatology, 26(1), pp. 139–145. doi: 
2261 [pii]. 
Boutros, M., Heigwer, F. and Laufer, C. (2015) ‘Microscopy-Based High-Content Screening’, 
Cell, 163(6), pp. 1314–1325. doi: 10.1016/j.cell.2015.11.007. 
Breslin, S. and O’Driscoll, L. (2013) ‘Three-dimensional cell culture: The missing link in drug 
discovery’, Drug Discovery Today, 18(5–6), pp. 240–249. doi: 10.1016/j.drudis.2012.10.003. 
Brew, K., Dinakarpandian, D. and Nagase, H. (2000) ‘Tissue inhibitors of metalloproteinases: 
evolution, structure and function’, Biochimica et Biophysica Acta (BBA) - Protein Structure 
and Molecular Enzymology, 1477(1), pp. 267–283. doi: 10.1016/S0167-4838(99)00279-4. 
Brew, K. and Nagase, H. (2010) ‘The tissue inhibitors of metalloproteinases (TIMPs): An 
ancient family with structural and functional diversity’, Biochimica et Biophysica Acta (BBA) - 
Molecular Cell Research, 1803(1), pp. 55–71. doi: 10.1016/j.bbamcr.2010.01.003. 
C, A. et al. (2019) ‘Inkjet printing of thermally activated delayed fluorescence (TADF) 
dendrimer for OLEDs applications’, Organic Electronics: physics, materials, applications. 
North-Holland, 74, pp. 218–227. doi: 10.1016/j.orgel.2019.07.011. 
Cader, H. K. et al. (2019) ‘Water-based 3D inkjet printing of an oral pharmaceutical dosage 
form’, International Journal of Pharmaceutics. Elsevier, 564, pp. 359–368. doi: 
10.1016/J.IJPHARM.2019.04.026. 
Cai, Y. et al. (2015) ‘Oxygen transport in a three-dimensional microvascular network 
incorporated with early tumour growth and preexisting vessel cooption: Numerical 




Campbell, P. G. et al. (2005) ‘Engineered spatial patterns of FGF-2 immobilized on fibrin 
direct cell organization’, Biomaterials, 26(33), pp. 6762–6770. doi: 
10.1016/j.biomaterials.2005.04.032. 
Caplan, A. I. (2009) ‘New Era of Cell-Based Orthopedic Therapies’, Tissue Engineering Part B: 
Reviews, 15(2), pp. 195–200. doi: 10.1089/ten.teb.2008.0515. 
Caplan, A. I. and Bruder, S. P. (2001) ‘Mesenchymal stem cells: building blocks for molecular 
medicine in the 21st century’, Trends in Molecular Medicine. Elsevier Current Trends, 7(6), 
pp. 259–264. doi: 10.1016/S1471-4914(01)02016-0. 
Caron, M. M. J. et al. (2012) ‘Redifferentiation of dedifferentiated human articular 
chondrocytes: comparison of 2D and 3D cultures’, Osteoarthritis and Cartilage. W.B. 
Saunders, 20(10), pp. 1170–1178. Available at: 
https://www.sciencedirect.com/science/article/pii/S1063458412008710. 
Castañeda, S. et al. (2012) ‘Subchondral bone as a key target for osteoarthritis treatment’, 
Biochemical Pharmacology, pp. 315–323. doi: 10.1016/j.bcp.2011.09.018. 
Cataldi, A. et al. (1994) ‘The behaviour of nuclear domains in the course of apoptosis’, 
Histochemistry, 102(3), pp. 221–231. doi: 10.1007/BF00268899. 
Cawston, T. E. and Wilson, A. J. (2006) ‘Understanding the role of tissue degrading enzymes 
and their inhibitors in development and disease’, Best Practice & Research Clinical 
Rheumatology, 20(5), pp. 983–1002. doi: 10.1016/j.berh.2006.06.007. 
Chaganti, R. K. and Lane, N. E. (2011) ‘Risk factors for incident osteoarthritis of the hip and 
knee’, Current Reviews in Musculoskeletal Medicine, 4(3), pp. 99–104. doi: 10.1007/s12178-
011-9088-5. 
Chahal, D., Ahmadi, A. and Cheung, K. C. (2012) ‘Improving piezoelectric cell printing 
accuracy and reliability through neutral buoyancy of suspensions’, Biotechnology and 
Bioengineering, 109(11), pp. 2932–2940. doi: 10.1002/bit.24562. 
Chang, C. C. et al. (2011) ‘Direct-write bioprinting three-dimensional biohybrid systems for 
future regenerative therapies’, Journal of Biomedical Materials Research - Part B Applied 
Biomaterials, pp. 160–170. doi: 10.1002/jbm.b.31831. 




cell survival from solid freeform fabrication-based direct cell writing’, Tissue Engineering - 
Part A. Mary Ann Liebert Inc., 14(1), pp. 41–48. doi: 10.1089/ten.a.2007.0004. 
Chen, W. H. et al. (2009) ‘In vitro stage-specific chondrogenesis of mesenchymal stem cells 
committed to chondrocytes’, Arthritis and Rheumatism, 60(2), pp. 450–459. doi: 
10.1002/art.24265. 
Chen, Y. et al. (2017) ‘Edge effect detection for real-time cellular analyzer using statistical 
analysis’, RSC Advances, 7(34), pp. 20833–20839. doi: 10.1039/c6ra26375e. 
Chevalier, X. et al. (2009) ‘Intraarticular injection of anakinra in osteoarthritis of the knee: A 
multicenter, randomized, double-blind, placebo-controlled study’, Arthritis & Rheumatism. 
Wiley Subscription Services, Inc., A Wiley Company, 61(3), pp. 344–352. doi: 
10.1002/art.24096. 
Choi, Y. Y. et al. (2010) ‘Controlled-size embryoid body formation in concave microwell 
arrays’, Biomaterials, 31(15), pp. 4296–4303. doi: 10.1016/j.biomaterials.2010.01.115. 
Chowdhury, T. T. et al. (2008) ‘Signal transduction pathways involving p38 MAPK, JNK, NFκB 
and AP-1 influences the response of chondrocytes cultured in agarose constructs to IL-1β 
and dynamic compression’, Inflammation Research, 57(7), pp. 306–313. doi: 
10.1007/s00011-007-7126-y. 
Claassen, H. et al. (2011) ‘C-28/I2 and T/C-28a2 chondrocytes as well as human primary 
articular chondrocytes express sex hormone and insulin receptors—Useful cells in study of 
cartilage metabolism’, Annals of Anatomy - Anatomischer Anzeiger. Urban & Fischer, 193(1), 
pp. 23–29. doi: 10.1016/J.AANAT.2010.09.005. 
Clark, E. C. et al. (2016) ‘Evaluation of cell-laden polyelectrolyte hydrogels incorporating 
poly( l -Lysine) for applications in cartilage tissue engineering’, Biomaterials, 83, pp. 332–
346. doi: 10.1016/j.biomaterials.2016.01.020. 
Clav, A. et al. (2016) ‘Third-Generation Autologous Chondrocyte Implantation Versus 
Mosaicplasty for Knee Cartilage Injury: 2-Year Randomized Trial’, Journal of Orthopaedic 
Research, 34(4), pp. 658–665. doi: 10.1002/jor.23152. 
Clutterbuck, A. L. et al. (2011) ‘High throughput proteomic analysis of the secretome in an 




704–15. doi: 10.1016/j.jprot.2011.02.017. 
Da Conceicao Ribeiro, R. et al. (2019) ‘Reactive jet impingement bioprinting of high cell 
density gels for bone microtissue fabrication’, Biofabrication, 11(1). doi: 10.1088/1758-
5090/aaf625. 
Cova, M. and Toffanin, R. (2002) ‘MR microscopy of hyaline cartilage: Current status’, 
European Radiology, pp. 814–823. doi: 10.1007/s003300101128. 
Cozens, D. et al. (2018) ‘Development and optimization of a differentiated airway epithelial 
cell model of the bovine respiratory tract’, Scientific Reports, 8(1), p. 853. doi: 
10.1038/s41598-017-19079-y. 
Cross, M. et al. (2014) ‘The global burden of hip and knee osteoarthritis: estimates from the 
Global Burden of Disease 2010 study.’, Annals of the rheumatic diseases, 73(7), pp. 1323–30. 
doi: 10.1136/annrheumdis-2013-204763. 
Cui, X. et al. (2010) ‘Cell damage evaluation of thermal inkjet printed chinese hamster ovary 
cells’, Biotechnology and Bioengineering, 106(6), pp. 963–969. doi: 10.1002/bit.22762. 
Dahlin, R. L. et al. (2014) ‘TGF-β3-induced chondrogenesis in co-cultures of chondrocytes and 
mesenchymal stem cells on biodegradable scaffolds’, Biomaterials, 35(1), pp. 123–132. doi: 
10.1016/j.biomaterials.2013.09.086. 
Das, R. H. J. et al. (2008) ‘In vitro expansion affects the response of chondrocytes to 
mechanical stimulation’, Osteoarthritis and Cartilage. W.B. Saunders, 16(3), pp. 385–391. 
doi: 10.1016/J.JOCA.2007.07.014. 
Dehne, T. et al. (2010) ‘Gene expression profiling of primary human articular chondrocytes in 
high-density micromasses reveals patterns of recovery, maintenance, re- and 
dedifferentiation’, Gene, 462(1–2), pp. 8–17. doi: 10.1016/j.gene.2010.04.006. 
Derby, B. (2010) ‘Inkjet Printing of Functional and Structural Materials: Fluid Property 
Requirements, Feature Stability, and Resolution’, Annual Review of Materials Research, 
40(1), pp. 395–414. doi: 10.1146/annurev-matsci-070909-104502. 
Dexheimer, V., Frank, S. and Richter, W. (2012) ‘Proliferation as a requirement for in vitro 
chondrogenesis of human mesenchymal stem cells’, Stem Cells and Development, 21(12), pp. 




Diaz-Romero, J. et al. (2005) ‘Immunophenotypic analysis of human articular chondrocytes: 
Changes in surface markers associated with cell expansion in monolayer culture’, Journal of 
Cellular Physiology, 202(3), pp. 731–742. doi: 10.1002/jcp.20164. 
Dieppe, P. A. and Lohmander, L. S. (2005) ‘Pathogenesis and management of pain in 
osteoarthritis’, Lancet, 365(9463), pp. 965–973. doi: 10.1016/S0140-6736(05)71086-2. 
DiMasi, J. A., Grabowski, H. G. and Hansen, R. W. (2016) ‘Innovation in the pharmaceutical 
industry: New estimates of R&D costs’, Journal of Health Economics, 47, pp. 20–33. doi: 
10.1016/j.jhealeco.2016.01.012. 
Dimitri, N. (2011) ‘An assessment of R&D productivity in the pharmaceutical industry’, 
Trends in Pharmacological Sciences, 32(12), pp. 683–685. doi: 10.1016/j.tips.2011.09.005. 
Dobre, O. et al. (2018) ‘An immortalised mesenchymal stem cell line maintains mechano-
responsive behaviour and can be used as a reporter of substrate stiffness’, Scientific Reports. 
Nature Publishing Group, 8(1), p. 8981. doi: 10.1038/s41598-018-27346-9. 
Dominici, M. et al. (2006) ‘Minimal criteria for defining multipotent mesenchymal stromal 
cells. The International Society for Cellular Therapy position statement.’, Cytotherapy, 8(4), 
pp. 315–7. doi: 10.1080/14653240600855905. 
Edmondson, R. et al. (2014) ‘Three-dimensional cell culture systems and their applications in 
drug discovery and cell-based biosensors’, Assay and Drug Development Technologies. Mary 
Ann Liebert, Inc., 12(4), pp. 207–218. doi: 10.1089/adt.2014.573. 
Ehret, F., Vogler, S. and Kempermann, G. (2015) ‘A co-culture model of the hippocampal 
neurogenic niche reveals differential effects of astrocytes, endothelial cells and pericytes on 
proliferation and differentiation of adult murine precursor cells’, Stem Cell Research, 15(3), 
pp. 514–521. doi: 10.1016/j.scr.2015.09.010. 
Eidet, J. R. et al. (2014) ‘Objective assessment of changes in nuclear morphology and cell 
distribution following induction of apoptosis’, Diagnostic Pathology, 9(1). doi: 10.1186/1746-
1596-9-92. 
Elahi, K. C. et al. (2016) ‘Human mesenchymal stromal cells from different sources diverge in 
their expression of cell surface proteins and display distinct differentiation patterns’, Stem 




Elvidge, J., Bullement, A. and Hatswell, A. J. (2016) ‘Cost Effectiveness of Characterised 
Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK’, 
PharmacoEconomics. Springer International Publishing, 34(11), pp. 1145–1159. doi: 
10.1007/s40273-016-0423-y. 
Erggelet, C. and Vavken, P. (2016) ‘Microfracture for the treatment of cartilage defects in the 
knee joint – A golden standard?’, Journal of Clinical Orthopaedics and Trauma, 7(3), pp. 145–
152. doi: 10.1016/j.jcot.2016.06.015. 
Evans, C. H., Ghivizzani, S. C. and Robbins, P. D. (2013) ‘Arthritis gene therapy and its 
tortuous path into the clinic’, Translational Research, 161(4), pp. 205–216. doi: 
10.1016/j.trsl.2013.01.002. 
Faulkner-Jones, A. et al. (2013) ‘Development of a valve-based cell printer for the formation 
of human embryonic stem cell spheroid aggregates’, Biofabrication, 5(1). doi: 10.1088/1758-
5082/5/1/015013. 
Faulkner-Jones, A. et al. (2015) ‘Bioprinting of human pluripotent stem cells and their 
directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D’, 
Biofabrication. IOP Publishing, 7(4), p. 044102. doi: 10.1088/1758-5090/7/4/044102. 
Faulkner-Jones, A. (2015) Development of Multivalve - Based Bioprinting Technology. Heriot-
Watt University. 
Fennema, E. et al. (2013) ‘Spheroid culture as a tool for creating 3D complex tissues’, Trends 
in Biotechnology. Elsevier Ltd, 31(2), pp. 108–115. doi: 10.1016/j.tibtech.2012.12.003. 
Finger, F. et al. (2003) ‘Molecular Phenotyping of Human Chondrocyte Cell Lines T/C-28a2, 
T/C-28a4, and C-28/I2’, Arthritis and Rheumatism, 48(12), pp. 3395–3403. doi: 
10.1002/art.11341. 
Fitzgerald, J. B. et al. (2008) ‘Shear- and compression-induced chondrocyte transcription 
requires MAPK activation in cartilage explants.’, The Journal of biological chemistry. 
American Society for Biochemistry and Molecular Biology, 283(11), pp. 6735–43. doi: 
10.1074/jbc.M708670200. 
Foldager, C. B. et al. (2012) ‘Cell Seeding Densities in Autologous Chondrocyte Implantation 





Foty, R. (2011) ‘A Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids’, 
Journal of Visualized Experiments. MyJoVE Corporation, (51). doi: 10.3791/2720. 
Friedenstein, A. J., Chailakhjan, R. K. and Lalykin, K. S. (1970) ‘The development of fibroblast 
colonies in marrow and spleen cells’, Cell Tissue Kinet., 3, pp. 393–403. doi: 10.1111/j.1365-
2184.1970.tb00347.x. 
Friedenstein, A. J., Gorskaja, J. F. and Kulagina, N. N. (1976) ‘Fibroblast precursors in normal 
and irradiated mouse hematopoietic organs.’, Experimental Hematology, 4(5), pp. 267–74. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/976387. 
Frith, J. and Genever, P. (2008) ‘Transcriptional control of mesenchymal stem cell 
differentiation’, Transfusion Medicine and Hemotherapy. Karger Publishers, 35(3), pp. 216–
227. doi: 10.1159/000127448. 
Fromm, J. E. (1984) ‘Numerical Calculation of the Fluid Dynamics of Drop-on-Demand Jets’, 
IBM Journal of Research and Development, 28(3), pp. 322–333. doi: 10.1147/rd.283.0322. 
Futrega, K. et al. (2015) ‘The microwell-mesh: A novel device and protocol for the high 
throughput manufacturing of cartilage microtissues’, Biomaterials, 62, pp. 1–12. doi: 
10.1016/j.biomaterials.2015.05.013. 
Gaber, T. et al. (2012) ‘Osteoarthritis synovial fluid activates pro-inflammatory cytokines in 
primary human chondrocytes’, International Orthopaedics, 37(1), pp. 145–151. doi: 
10.1007/s00264-012-1724-1. 
Gabriel, N. et al. (2010) ‘Development of an in vitro model of feline cartilage degradation’, 
Journal of Feline Medicine and Surgery. SAGE PublicationsSage UK: London, England, 12(8), 
pp. 614–620. doi: 10.1016/j.jfms.2010.03.007. 
Ganesan, S. et al. (2019) ‘Inkjet printing of zinc oxide and P3HT:ICBA in ambient conditions 
for inverted bulk heterojunction solar cells’, Optical Materials. North-Holland, 94, pp. 430–
435. doi: 10.1016/J.OPTMAT.2019.05.031. 
Gebauer, M. et al. (2005) ‘Comparison of the chondrosarcoma cell line SW1353 with primary 
human adult articular chondrocytes with regard to their gene expression profile and 





Gendron, C. et al. (2007) ‘Proteolytic activities of human ADAMTS-5: comparative studies 
with ADAMTS-4.’, The Journal of biological chemistry. American Society for Biochemistry and 
Molecular Biology, 282(25), pp. 18294–306. doi: 10.1074/jbc.M701523200. 
Geurts, J. et al. (2018) ‘Novel ex vivo human osteochondral explant model of knee and spine 
osteoarthritis enables assessment of inflammatory and drug treatment responses’, 
International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute 
(MDPI), 19(5). doi: 10.3390/ijms19051314. 
Glasson, S. S. et al. (2005) ‘Deletion of active ADAMTS5 prevents cartilage degradation in a 
murine model of osteoarthritis’, Nature. Nature Publishing Group, 434(7033), pp. 644–648. 
doi: 10.1038/nature03369. 
Glyn-Jones, S. et al. (2015) ‘Osteoarthritis’, The Lancet. Elsevier, 386(9991), pp. 376–387. doi: 
10.1016/S0140-6736(14)60802-3. 
Goldring, M. B. et al. (1994) ‘Interleukin-1 beta-modulated gene expression in immortalized 
human chondrocytes.’, The Journal of Clinical investigation, 94(6), pp. 2307–16. doi: 
10.1172/JCI117595. 
Graceffa, V. et al. (2019) ‘Chasing Chimeras – The elusive stable chondrogenic phenotype’, 
Biomaterials. Elsevier, 192, pp. 199–225. doi: 10.1016/j.biomaterials.2018.11.014. 
Greenberg, D. D. et al. (2006) ‘Biochemical effects of two different hyaluronic acid products 
in a co-culture model of osteoarthritis’, Osteoarthritis and Cartilage, 14(8), pp. 814–822. doi: 
10.1016/j.joca.2006.02.006. 
van Griensven, M. et al. (2019) ‘Mesenchymal Stem Cell Therapy for Osteoarthritis: The 
Critical Role of the Cell Secretome’, Front. Bioeng. Biotechnol, 7(9), p. 9. doi: 
10.3389/fbioe.2019.00009. 
Groll, J. et al. (2016) ‘Biofabrication: reappraising the definition of an evolving field.’, 
Biofabrication, 8(1), p. 013001. doi: 10.1088/1758-5090/8/1/013001. 
Gudapati, H., Dey, M. and Ozbolat, I. (2016) ‘A comprehensive review on droplet-based 





Guillemot, F. et al. (2010) ‘High-throughput laser printing of cells and biomaterials for tissue 
engineering’, in Acta Biomaterialia. Elsevier BV, pp. 2494–2500. doi: 
10.1016/j.actbio.2009.09.029. 
Guillotin, B. et al. (2010) ‘Laser assisted bioprinting of engineered tissue with high cell 
density and microscale organization’, Biomaterials, 31(28), pp. 7250–7256. doi: 
10.1016/j.biomaterials.2010.05.055. 
Guillotin, B. and Guillemot, F. (2011) ‘Cell patterning technologies for organotypic tissue 
fabrication’, Trends in Biotechnology, pp. 183–190. doi: 10.1016/j.tibtech.2010.12.008. 
Gutbier, S. et al. (2018) ‘Major changes of cell function and toxicant sensitivity in cultured 
cells undergoing mild, quasi-natural genetic drift’, Archives of Toxicology. Springer Berlin 
Heidelberg, 92(12), pp. 3487–3503. doi: 10.1007/s00204-018-2326-5. 
Hadimioglu, B., Stearns, R. and Ellson, R. (2016) ‘Moving Liquids with Sound: The Physics of 
Acoustic Droplet Ejection for Robust Laboratory Automation in Life Sciences’, Journal of 
Laboratory Automation. SAGE Publications Inc., 21(1), pp. 4–18. doi: 
10.1177/2211068215615096. 
Hass, R. et al. (2011) ‘Different populations and sources of human mesenchymal stem cells 
(MSC): A comparison of adult and neonatal tissue-derived MSC.’, Cell communication and 
signaling : CCS. BioMed Central, 9, p. 12. doi: 10.1186/1478-811X-9-12. 
Hassell, B. A. et al. (2017) ‘Human Organ Chip Models Recapitulate Orthotopic Lung Cancer 
Growth, Therapeutic Responses, and Tumor Dormancy In Vitro’, Cell Reports, 21(2), pp. 508–
516. doi: 10.1016/j.celrep.2017.09.043. 
Hendriks, J., Riesle, J. and van Blitterswijk, C. A. (2007) ‘Co-culture in cartilage tissue 
engineering’, Journal of Tissue Engineering and Regenerative Medicine, 1(3), pp. 170–178. 
doi: 10.1002/term.19. 
Heo, J. S. et al. (2016) ‘Comparison of molecular profiles of human mesenchymal stem cells 
derived from bone marrow, umbilical cord blood, placenta and adipose tissue’, International 
Journal of Molecular Medicine. Spandidos Publications, 37(1), pp. 115–125. doi: 
10.3892/ijmm.2015.2413. 




of human bone marrow stromal cells using various conversion protocols’, Journal of 
Neuroscience Research. John Wiley & Sons, Ltd, 83(8), pp. 1502–1514. doi: 
10.1002/jnr.20840. 
Hino, K. et al. (2014) ‘Master regulator for chondrogenesis, Sox9, regulates transcriptional 
activation of the endoplasmic reticulum stress transducer BBF2H7/CREB3L2 in 
chondrocytes’, Journal of Biological Chemistry, 289(20), pp. 13810–13820. doi: 
10.1074/jbc.M113.543322. 
Hopp, B. et al. (2005) ‘Survival and proliferative ability of various living cell types after laser-
induced forward transfer’, Tissue Engineering, 11(11–12), pp. 1817–1823. doi: 
10.1089/ten.2005.11.1817. 
Horvath, L. et al. (2015) ‘Engineering an in vitro air-blood barrier by 3D bioprinting’, Scientific 
Reports, 5. doi: 10.1038/srep07974. 
Hu, K. et al. (2006) ‘Pathogenesis of osteoarthritis-like changes in the joints of mice deficient 
in type IX collagen’, Arthritis & Rheumatism. Wiley Subscription Services, Inc., A Wiley 
Company, 54(9), pp. 2891–2900. doi: 10.1002/art.22040. 
Huang, S. Bin et al. (2015) ‘Development of a pneumatically driven active cover lid for multi-
well microplates for use in perfusion three-dimensional cell culture’, Scientific Reports, 5. 
doi: 10.1038/srep18352. 
Huang, Y. et al. (2017) ‘Optical coherence tomography detects necrotic regions and 
volumetrically quantifies multicellular tumor spheroids’, Cancer Research, 77(21), pp. 6011–
6020. doi: 10.1158/0008-5472.CAN-17-0821. 
Hurley, E. T. et al. (2018) ‘Limited evidence for adipose-derived stem cell therapy on the 
treatment of osteoarthritis’, Sports Traumatology, Arthroscopy, 26, pp. 3499–3507. doi: 
10.1007/s00167-018-4955-x. 
Hutchinson, G. H. (1978) ‘Progress in water based printing inks’, Pigment & Resin 
Technology, 7(11), pp. 4–13. doi: 10.1108/eb041437. 
Hwang, N. S. et al. (2011) ‘Chondrogenic priming adipose-mesenchymal stem cells for 





Ikenoue, T. et al. (2003) ‘Mechanoregulation of human articular chondrocyte aggrecan and 
type II collagen expression by intermittent hydrostatic pressure in vitro’, Journal of 
Orthopaedic Research. Wiley Subscription Services, Inc., A Wiley Company, 21(1), pp. 110–
116. doi: 10.1016/S0736-0266(02)00091-8. 
Imaduwage, K. P. et al. (2017) ‘Rapid LC-MS Based High-Throughput Screening Method, 
Affording No False Positives or False Negatives, Identifies a New Inhibitor for Carbonic 
Anhydrase’, Scientific Reports, 7(1). doi: 10.1038/s41598-017-08602-w. 
James, S. et al. (2015) ‘Multiparameter Analysis of Human Bone Marrow Stromal Cells 
Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes’, Stem Cell 
Reports. The Authors, 4(6), pp. 1004–1015. doi: 10.1016/j.stemcr.2015.05.005. 
Jang, D., Kim, D. and Moon, J. (2009) ‘Influence of fluid physical properties on ink-jet 
printability’, Langmuir, 25(5), pp. 2629–2635. doi: 10.1021/la900059m. 
Jean-Philippe, C. et al. (2012) ‘A novel specific edge effect correction method for RNA 
interference screenings’, Bioinformatics, 28(2), pp. 261–268. doi: 
10.1093/bioinformatics/btr648. 
Jeon, S.-J. et al. (2007) ‘Bone marrow mesenchymal stem cells are progenitors in vitro for 
inner ear hair cells’, Molecular and Cellular Neuroscience, 34(1), pp. 59–68. doi: 
10.1016/j.mcn.2006.10.003. 
Joh, D. Y. et al. (2017) ‘Inkjet-printed point-of-care immunoassay on a nanoscale polymer 
brush enables subpicomolar detection of analytes in blood’, Proceedings of the National 
Academy of Sciences of the United States of America, 114(34), pp. E7054–E7062. doi: 
10.1073/pnas.1703200114. 
Johnson, C. I., Argyle, D. J. and Clements, D. N. (2016) ‘In vitro models for the study of 
osteoarthritis’, The Veterinary Journal, 209, pp. 40–49. doi: 10.1016/j.tvjl.2015.07.011. 
Joshi, P. and Lee, M.-Y. (2015) ‘High Content Imaging (HCI) on Miniaturized Three-
Dimensional (3D) Cell Cultures’, Biosensors, 5, pp. 768–790. doi: 10.3390/bios5040768. 
Jotanovic, Z. et al. (2012) ‘Role of Interleukin-1 Inhibitors in Osteoarthritis’, Drugs & Aging. 





Jung, S. (2011) Fluid characterisation and drop impact in inkjet printing for organic 
semiconductor devices. University of Cambridge. Available at: 
https://core.ac.uk/download/pdf/1336887.pdf. 
Junker, S. et al. (2016) ‘Expression of adipokines in osteoarthritis osteophytes and their 
effect on osteoblasts’, Matrix Biology, 62, pp. 75–91. doi: 10.1016/j.matbio.2016.11.005. 
Kaartinen, L. et al. (1993) ‘Rat Tracheal Epithelial Cell Diffeentiation In Vitro’, In Vitro Cell 
Development Biology, (29A), pp. 481–492. 
Kačarević, Ž. P. et al. (2018) ‘An introduction to 3D bioprinting: Possibilities, challenges and 
future aspects’, Materials. MDPI AG. doi: 10.3390/ma11112199. 
Kahl, M. et al. (2019) ‘Ultra-low-cost 3D bioprinting: Modification and application of an off-
the-shelf desktop 3D-printer for biofabrication’, Frontiers in Bioengineering and 
Biotechnology, 7(JUL), pp. 1–12. doi: 10.3389/fbioe.2019.00184. 
Kämpfer, A. A. M. et al. (2017) ‘Development of an in vitro co-culture model to mimic the 
human intestine in healthy and diseased state’, Toxicology in Vitro. Pergamon, 45, pp. 31–
43. doi: 10.1016/j.tiv.2017.08.011. 
Kang, Y. B. et al. (2013) ‘Layered long-term co-culture of hepatocytes and endothelial cells 
on a transwell membrane: Toward engineering the liver sinusoid’, Biofabrication, 5(4), pp. 
45008–45020. doi: 10.1088/1758-5082/5/4/045008. 
Karlsen, T. A., Shahdadfar, A. and Brinchmann, J. E. (2011) ‘Human primary articular 
chondrocytes, chondroblasts-like cells, and dedifferentiated chondrocytes: Differences in 
gene, MicroRNA, and protein expression and phenotype’, Tissue Engineering - Part C: 
Methods, 17(2), pp. 219–227. doi: 10.1089/ten.tec.2010.0200. 
Karnieli, O. et al. (2007) ‘Generation of Insulin-Producing Cells from Human Bone Marrow 
Mesenchymal Stem Cells by Genetic Manipulation’, Stem Cells. John Wiley & Sons, Ltd, 
25(11), pp. 2837–2844. doi: 10.1634/stemcells.2007-0164. 
Kartmann, S. et al. (2015) ‘A disposable dispensing valve for non-contact microliter 
applications in a 96-well plate format’, Micromachines, 6(4), pp. 423–436. doi: 
10.3390/mi6040423. 




Chip, pp. 34–57. doi: 10.1039/b711887b. 
Kellgren, J. H. and Lawrence, J. S. (1957) ‘Radiological Assessment of Osteo-Arthrosis’, Annals 
of the Rheumatic Diseases, 16(4), pp. 494–502. doi: 10.1136/ard.16.4.494. 
Ketterl, N. et al. (2015) ‘A robust potency assay highlights significant donor variation of 
human mesenchymal stem/progenitor cell immune modulatory capacity and extended 
radio-resistance’, Stem Cell Research & Therapy. BioMed Central, 6(1), p. 236. doi: 
10.1186/s13287-015-0233-8. 
Kevorkian, L. et al. (2004) ‘Expression profiling of metalloproteinases and their inhibitors in 
cartilage’, Arthritis & Rheumatism. Wiley Subscription Services, Inc., A Wiley Company, 50(1), 
pp. 131–141. doi: 10.1002/art.11433. 
Khalate, A. A. et al. (2012) ‘A waveform design method for a piezo inkjet printhead based on 
robust feedforward control’, Journal of Microelectromechanical Systems, 21(6), pp. 1365–
1374. doi: 10.1109/JMEMS.2012.2205899. 
Khan, A. et al. (2012) ‘Direct printing of copper conductive micro-tracks by multi-nozzle 
electrohydrodynamic inkjet printing process’, Journal of Materials Processing Technology. 
Elsevier, 212(3), pp. 700–706. doi: 10.1016/J.JMATPROTEC.2011.10.024. 
Kim, H. A. and Cheon, E. J. (2012) ‘Animal Model of Osteoarthritis’, Journal of Rheumatic 
Diseases, 19(5), p. 239. doi: 10.4078/jrd.2012.19.5.239. 
Kim, J. D. et al. (2010) ‘Piezoelectric inkjet printing of polymers: Stem cell patterning on 
polymer substrates’, Polymer. Elsevier Ltd, 51(10), pp. 2147–2154. doi: 
10.1016/j.polymer.2010.03.038. 
Kim, M. et al. (2019) ‘Extracellular vesicles mediate improved functional outcomes in 
engineered cartilage produced from MSC/chondrocyte cocultures’, Proceedings of the 
National Academy of Sciences of the United States of America, 116(5), pp. 1569–1578. doi: 
10.1073/pnas.1815447116. 
Kim, Y.-M. et al. (2008) ‘Design and Fabrication of Electrostatic Inkjet Head using Silicon 
Micromachining Technology’, JSTS:Journal of Semiconductor Technology and Science, 8(2), 
pp. 121–127. doi: 10.5573/jsts.2008.8.2.121. 




physiology to enable nephrotoxicity testing’, Frontiers in Physiology, 8(MAR), p. 123. doi: 
10.3389/fphys.2017.00123. 
Knight, E. (2013) Influence of the micro-environment on the maintenance and differentiation 
of pluripotent stem cells. University of Durham. Available at: http://etheses.dur.ac.uk. 
Koch, L. et al. (2010) ‘Laser printing of skin cells and human stem cells’, Tissue Engineering - 
Part C: Methods. Mary Ann Liebert Inc., 16(5), pp. 847–854. doi: 10.1089/ten.tec.2009.0397. 
Koch, L. et al. (2018) ‘Laser bioprinting of human induced pluripotent stem cells - The effect 
of printing and biomaterials on cell survival, pluripotency, and differentiation’, 
Biofabrication. Institute of Physics Publishing, 10(3). doi: 10.1088/1758-5090/aab981. 
Kojima, N., Takeuchi, S. and Sakai, Y. (2012) ‘Rapid aggregation of heterogeneous cells and 
multiple-sized microspheres in methylcellulose medium’, Biomaterials. Elsevier, 33(18), pp. 
4508–4514. doi: 10.1016/J.BIOMATERIALS.2012.02.065. 
Kubosch, E. J. et al. (2016) ‘The trans-well coculture of human synovial mesenchymal stem 
cells with chondrocytes leads to self-organization, chondrogenic differentiation, and 
secretion of TGFβ’, Stem Cell Research and Therapy. BioMed Central, 7(1), p. 64. doi: 
10.1186/s13287-016-0322-3. 
Kuyinu, E. L. et al. (2016) ‘Animal models of osteoarthritis: classification, update, and 
measurement of outcomes.’, Journal of orthopaedic surgery and research. BioMed Central, 
11, p. 19. doi: 10.1186/s13018-016-0346-5. 
Kwon, K.-S. (2010) ‘Experimental analysis of waveform effects on satellite and ligament 
behavior via in situ measurement of the drop-on-demand drop formation curve and the 
instantaneous jetting speed curve’, Journal of Micromechanics and Microengineering, 
20(11), p. 115005. doi: 10.1088/0960-1317/20/11/115005. 
Kwon, K. S. (2009) ‘Waveform design methods for piezo inkjet dispensers based on 
measured meniscus motion’, Journal of Microelectromechanical Systems, 18(5), pp. 1118–
1125. doi: 10.1109/JMEMS.2009.2026465. 
Kyostio-Moore, S. et al. (2011) ‘STR/ort mice, a model for spontaneous osteoarthritis, exhibit 
elevated levels of both local and systemic inflammatory markers’, Comparative Medicine, 




Larson, B. et al. (2012) ‘Automation of cell-based drug absorption assays in 96-well format 
using permeable support systems’, Journal of Laboratory Automation, 17(3), pp. 222–232. 
doi: 10.1177/2211068211428190. 
Lazzari, G. et al. (2019) ‘Light sheet fluorescence microscopy versus confocal microscopy: in 
quest of a suitable tool to assess drug and nanomedicine penetration into multicellular 
tumor spheroids’, European Journal of Pharmaceutics and Biopharmaceutics. Elsevier, 142, 
pp. 195–203. doi: 10.1016/J.EJPB.2019.06.019. 
Lee, Geon Hui et al. (2018) ‘Networked concave microwell arrays for constructing 3D cell 
spheroids’, Biofabrication. IOP Publishing, 10(1), p. 015001. doi: 10.1088/1758-5090/aa9876. 
Lee, V. et al. (2014) ‘Design and fabrication of human skin by three-dimensional bioprinting.’, 
Tissue engineering. Part C, Methods, 20(6), pp. 473–84. doi: 10.1089/ten.TEC.2013.0335. 
Lemmo, A. V, Rose, D. J. and Tisone, T. C. (1998) ‘Inkjet dispensing technology: Applications 
in drug discovery’, Current Opinion in Biotechnology, 9(6), pp. 615–617. doi: 10.1016/S0958-
1669(98)80139-0. 
Van Lent, P. L. E. M. et al. (2012) ‘Active involvement of alarmins S100A8 and S100A9 in the 
regulation of synovial activation and joint destruction during mouse and human 
osteoarthritis’, Arthritis and Rheumatism. Wiley Subscription Services, Inc., A Wiley 
Company, 64(5), pp. 1466–1476. doi: 10.1002/art.34315. 
Leung, B. M. et al. (2015) ‘Media additives to promote spheroid circularity and compactness 
in hanging drop platform’, Biomaterials Science, 3(2), pp. 336–344. doi: 
10.1039/c4bm00319e. 
Li, C. et al. (2015) ‘Comparative analysis of human mesenchymal stem cells from bone 
marrow and adipose tissue under xeno-free conditions for cell therapy’, Stem Cell Research 
& Therapy. BioMed Central, 6(1), p. 55. doi: 10.1186/s13287-015-0066-5. 
Li, G. et al. (2013) ‘Subchondral bone in osteoarthritis: insight into risk factors and 
microstructural changes’, Arthritis Research & Therapy. BioMed Central, 15(6), p. 223. doi: 
10.1186/ar4405. 
Li, S. et al. (2015) ‘Chondrogenic potential of human articular chondrocytes and skeletal 





Li, X. et al. (2016) ‘Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Contribute 
to Chondrogenesis in Coculture with Chondrocytes’, BioMed Research International, 2016. 
doi: 10.1155/2016/3827057. 
Liberio, M. S. et al. (2014) ‘Differential effects of tissue culture coating substrates on 
prostate cancer cell adherence, morphology and behavior’, PLoS ONE. Edited by L. R. 
Languino. Public Library of Science, 9(11), p. e112122. doi: 10.1371/journal.pone.0112122. 
Liberski, A. R., Delaney, J. T. and Schubert, U. S. (2011) ‘“One cell-one well”: A new approach 
to inkjet printing single cell microarrays’, ACS Combinatorial Science. American Chemical 
Society, 13(2), pp. 190–195. doi: 10.1021/co100061c. 
Lin, C.-C. et al. (2009) ‘IL-1β promotes A549 cell migration via MAPKs/AP-1- and NF-κB-
dependent matrix metalloproteinase-9 expression’, Cellular Signalling, 21(11), pp. 1652–
1662. doi: 10.1016/j.cellsig.2009.07.002. 
Ling, K. et al. (2015) ‘Bioprinting-Based High-Throughput Fabrication of Three-Dimensional 
MCF-7 Human Breast Cancer Cellular Spheroids’, Engineering. Elsevier, 1(2), pp. 269–274. 
doi: 10.15302/J-ENG-2015062. 
Liu, Y. and Derby, B. (2019) ‘Experimental study of the parameters for stable drop-on-
demand inkjet performance’, Physics of Fluids, 31(3), p. 32004. doi: 10.1063/1.5085868. 
Loeser, R. F., Collins, J. A. and Diekman, B. O. (2016) ‘Ageing and the pathogenesis of 
osteoarthritis’, Nature Reviews Rheumatology, pp. 412–420. doi: 10.1038/nrrheum.2016.65. 
Löffek, S., Schilling, O. and Franzke, C.-W. (2011) ‘Biological role of matrix 
metalloproteinases: a critical balance’, European Respiratory Journal, 38(1). 
Lorber, B. et al. (2014) ‘Adult rat retinal ganglion cells and glia can be printed by piezoelectric 
inkjet printing.’, Biofabrication, 6(1), p. 015001. doi: 10.1088/1758-5082/6/1/015001. 
Lu, T. J. et al. (2017) ‘Chondrogenic differentiation of mesenchymal stem cells in three-
dimensional chitosan film culture’, Cell Transplantation, 26(3), pp. 417–427. doi: 
10.3727/096368916X693464. 
Lund, M. D. and Ward, J. P. (1998) ‘On-page inkjet printhead spitting system system’. 




Lundholt, B. K., Scudder, K. M. and Pagliaro, L. (2003) ‘A simple technique for reducing edge 
effect in cell-based assays’, Journal of Biomolecular Screening, 8(5), pp. 566–570. doi: 
10.1177/1087057103256465. 
Luukkainen, A. et al. (2018) ‘A Co-culture Model of PBMC and Stem Cell Derived Human 
Nasal Epithelium Reveals Rapid Activation of NK and Innate T Cells Upon Influenza A Virus 
Infection of the Nasal Epithelium’, Frontiers in Immunology. Frontiers, 9, p. 2514. doi: 
10.3389/fimmu.2018.02514. 
Ma, B. et al. (2013) ‘Gene expression profiling of dedifferentiated human articular 
chondrocytes in monolayer culture’, Osteoarthritis and Cartilage, 21(4), pp. 599–603. doi: 
10.1016/j.joca.2013.01.014. 
Ma, L. D. et al. (2018) ‘Design and fabrication of a liver-on-a-chip platform for convenient, 
highly efficient, and safe: In situ perfusion culture of 3D hepatic spheroids’, Lab on a Chip. 
The Royal Society of Chemistry, 18(17), pp. 2547–2562. doi: 10.1039/c8lc00333e. 
Macrory, L. et al. (2009) ‘An exploration of the ability of tepoxalin to ameliorate the 
degradation of articular cartilage in a canine in vitro model’, BMC Veterinary Research. 
BioMed Central, 5(1), p. 25. doi: 10.1186/1746-6148-5-25. 
Madden, J. C. et al. (2012) ‘Strategies for the optimisation of in vivo experiments in 
accordance with the 3Rs philosophy’, Regulatory Toxicology and Pharmacology, 63(1), pp. 
140–154. doi: 10.1016/j.yrtph.2012.03.010. 
Madry, H. and Cucchiarini, M. (2016) ‘Expert Opinion on Biological Therapy Gene therapy for 
human osteoarthritis: principles and clinical translation Gene therapy for human 
osteoarthritis: principles and clinical translation’, Expert Opinion on Biological Therapy, 
16(3), pp. 331–346. doi: 10.1517/14712598.2016.1124084. 
Mahay, D., Terenghi, G. and Shawcross, S. G. (2008) ‘Schwann cell mediated trophic effects 
by differentiated mesenchymal stem cells’, Experimental Cell Research. Academic Press, 
314(14), pp. 2692–2701. doi: 10.1016/J.YEXCR.2008.05.013. 
Maksymowych, W. P. et al. (2012) ‘Targeting tumour necrosis factor alleviates signs and 
symptoms of inflammatory osteoarthritis of the knee’, Arthritis Research and Therapy. 




Malda, J. et al. (2004) ‘Oxygen Gradients in Tissue-Engineered PEGT/PBT Cartilaginous 
Constructs: Measurement and Modeling’, Biotechnology and Bioengineering, 86(1), pp. 9–
18. doi: 10.1002/bit.20038. 
Malfait, A. M., Little, C. B. and McDougall, J. J. (2013) ‘A commentary on modelling 
osteoarthritis pain in small animals’, Osteoarthritis and Cartilage. NIH Public Access, 21(9), 
pp. 1316–1326. doi: 10.1016/j.joca.2013.06.003. 
Marga, F. et al. (2012) ‘Toward engineering functional organ modules by additive 
manufacturing’, Biofabrication. doi: 10.1088/1758-5082/4/2/022001. 
Marshall, J., Barnes, A. and Genever, P. (2018) ‘Analysis of the Intrinsic Self-Organising 
Properties of Mesenchymal Stromal Cells in Three-Dimensional Co-Culture Models with 
Endothelial Cells’, Bioengineering, 5(4), p. 92. doi: 10.3390/bioengineering5040092. 
Martel-Pelletier, J., Welsch, D. J. and Pelletier, J.-P. (2001) ‘Metalloproteases and inhibitors 
in arthritic diseases’, Best Practice & Research Clinical Rheumatology, 15(5), pp. 805–829. 
doi: 10.1053/berh.2001.0195. 
Marx, U. et al. (2018) ‘Bioengineering of a Full-Thickness Skin Equivalent in a 96-Well Insert 
Format for Substance Permeation Studies and Organ-On-A-Chip Applications’, 
Bioengineering. Multidisciplinary Digital Publishing Institute (MDPI), 5(2), p. 43. doi: 
10.3390/bioengineering5020043. 
McCoy, A. M. (2015) ‘Animal Models of Osteoarthritis: Comparisons and Key Considerations’, 
Veterinary Pathology, 52(5), pp. 803–818. doi: 10.1177/0300985815588611. 
McIlroy, C., Harlen, O. G. G. and Morrison, N. F. F. (2013) ‘Modelling the jetting of dilute 
polymer solutions in drop-on-demand inkjet printing’, Journal of Non-Newtonian Fluid 
Mechanics. Elsevier B.V., 201, pp. 17–28. doi: 10.1016/j.jnnfm.2013.05.007. 
McKee, C. and Chaudhry, G. R. (2017) ‘Advances and challenges in stem cell culture’, Colloids 
and Surfaces B: Biointerfaces. Elsevier, 159, pp. 62–77. doi: 
10.1016/J.COLSURFB.2017.07.051. 
McKinley, G. H. and Renardy, M. (2011) ‘Wolfgang von Ohnesorge’, Physics of Fluids, 23(12). 
doi: 10.1063/1.3663616. 




dynamics, and architecture optimization in three-dimensional tissue constructs with 
applications and insights in cerebral organoids’, Tissue Engineering - Part C: Methods, 22(3), 
pp. 221–249. doi: 10.1089/ten.tec.2015.0375. 
Melissaridou, S. et al. (2019) ‘The effect of 2D and 3D cell cultures on treatment response, 
EMT profile and stem cell features in head and neck cancer 11 Medical and Health Sciences 
1112 Oncology and Carcinogenesis’, Cancer Cell International. BioMed Central, 19(1), p. 16. 
doi: 10.1186/s12935-019-0733-1. 
Mennan, C. et al. (2018) ‘Human Articular Chondrocytes Retain Their Phenotype in Sustained 
Hypoxia While Normoxia Promotes Their Immunomodulatory Potential’, Cartilage. SAGE 
Publications Inc. doi: 10.1177/1947603518769714. 
Meretoja, V. V et al. (2012) ‘Enhanced chondrogenesis in co-cultures with articular 
chondrocytes and mesenchymal stem cells’, Biomaterials. NIH Public Access, 33(27), pp. 
6362–6369. doi: 10.1016/j.biomaterials.2012.05.042. 
Meretoja, V. V et al. (2014) ‘Articular chondrocyte redifferentiation in 3D co-cultures with 
mesenchymal stem cells’, Tissue Engineering - Part C: Methods, 20(6), pp. 514–523. doi: 
10.1089/ten.tec.2013.0532. 
Michael, S. et al. (2008) ‘A robotic platform for quantitative high-throughput screening’, 
Assay and Drug Development Technologies, 6(5), pp. 637–657. doi: 10.1089/adt.2008.150. 
Michael, S. et al. (2013) ‘Tissue Engineered Skin Substitutes Created by Laser-Assisted 
Bioprinting Form Skin-Like Structures in the Dorsal Skin Fold Chamber in Mice’, PLoS ONE, 
8(3). doi: 10.1371/journal.pone.0057741. 
Miers, J. C. and Zhou, W. (2017) ‘Droplet formation at megahertz frequency’, AIChE Journal, 
63(6), pp. 2367–2377. doi: 10.1002/aic.15578. 
Mikhailova, A. et al. (2014) ‘Small-molecule induction promotes corneal epithelial cell 
differentiation from human induced pluripotent stem cells’, Stem Cell Reports, 2(2), pp. 219–
231. doi: 10.1016/j.stemcr.2013.12.014. 
Miki, Y. et al. (2012) ‘The advantages of co-culture over mono cell culture in simulating in 
vivo environment’, The Journal of Steroid Biochemistry and Molecular Biology, 131(3), pp. 




Min, D. et al. (2018) ‘Bioprinting of biomimetic skin containing melanocytes’, Experimental 
Dermatology, p. 27. doi: 10.1111/exd.13376. 
Minegishi, Y., Hosokawa, K. and Tsumaki, N. (2013) ‘Time-lapse observation of the 
dedifferentiation process in mouse chondrocytes using chondrocyte-specific reporters’, 
Osteoarthritis and Cartilage, 21(12), pp. 1968–1975. doi: 10.1016/j.joca.2013.09.004. 
Mironov, V., Kasyanov, V. and Markwald, R. R. (2011) ‘Organ printing: From bioprinter to 
organ biofabrication line’, Current Opinion in Biotechnology, pp. 667–673. doi: 
10.1016/j.copbio.2011.02.006. 
Mistry, H. et al. (2015) Autologous chondrocyte implantation in the knee, Health Technology 
Assessment. doi: 10.1002/14651858.cd003323.pub3. 
Mobasheri, A. and Batt, M. (2016) ‘An update on the pathophysiology of osteoarthritis’, 
Annals of Physical and Rehabilitation Medicine. Elsevier Masson, 59(5–6), pp. 333–339. doi: 
10.1016/j.rehab.2016.07.004. 
Mohanraj, B. et al. (2014) ‘A high-throughput model of post-traumatic osteoarthritis using 
engineered cartilage tissue analogs’, Osteoarthritis and Cartilage. NIH Public Access, 22(9), 
pp. 1282–1290. doi: 10.1016/j.joca.2014.06.032. 
Moon, S. et al. (2011) ‘Drop-on-demand single cell isolation and total RNA analysis’, PLoS 
ONE, 6(3). doi: 10.1371/journal.pone.0017455. 
Mosaad, E. et al. (2018) ‘Using high throughput microtissue culture to study the difference in 
prostate cancer cell behavior and drug response in 2D and 3D co-cultures’, BMC Cancer. 
BioMed Central, 18(1), p. 592. doi: 10.1186/s12885-018-4473-8. 
Moseler, O. and Straky, H. (2000) ‘Fault Detection of a Solenoid Valve for Hydraulic Systems 
in Vehicles’, IFAC Proceedings Volumes, 33(11), pp. 119–124. doi: 10.1016/s1474-
6670(17)37347-0. 
Moskowitz, R. W. et al. (1973) ‘Experimentally Induced Degenerative Joint Lesions Following 
Partial Meniscectomy in the Rabbit’, Arthritis & Rheumatism. John Wiley & Sons, Inc., 16(3), 
pp. 397–405. doi: 10.1002/art.1780160317. 
Mosmann, T. (1983) ‘Rapid colorimetric assay for cellular growth and survival: Application to 




pp. 55–63. doi: 10.1016/0022-1759(83)90303-4. 
Mountain, D. J. H. et al. (2007) ‘Interleukin-1β increases expression and activity of matrix 
metalloproteinase-2 in cardiac microvascular endothelial cells: Role of PKCα/β1 and MAPKs’, 
American Journal of Physiology - Cell Physiology, 292(2), pp. C867-75. doi: 
10.1152/ajpcell.00161.2006. 
Murab, S. et al. (2013) ‘Matrix-embedded cytokines to simulate osteoarthritis-like cartilage 
microenvironments.’, Tissue engineering. Part A. Mary Ann Liebert, Inc., 19(15–16), pp. 
1733–53. doi: 10.1089/ten.TEA.2012.0385. 
Murphy, K. C. et al. (2016) ‘Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype 
Through α 2 β 1 Signaling’, STEM CELLS Translational Medicine. Wiley-Blackwell, 5(9), pp. 
1229–1237. doi: 10.5966/sctm.2015-0412. 
Murphy, S. V., Skardal, A. and Atala, A. (2013) ‘Evaluation of hydrogels for bio-printing 
applications’, Journal of Biomedical Materials Research - Part A, 101 A(1), pp. 272–284. doi: 
10.1002/jbm.a.34326. 
Murphy, S. V and Atala, A. (2014) ‘3D bioprinting of tissues and organs.’, Nature 
Biotechnology. Nature Publishing Group, 32(8), pp. 773–785. doi: 10.1038/nbt.2958. 
Mwale, F. et al. (2006) ‘Limitations of Using Aggrecan and Type X Collagen as Markers of 
Chondrogenesis in Mesenchymal Stem Cell Differentiation’, Journal of Orthopaedic Research, 
pp. 1791–1798. doi: 10.1002/jor. 
Nath, S. and Devi, G. R. (2016) ‘Three-dimensional culture systems in cancer research: Focus 
on tumor spheroid model’, Pharmacology & Therapeutics. Pergamon, 163, pp. 94–108. doi: 
10.1016/J.PHARMTHERA.2016.03.013. 
National Institute for Health and Care Excellence (2005) The use of autologous chondrocyte 
implantation for the treatment of cartilage defects in the knee joints - Technical appraisal 
guidance TA89. Available at: https://www.nice.org.uk/guidance/ta89. 
National Institute for Health and Care Excellence (2014) Osteoarthritis: care and 
management - Clinical guideline CG177. doi: nice.org.uk/guidance/cg177. 
National Institute for Health and Care Excellence (2017) Autologous chondrocyte 




appraisal guidance TA477. Available at: 
https://www.nice.org.uk/guidance/ta477/resources/autologous-chondrocyte-implantation-
for-treating-symptomatic-articular-cartilage-defects-of-the-knee-pdf-82604971061701. 
National Institute for Health and Care Excellence (2018) Autologous chondrocyte 
implantation using chondrosphere for treating symptomatic articular cartilage defects of the 
knee - Technical appraisal guidance TA508. Available at: www.nice.org.uk/guidance/ta508. 
Niemeyer, P. et al. (2016) ‘Autologous chondrocyte implantation (ACI) for cartilage defects 
of the knee: A guideline by the working group “Clinical Tissue Regeneration” of the German 
Society of Orthopaedics and Trauma (DGOU)’, Knee, 23(3), pp. 426–435. doi: 
10.1016/j.knee.2016.02.001. 
Niles, W. D. and Coassin, P. J. (2005) ‘Piezo- and Solenoid Valve-Based Liquid Dispensing for 
Miniaturized Assays’, Assay and Drug Development Technologies, 3(2), pp. 189–202. doi: 
10.1089/adt.2005.3.189. 
Ong, C. S. et al. (2018) ‘In vivo therapeutic applications of cell spheroids’, Biotechnology 
Advances. Elsevier, 36(2), pp. 494–505. doi: 10.1016/J.BIOTECHADV.2018.02.003. 
Osterman, C. et al. (2015) ‘Platelet-Rich Plasma Increases Anti-inflammatory Markers in a 
Human Coculture Model for Osteoarthritis.’, The American Journal of Sports Medicine, 43(6), 
pp. 1474–84. doi: 10.1177/0363546515570463. 
Pampaloni, F., Ansari, N. and Stelzer, E. H. K. (2013) ‘High-resolution deep imaging of live 
cellular spheroids with light-sheet-based fluorescence microscopy’, Cell and Tissue Research, 
pp. 161–177. doi: 10.1007/s00441-013-1589-7. 
Park, D. (2013) ‘Method and Apparatus for Purging and Supplying Ink to an Inkjet Printing 
Apparatus’. United States of America: United States Patent and Trademark Office. 
Park, J. et al. (2017) ‘Hypergravity-induced multicellular spheroid generation with different 
morphological patterns precisely controlled on a centrifugal microfluidic platform’, 
Biofabrication. IOP Publishing, 9(4), p. 045006. doi: 10.1088/1758-5090/aa9472. 
Park, J. A. et al. (2017) ‘Freeform micropatterning of living cells into cell culture medium 





Parrish, J. et al. (2018) ‘A 96-well microplate bioreactor platform supporting individual dual 
perfusion and high-throughput assessment of simple or biofabricated 3D tissue models’, Lab 
on a Chip, 18(18), pp. 2757–2775. doi: 10.1039/c8lc00485d. 
Parsa, S. et al. (2010) ‘Effects of surfactant and gentle agitation on inkjet dispensing of living 
cells’, Biofabrication, 2(2), p. 025003. doi: 10.1088/1758-5082/2/2/025003. 
Pas, H. I. et al. (2017) ‘Stem cell injections in knee osteoarthritis: a systematic review of the 
literature’, British Journal of Sports Medicine, 51(15), pp. 1125–1133. doi: 10.1136/bjsports-
2016-096793. 
Paul, S. M. et al. (2010) ‘How to improve RD productivity: The pharmaceutical industry’s 
grand challenge’, Nature Reviews Drug Discovery, 9(3), pp. 203–214. doi: 10.1038/nrd3078. 
Pawlowski, N. E. and Childers, W. D. (2001) ‘Air purge apparatus for inkjet print cartridges’. 
European Patent Office. 
Pennock, R. et al. (2015) ‘Human cell dedifferentiation in mesenchymal condensates through 
controlled autophagy’, Scientific Reports, 5(1). doi: 10.1038/srep13113. 
Perelaer, J. et al. (2009) ‘The Spreading of Inkjet-Printed Droplets with Varying Polymer 
Molar Mass on a Dry Solid Substrate’, Macromolecular Chemistry and Physics, 210(6), pp. 
495–502. doi: 10.1002/macp.200800569. 
Pérez-García, S. et al. (2016) ‘Healthy and Osteoarthritic Synovial Fibroblasts Produce a 
Disintegrin and Metalloproteinase with Thrombospondin Motifs 4, 5, 7, and 12: Induction by 
IL-1β and Fibronectin and Contribution to Cartilage Damage’, The American Journal of 
Pathology, 186(9), pp. 2449–2461. doi: 10.1016/j.ajpath.2016.05.017. 
Pfeifer, C. R. et al. (2018) ‘Constricted migration increases DNA damage and independently 
represses cell cycle’, Molecular Biology of the Cell, 29(16), pp. 1948–1962. doi: 
10.1091/mbc.E18-02-0079. 
Phillippi, J. A. et al. (2008) ‘Microenvironments Engineered by Inkjet Bioprinting Spatially 
Direct Adult Stem Cells Toward Muscle- and Bone-Like Subpopulations’, Stem Cells, 26(1), 
pp. 127–134. doi: 10.1634/stemcells.2007-0520. 
Pierik, A. et al. (2008) ‘Quality control of inkjet technology for DNA microarray fabrication’, 




Pingguan-Murphy, B. and Nawi, I. (2012) ‘Upregulation of matrix synthesis in chondrocyte-
seeded agarose following sustained bi-axial cyclic loading’, Clinics, 67(8), pp. 939–944. doi: 
10.6061/clinics/2012(08)14. 
Pond, M. J. and Nuki, G. (1973) ‘Experimentally-induced osteoarthritis in the dog.’, Annals of 
the Rheumatic Diseases. BMJ Group, 32(4), pp. 387–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/4726075. 
Quent, V. M. C. et al. (2010) ‘Discrepancies between metabolic activity and DNA content as 
tool to assess cell proliferation in cancer research’, Journal of Cellular and Molecular 
Medicine, 14(4), pp. 1003–1013. doi: 10.1111/j.1582-4934.2010.01013.x. 
Rahmati, M., Mobasheri, A. and Mozafari, M. (2016) ‘Inflammatory mediators in 
osteoarthritis: A critical review of the state of the art, prospects, and future challenges.’, 
Bone, 85, pp. 81–90. doi: 10.1016/j.bone.2016.01.019. 
Ramirez, J. C. C. and Tumolva, T. P. (2018) ‘Analysis and optimization of water-based printing 
ink formulations for polyethylene films’, Applied Adhesion Science. Springer International 
Publishing, 6(1), pp. 1–21. doi: 10.1186/s40563-017-0102-z. 
Razban, A. and Davies, B. L. (1991) ‘An automated system for dispensing adhesives’, 
International Journal of Adhesion and Adhesives, 11(3), pp. 187–191. doi: 10.1016/0143-
7496(91)90022-A. 
Reis, N. and Derby, B. (2000) ‘Ink jet deposition of ceramic suspensions: Modelling and 
experiments of droplet formation’, Materials Research Society Symposium - Proceedings, 
624(January 2000), pp. 65–70. doi: 10.1557/PROC-625-117. 
Rengel, Y., Ospelt, C. and Gay, S. (2007) ‘Proteinases in the joint: Clinical relevance of 
proteinases in joint destruction’, Arthritis Research and Therapy, 9(5), pp. 1–10. doi: 
10.1186/ar2304. 
Restouin, A. et al. (2009) ‘A simplified, 96-well-adapted, ATP luminescence-based motility 
assay’, BioTechniques, 47(4), pp. 871–875. doi: 10.2144/000113250. 
Ribeiro, R. D. C. et al. (2017) ‘Temporary Single-Cell Coating for Bioprocessing with a Cationic 





Richardson, J. B. et al. (2017) ‘Efficacy and safety of autologous cell therapies for knee 
cartilage defects (autologous stem cells, chondrocytes or the two): Randomized controlled 
trial design’, Regenerative Medicine, 12(5), pp. 493–501. doi: 10.2217/rme-2017-0032. 
Riffle, S. et al. (2017) ‘Linking hypoxia, DNA damage and proliferation in multicellular tumor 
spheroids’, BMC Cancer, 17(1). doi: 10.1186/s12885-017-3319-0. 
Rigoglou, S. and Papavassiliou, A. G. (2013) ‘The NF-κB signalling pathway in osteoarthritis’, 
The International Journal of Biochemistry & Cell Biology, 45(11), pp. 2580–2584. doi: 
10.1016/j.biocel.2013.08.018. 
Rodríguez-Puente, S., Linacero-Blanco, J. and Guasch, A. (2013) ‘A simple and effective 
calibration method to determine the accuracy of liquid-handling nano-dispenser devices’, 
Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 
69(3), pp. 336–341. doi: 10.1107/S1744309113000791. 
Roger, M. et al. (2019) ‘Bioengineering the microanatomy of human skin’, Journal of 
Anatomy. doi: 10.1111/joa.12942. 
Roshanghias, A., Krivec, M. and Baumgart, M. (2017) ‘Sintering strategies for inkjet printed 
metallic traces in 3D printed electronics’, Flexible and Printed Electronics, 2(4). doi: 
10.1088/2058-8585/aa8ed8. 
Roth, E. A. et al. (2004) ‘Inkjet printing for high-throughput cell patterning’, Biomaterials, 
25(17), pp. 3707–3715. doi: 10.1016/j.biomaterials.2003.10.052. 
Russell, W. and Burch, R. (1959) The Principles of Humane Experimental Technique. London: 
Methuen. 
Sakamoto, J. et al. (2009) ‘Immobilization-Induced Cartilage Degeneration Mediated Through 
Expression of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and 
Chondromodulin-I’, Connective Tissue Research. Taylor & Francis, 50(1), pp. 37–45. doi: 
10.1080/03008200802412454. 
San Antonio, J. D. and Tuan, R. S. (1986) ‘Chondrogenesis of limb bud mesenchyme in vitro: 
Stimulation by cations’, Developmental Biology, 115(2), pp. 313–324. doi: 10.1016/0012-
1606(86)90252-6. 




piezoelectric drop-on-demand inkjet printing’, Biomaterials, 29(2), pp. 193–203. doi: 
10.1016/j.biomaterials.2007.09.032. 
Sawada, S. et al. (2016) ‘Establishment of mesenchymal stem cell lines derived from the 
bone marrow of green fluorescent protein-transgenic mice exhibiting a diversity in 
intracellular transforming growth factor-β and bone morphogenetic protein signaling’, 
Molecular Medicine Reports, 13(3), pp. 2023–2031. doi: 10.3892/mmr.2016.4794. 
Schnabel, M. et al. (2002) ‘Dedifferentiation-associated changes in morphology and gene 
expression in primary human articular chondrocytes in cell culture’, Osteoarthritis and 
Cartilage, 10, pp. 62–70. doi: 10.1053/joca.2001.0482. 
Secunda, R. et al. (2015) ‘Isolation, expansion and characterisation of mesenchymal stem 
cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a 
comparative study’, Cytotechnology. Springer, 67(5), pp. 793–807. doi: 10.1007/s10616-014-
9718-z. 
Shimizu, H., Yokoyama, S. and Asahara, H. (2007) ‘Growth and differentiation of the 
developing limb bud from the perspective of chondrogenesis’, Development Growth and 
Differentiation, 49(6), pp. 449–454. doi: 10.1111/j.1440-169X.2007.00945.x. 
Shin, K. et al. (2013) ‘The Efficacy of Diacerein in Hand Osteoarthritis: A Double-Blind, 
Randomized, Placebo-Controlled Study’, Clinical Therapeutics, 35(4), pp. 431–439. doi: 
10.1016/j.clinthera.2013.02.009. 
Shterev, I. D. et al. (2018) ‘Bayesian Multi-Plate High-Throughput Screening of Compounds’, 
Scientific Reports. Nature Publishing Group, 8(1), p. 9551. doi: 10.1038/s41598-018-27531-
w. 
Shun, T. Y. et al. (2011) ‘Identifying actives from HTS data sets: Practical approaches for the 
selection of an appropriate HTS data-processing method and quality control review’, Journal 
of Biomolecular Screening, 16(1), pp. 1–14. doi: 10.1177/1087057110389039. 
Sip, C. G., Bhattacharjee, N. and Folch, A. (2014) ‘Microfluidic transwell inserts for generation 
of tissue culture-friendly gradients in well plates’, Lab on a Chip, 14, pp. 302–314. doi: 
10.1039/c3lc51052b. 




engineered constructs’, Tissue Engineering, 10(9–10), pp. 1566–1576. doi: 
10.1089/ten.2004.10.1566. 
Smith, C. M. et al. (2007) ‘Characterizing environmental factors that impact the viability of 
tissue-engineered constructs fabricated by a direct-write bioassembly tool’, Tissue 
Engineering, 13(2), pp. 373–383. doi: 10.1089/ten.2006.0101. 
Smyrek, I. and Stelzer, E. H. K. (2017) ‘Quantitative three-dimensional evaluation of 
immunofluorescence staining for large whole mount spheroids with light sheet microscopy’, 
Biomedical Optics Express, 8(2), p. 484. doi: 10.1364/boe.8.000484. 
Solorio, L. D. et al. (2010) ‘Chondrogenic differentiation of human mesenchymal stem cell 
aggregates via controlled release of TGF-β1 from incorporated polymer microspheres’, 
Journal of Biomedical Materials Research - Part A. NIH Public Access, 92(3), pp. 1139–1144. 
doi: 10.1002/jbm.a.32440. 
Song, R. et al. (2007) ‘Aggrecan Degradation in Human Articular Cartilage Explants Is 
Mediated by Both ADAMTS-4 and ADAMTS-5’, Arthritis & Rheumatism, 56(2), pp. 575–585. 
doi: 10.1002/art.22334. 
Sophia Fox, A. J., Bedi, A. and Rodeo, S. A. (2009) ‘The basic science of articular cartilage: 
Structure, composition, and function’, Sports Health. SAGE Publications, 1(6), pp. 461–468. 
doi: 10.1177/1941738109350438. 
Staat, E.-J. (2016) Droplet dynamics during flight, impact and evaporation. University of 
Twente. doi: 10.3990/1.9789036540810. 
Stangegaard, M. et al. (2011) ‘A Simple method for validation and verification of pipettes 
mounted on automated liquid handlers’, Journal of Laboratory Automation, 16(5), pp. 381–
386. doi: 10.1016/j.jala.2009.06.004. 
Starkuviene, V. and Pepperkok, R. (2007) ‘The potential of high-content high-throughput 
microscopy in drug discovery’, British Journal of Pharmacology. Wiley-Blackwell, 152(1), pp. 
62–71. doi: 10.1038/sj.bjp.0707346. 
Stone, N. L., England, T. J. and O’Sullivan, S. E. (2019) ‘A Novel Transwell Blood Brain Barrier 





Stow, C. D. and Hadfield, M. G. (1981) ‘An Experimental Investigation of Fluid Flow Resulting 
from the Impact of a Water Drop with an Unyielding Dry Surface’, Proceedings of the Royal 
Society A: Mathematical, Physical and Engineering Sciences, 373(1755), pp. 419–441. doi: 
10.1098/rspa.1981.0002. 
Sturgess, C. et al. (2017) ‘3D reactive inkjet printing of polydimethylsiloxane’, Journal of 
Materials Chemistry C. The Royal Society of Chemistry, 5(37), pp. 9733–9743. doi: 
10.1039/C7TC02412F. 
Szymański, P., Markowicz, M. and Mikiciuk-Olasik, E. (2012) ‘Adaptation of high-throughput 
screening in drug discovery-toxicological screening tests.’, International journal of molecular 
sciences. Multidisciplinary Digital Publishing Institute  (MDPI), 13(1), pp. 427–52. doi: 
10.3390/ijms13010427. 
Tat, S. K. et al. (2011) ‘Strontium ranelate inhibits key factors affecting bone remodeling in 
human osteoarthritic subchondral bone osteoblasts’, Bone, 49(3), pp. 559–567. doi: 
10.1016/j.bone.2011.06.005. 
Taylor, P. B. et al. (2002) ‘A Standard Operating Procedure for Assessing Liquid Handler 
Performance in High-Throughput Screening’, Journal of Biomolecular Screening. SAGE 
Publications, 7(6), pp. 554–569. doi: 10.1177/1087057102238630. 
Teeple, E. et al. (2013) ‘Animal models of osteoarthritis: challenges of model selection and 
analysis.’, The AAPS journal. Springer, 15(2), pp. 438–46. doi: 10.1208/s12248-013-9454-x. 
Thakur, M. et al. (2012) ‘Characterisation of a Peripheral Neuropathic Component of the Rat 
Monoiodoacetate Model of Osteoarthritis’, PLoS ONE. Edited by M. L. Baccei. Public Library 
of Science, 7(3), p. e33730. doi: 10.1371/journal.pone.0033730. 
Thysen, S., Luyten, F. P. and Lories, R. J. U. (2015) ‘Targets, models and challenges in 
osteoarthritis research’, Disease Models and Mechanisms, 8(1), pp. 17–30. doi: 
10.1242/dmm.016881. 
Torsvik, A. et al. (2014) ‘U-251 revisited: genetic drift and phenotypic consequences of long-
term cultures of glioblastoma cells’, Cancer Medicine. John Wiley & Sons, Ltd, 3(4), pp. 812–
824. doi: 10.1002/cam4.219. 




for pre-clinical and clinical cell dose production’, Journal of Translational Medicine, 17(1), p. 
128. doi: 10.1186/s12967-019-1877-4. 
Trudel, G., Uhthoff, H. K. and Laneuville, O. (2005) ‘Prothrombin gene expression in articular 
cartilage with a putative role in cartilage degeneration secondary to joint immobility.’, The 
Journal of Rheumatology, 32(8). 
Tse, C. (2015) Utilising inkjet printing for tissue engineering. University of Sheffield. Available 
at: http://etheses.whiterose.ac.uk/13950/1/THESIS_THESIS10alpha.pdf. 
Tse, C. et al. (2016) ‘Inkjet printing Schwann cells and neuronal analogue NG108-15 cells’, 
Biofabrication. IOP Publishing, 8(1), p. 015017. doi: 10.1088/1758-5090/8/1/015017. 
Tung, Y. C. et al. (2011) ‘High-throughput 3D spheroid culture and drug testing using a 384 
hanging drop array’, Analyst, 136(3), pp. 473–478. doi: 10.1039/c0an00609b. 
Uzarski, J. S. et al. (2017) ‘Essential design considerations for the resazurin reduction assay to 
noninvasively quantify cell expansion within perfused extracellular matrix scaffolds’, 
Biomaterials, 129, pp. 163–175. doi: 10.1016/j.biomaterials.2017.02.015. 
Verma, P. and Dalal, K. (2011) ‘ADAMTS-4 and ADAMTS-5: Key enzymes in osteoarthritis’, 
Journal of Cellular Biochemistry. Wiley Subscription Services, Inc., A Wiley Company, 112(12), 
pp. 3507–3514. doi: 10.1002/jcb.23298. 
Vinaiphat, A., Charngkaew, K. and Thongboonkerd, V. (2018) ‘More complete polarization of 
renal tubular epithelial cells by artificial urine’, Cell Death Discovery. Nature Publishing 
Group, 4(1), p. 47. doi: 10.1038/s41420-018-0112-z. 
Vincent, T. L. et al. (2012) ‘Mapping pathogenesis of arthritis through small animal models’, 
Rheumatology (United Kingdom), 51(11), pp. 1931–1941. doi: 
10.1093/rheumatology/kes035. 
Vos, T. et al. (2012) ‘Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and 
injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.’, 
Lancet (London, England). Elsevier, 380(9859), pp. 2163–96. doi: 10.1016/S0140-
6736(12)61729-2. 
Walzl, A. et al. (2014) ‘The resazurin reduction assay can distinguish cytotoxic from cytostatic 




Publications Inc., 19(7), pp. 1047–1059. doi: 10.1177/1087057114532352. 
Wang, J. et al. (2019) ‘Combined Autologous Chondrocyte and Bone Marrow Mesenchymal 
Stromal Cell Implantation in the Knee: An 8-year Follow Up of Two First-In-Man Cases’, Cell 
Transplantation, 28(7), pp. 924–931. doi: 10.1177/0963689719845328. 
Wasan, D. T. and Papoutsakis, E. T. (1995) ‘Interfacial Properties of Cell Culture Media with 
Cell-Protecting Additives’, Biotechnology and Bioengineering, 47(4), pp. 420–430. 
Wheeler, J. S. R. et al. (2014) ‘Polymer degradation during continuous ink-jet printing’, 
Polymer Degradation and Stability, 105, pp. 116–121. doi: 
10.1016/j.polymdegradstab.2014.04.007. 
Wijshoff, H. (2018) ‘Drop dynamics in the inkjet printing process’, Current Opinion in Colloid 
& Interface Science. Elsevier, 36, pp. 20–27. doi: 10.1016/J.COCIS.2017.11.004. 
Wilson, J. L. et al. (2014) ‘Alginate encapsulation parameters influence the differentiation of 
microencapsulated embryonic stem cell aggregates’, Biotechnology and Bioengineering, 
111(3), pp. 618–631. doi: 10.1002/bit.25121. 
Wilson, W. C. and Boland, T. (2003) ‘Cell and organ printing 1: Protein and cell printers’, 
Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology, 
272(2), pp. 491–496. doi: 10.1002/ar.a.10057. 
Woo, K. et al. (2013) ‘Relationship between printability and rheological behavior of ink-jet 
conductive inks’, Ceramics International, 39(6), pp. 7015–7021. doi: 
10.1016/j.ceramint.2013.02.039. 
Woodward, W. a and Tuan, R. S. (1999) ‘N-Cadherin expression and signaling in limb 
mesenchymal chondrogenesis: stimulation by poly-L-lysine’, Developmental Genetics, 24(1–
2), pp. 178–187. doi: 10.1002/(SICI)1520-6408(1999)24:1/2<178::AID-DVG16>3.0.CO;2-M. 
Wu, C. H. and Hwang, W. S. (2015) ‘The effect of the echo-time of a bipolar pulse waveform 
on molten metallic droplet formation by squeeze mode piezoelectric inkjet printing’, 
Microelectronics Reliability. Elsevier Ltd, 55(3–4), pp. 630–636. doi: 
10.1016/j.microrel.2014.11.014. 
Wu, L. et al. (2011) ‘Trophic effects of mesenchymal stem cells increase chondrocyte 





Xia, Y. et al. (2019) ‘Rescue of DNA damage after constricted migration reveals a mechano-
regulated threshold for cell cycle’, The Journal of Cell Biology, 218(8), pp. 2545–2563. doi: 
10.1083/jcb.201811100. 
Xing, D. et al. (2018) ‘Mesenchymal stem cells injections for knee osteoarthritis: a systematic 
overview’, Rheumatology International, pp. 1399–1411. doi: 10.1007/s00296-017-3906-z. 
Xiong, W. et al. (2017) ‘Experimental investigation on the height deviation of bumps printed 
by solder jet technology’, Journal of Materials Processing Technology. Elsevier, 243, pp. 291–
298. doi: 10.1016/J.JMATPROTEC.2016.12.031. 
Xu, T. et al. (2005) ‘Inkjet printing of viable mammalian cells.’, Biomaterials, 26(1), pp. 93–9. 
doi: 10.1016/j.biomaterials.2004.04.011. 
Xu, T. et al. (2006) ‘Viability and electrophysiology of neural cell structures generated by the 
inkjet printing method’, Biomaterials, 27(19), pp. 3580–3588. doi: 
10.1016/j.biomaterials.2006.01.048. 
Yamaguchi, S. et al. (2012) ‘Cell patterning through inkjet printing of one cell per droplet’, 
Biofabrication. IOP Publishing, 4(4), p. 045005. doi: 10.1088/1758-5082/4/4/045005. 
Yang, Y.-H., Lee, A. J. and Barabino, G. A. (2012) ‘Coculture-Driven Mesenchymal Stem Cell-
Differentiated Articular Chondrocyte-Like Cells Support Neocartilage Development’, Stem 
Cells Translational Medicine. Wiley-Blackwell, 1(11), pp. 843–854. doi: 10.5966/sctm.2012-
0083. 
Yasuda, T. (2006) ‘Cartilage destruction by matrix degradation products’, Modern 
Rheumatology. Springer, 16(4), pp. 197–205. doi: 10.1007/s10165-006-0490-6. 
Yeung, P. et al. (2018) ‘A human osteoarthritis osteochondral organ culture model for 
cartilage tissue engineering’, Biomaterials. Elsevier, 162, pp. 1–21. doi: 
10.1016/j.biomaterials.2018.02.002. 
Yokoi, K. (2011) ‘Numerical studies of droplet splashing on a dry surface: Triggering a splash 
with the dynamic contact angle’, Soft Matter, 7(11), pp. 5120–5123. doi: 
10.1039/c1sm05336a. 




Airway Mucosa’, Scientific Reports. Nature Publishing Group, 7(1), p. 8182. doi: 
10.1038/s41598-017-08567-w. 
Yus, J. et al. (2019) ‘Semiconductor water-based inks: Miniaturized NiO pseudocapacitor 
electrodes by inkjet printing’, Journal of the European Ceramic Society. Elsevier, 39(9), pp. 
2908–2914. doi: 10.1016/J.JEURCERAMSOC.2019.03.020. 
Yusof, A. et al. (2011) ‘Inkjet-like printing of single-cells’, Lab on a Chip. The Royal Society of 
Chemistry, 11(14), pp. 2447–2454. doi: 10.1039/c1lc20176j. 
Zhang, S., Handa-Corrigan, A. and Spier, R. E. (1992) ‘Foaming and media surfactant effects 
on the cultivation of animal cells in stirred and sparged bioreactors’, Journal of 
Biotechnology, 25(3), pp. 289–306. doi: 10.1016/0168-1656(92)90162-3. 
Zhang, X. et al. (2017) ‘Coculture of mesenchymal stem cells and endothelial cells enhances 
host tissue integration and epidermis maturation through AKT activation in gelatin 
methacryloyl hydrogel-based skin model’, Acta Biomaterialia. Elsevier, 59, pp. 317–326. doi: 
10.1016/J.ACTBIO.2017.07.001. 
Zhang, Z. et al. (2012) ‘Quality control of cell-based high-throughput drug screening’, Acta 
Pharmaceutica Sinica B. Elsevier, 2(5), pp. 429–438. doi: 10.1016/J.APSB.2012.03.006. 
Zhou, S., Cui, Z. and Urban, J. P. G. (2008) ‘Nutrient gradients in engineered cartilage: 
Metabolic kinetics measurement and mass transfer modelings’, Biotechnology and 
Bioengineering, 101(2), pp. 408–421. doi: 10.1002/bit.21887. 
Zimmermann, R. et al. (2019) ‘High resolution bioprinting of multi-component hydrogels’, 





MTT Calibration Curves 














































Appendix Figure 1 – MTT assay calibration curve data for the MSC and chondrocyte cell 
lines demonstrating the signal linearity across a concentration range of 2,500 - 20,000 cells 




PrestoBlue® Calibration Curves 





































































Appendix Figure 2 – PrestoBlue® assay calibration curve data for the MSC and chondrocyte 
cell lines demonstrating the signal linearity across a concentration range from 50 to 




Indirect Immunofluorescence Staining Controls 
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Appendix Figure 3 – Negative MSC and chondrocyte controls of collagen II (COLII, green) 
and aggrecan (AGCN, red) indirect immunofluorescence staining within sectioned tissue. 
Samples were stained using the primary antibody diluent alone followed by secondary 
antibody incubation. Scale bar = 100 μm. 
